AACAP Official Action (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41(2) Suppl., 26S–49S.
Aarsland, D., Larsen, J. P., Cummins, J. L. & Laake, K. (1999). Prevalence and clinical correlates of psychotic symtoms in Parkinson disease: a community-based study. Archives of Neurology, 56, 595–601.
Abramowitz, J. S. (1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. Journal of Consulting and Clinical Psychology, 65, 44–52.
AD2000 Collaborative Group (2004). Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomized double-blind trial. The Lancet, 363, 2105–15.
Agras, W. S., Walsh, B. T., Fairburn, C. G., Wilson, G. T. & Kraemer, H. C. (2000). A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Archives of General Psychiatry, 57, 459–66.
Alexander, J. F. & Parsons, B. V. (1982). Functional Family Therapy. Monterey, CA: Brooks/Cole.
Alexander, C. N., Robinson, P. & Rainforth, M. (1994). Treating and preventing alcohol, nicotine, and drug abuse through Transcendental Meditation: a review and statistical meta-analysis. Alcoholism Treatment Quarterly, 11, 13–87.
Altshuler, L. L., Bauer, M., Frye, M. A. et al. (2001). Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. American Journal of Psychiatry, 158(10), 1617–22.
Aman, M. G., McDougle, C. J., Scahill, L. et al. (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1143–54.
American Academy of Child and Adolescent Psychiatry (1997a). Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 122S–39S.
American Academy of Child and Adolescent Psychiatry (1997b). Practice parameters for the assessment and treatment of children with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 36 (Suppl.), S4–S26.
American Academy of Child and Adolescent Psychiatry (1998a). Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37 (Suppl.), S27–S45.
American Academy of Child and Adolescent Psychiatry (1998b). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37 (Suppl.), S4–S26.
American Academy of Child and Adolescent Psychiatry (2004). Practice parameter for use of electroconvulsive therapy with adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1521–39.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn: DSM-IV. Washington, DC: American Psychiatric Association.
American Psychiatric Association (1997). Practice guideline for the treatment of patients with Alzheimer’s disease and other dementias of late life. American Journal of Psychiatry, 154 (Suppl.), 1–39.
American Psychiatric Association (1998). Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association. American Journal of Psychiatry, 155 (5 Suppl.), 1–34.
American Psychiatric Association (1999). Practice guideline for the treatment of patients with delirium. American Journal of Psychiatry, 156 (May Suppl.), 1–20.
American Psychiatric Association (2000). Practice guideline for the treatment of patients with eating disorders (revision). American Psychiatric Association Work Group on Eating Disorders. American Journal of Psychiatry, 157(1) Suppl., 1–39.
American Psychiatric Association (2002). Reactive Attachment Disorder: Position Statement. APA Document No. 200205. Washington, DC: The American Psychiatric Association.
American Psychiatric Association (2006). Practice Guidelines for the Treatment of Patients with Substance Use Disorders, 2nd edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association Practice Guidelines (2000). Practice guidelines for the treatment of patients with eating disorders (Revision). Supplement to The American Journal of Psychiatry, 151(1), 1–39.
American Society of Addiction Medicine (
2001).
ASAM Public Policy Statement. Retrieved 30 August, 2004, from the American Society of Addiction Medicine website:
http://www.asam.org/ppol/treatment.htm Anastopoulos, A. D., Shelton, T. L, DuPaul, G. J. & Guevremont, D. C. (1993). Parent training for attention-deficit hyperactivity disorder: its impact on parent functioning. Journal of Abnormal Child Psychology, 21, 581–95.
Ancoli-Israel, S., Martin, J. L., Gehrman, P. et al. (2003). Effect of light on agitation in institutionalized patients with severe Alzheimer disease. American Journal of Geriatric Psychiatry, 11, 194–203.
Anders, T. F. & Eiben, L. A. (1997). Pediatric sleep disorders: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 9–20.
Andersen, A. E. (1999). Using medical information psychotherapeutically. In: P. S. Mehler & A. E. Andersen, eds. Eating Disorders: A Guide to Medical Care and Complications. Baltimore: The Johns Hopkins University Press, pp. 192–201.
Andersen, G., Vestergaard, K. & Lauritzen, L. (1994). Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 25, 1099–104.
Anderson, D. (1981). Perspectives on Treatment: The Minnesota Experience. Center City, MN: Hazelden.
Anderson, I. M., Delvai, N. A., Ashim, B. et al. (2007). Adjunctive fast repetitive transcranial magnetic stimulation in depression. British Journal of Psychiatry, 190, 533–4.
Anderson, I. M., Nutt, D. J. & Deakin, J. F. (2000). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. Journal of Psychopharmacology, 14, 3–20.
Anderson, P., Chisholm, D. & Fuhr Dipl-Psych, D. C. (2009). Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. The Lancet, 373 (9682), 2234–46.
Andersson, G., Carlbring, P., Holmstrom, A. et al. (2006). Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial. Journal of Consulting and Clinical Psychology, 74, 677–86.
Andersson, G., Waara, J., Jonssonm, U., Malmaeus, F., Carlbreng, P. & Ost, L. G. (2009). Internet-based self-help versus one-session exposure in the treatment of spider phobia in randomized control trial. Cognitive and Behavioural Therapy, 39, 114–20.
Andresen, R., Oades, L. & Caputi, P. (2003). The experience of recovery from schizophrenia: towards an empirically validated stage model. Australian and New Zealand Journal of Psychiatry, 37, 586–94.
Andrews, D. G., O’Connor, P., Mulder, C., McLennan, J., Derham, H., Weigall, S. & Say, S. (1996). Computerised psychoeducation for patients with eating disorders. Australian and New Zealand Journal of Psychiatry, 30, 492–7.
Andrews, G. & Slade, T. (2006). Agoraphobia without a history of panic disorder may be part of the panic disorder syndrome. Journal of Nervous and Mental Disease, 190, 624–30.
Andrews, G., Cuijpers, P., Craske, M. G., McEvoy, P. & Titov, N. (2010). Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One, 5. pii: e13196.
Anton, R. F., Moak, D. H, Latham, P. et al. (2005). Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. Journal of Clinical Psychopharmacology, 25, 349–57.
Anton, R. F., O’Malley, S. O., Ciraulo, D. A. et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: a randomized controlled trial. Journal of the American Medical Association, 295, 2003–17.
Antonioli, C. & Reveley, M. A. (2005). Randomised controlled trial of animal facilitated therapy with dolphins in the treatment of depression. British Medical Journal, 331, 1231.
Apodaca, T. R. & Miller, W. R. (2003). A meta-analysis of the effectiveness of bibliotherapy for alcohol problems. Journal of Clinical Psychology, 59, 289–304.
Appolinario, J. C., Bacaltchuk, J., Sichieri, R. et al. (2003). A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Archives of General Psychiatry, 60(11), 1109–16.
Arbiter, E. A. & Black, D. (1991). Pica and iron-deficiency anaemia. Child: Care, Health and Development, 17, 231–34.
Armenteros, J. & Davies, M. (2006). Antipsychotics in early-onset schizophrenia: systematic review and meta-analysis. European Journal of Child and Adolescent Psychiatry, 15, 141–8.
Arnold, L. M., McElroy, S. L., Hudson, J. I., Welge, J. A., Bennett, A. J. & Keck, P. E. (2002). A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. Journal of Clinical Psychiatry, 63(11), 1028–33.
Aschenbrand, S. G., Kendall, P. C., Webb, A., Safford, S. M. & Flannery-Schroeder, E. (2003). Is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? A seven-year longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1478–85.
Ashton, C. H., Rawlins, M. D. & Tyrer, S. P. et al. (1990). A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. British Journal of Psychiatry, 157, 232–8.
Asplund, C. A., Aaronson, J. W. & Aaronson, H. E. (2004). 3 Regimens for alcohol withdrawal and detoxification. Journal Family Practice, 53, 545–54.
Atmaca, M., Kuloglu, M., Tezcan, E. et al. (2002). The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. International Journal of Impotence Research, 14(6), 502–5.
Australian Institute of Health and Welfare (2003). Alcohol and other drug treatment services in Australia: Findings from the National Minimum Data Set 2001–02. Vol. 16 Bulletin No. 10, AIHW cat. no. AUS 40. 2003. Canberra: Australian Institute of Health and Welfare.
Avery, D. H., Eder, D. N. & Bolte, M. A. et al. (2001). Dawn simulation and bright light in the treatment of SAD: a controlled study. Biological Psychiatry, 50(3), 205–16.
Babor, T. F. & Grant, M. (1992). Programme on Substance Abuse. Project on Identification and Management of Alcohol Related Problems. Report on Phase II: A Randomised Controlled Trial of Brief Interventions in Primary Health Care. Geneva: World Health Organisation.
Babor, T., Carroll, K. M., Christiansen, K. et al. (2004). Brief treatments for cannabis dependence: findings from a randomized multi-site trial. Journal of Consulting and Clinical Psychology, 72, 455–66.
Babyak, M., Blumenthal, J. A. & Herman, S. et al. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine, 62(5), 633–8.
Bacaltchuk, J. & Hay, P. (2003). Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database of Systematic Reviews, CD003391. Oxford: Update Software Ltd.
Baillargeon, L., Landreville, P., Verreault, R., Beauchemin, J. P., Gregoire, J. P. & Morin, C. M. (2003). Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. Canadian Medical Association Journal, 169, 1015–20.
Baille, A., Mattick, R. P., Hall, W. & Webster, P. (1994). Meta-analytic review of the efficacy of smoking cessation interventions. Drug and Alcohol Review, 13, 157–70.
Baker, A., Boggs, T. G. & Lewin, T. J. (2001). Randomized controlled brief cognitive-behavioural interventions among regular users of amphetamine. Addiction, 96, 1279–87.
Baker, D. G., Diamond, B. I., Gillette, G. et al. (1995). A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl), 122, 386–9.
Bakermans-Kranenburg, M. J., van IJzendoorn, M. H. & Juffer, F. (2003). Less is more: Meta-analysis of sensitivity and attachment interventions in early childhood. Psychological Bulletin, 129, 195–215.
Bakker, A., van Balkom, A. J. & Spinhoven, P. (2002). SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatrica Scandinavica, 106(3), 163–7.
Baldwin, D. S., Anderson, I. M., Nutt, D. J. et al. (2005). Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 19, 567–96.
Baldwin, D. S., Huusom, A. K. & Maehlum, E. (2006). Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study. British Journal of Psychiatry, 189, 264–72.
Ballard, C. G., Thomas, A., Fossey, J. et al. (2004). A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. Journal of Clinical Psychiatry, 65, 114–19.
Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y. et al. (2001). Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. Journal of Clinical Psychiatry, 62 (Suppl. 11), 53–8.
Ballesteros, J. & Callado, L. F. (2004). Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomized controlled trials. Journal of Affective Disorders, 79(1–3), 137–47.
Bancroft, J. (1989). Human Sexuality and its Problems. Edinburgh: Churchill Livingstone, pp. 128–13.
Bank, L., Marlowe, J. H., Reid, J. B., Patterson, G. R & Weinrott, M. R. (1991). A comparative evaluation of parent training interventions for families of chronic delinquents. Journal of Abnormal Child Psychology, 19, 15–33.
Barbaric, N. C., McConaha, C. W., Halmi, K. A. et al. (2004). Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa. International Journal of Eating Disorders, 35(1), 10–15.
Barber, J. G. & Gilbertson, R. (1997). Unilateral interventions for women living with heavy drinkers. Social Work, 42, 69–78.
Barbini, B., Colombo, C., Benedetti, F., Campori, E., Bellodi, L. & Smeraldi, E. (1998). The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Research, 79(1), 43–50.
Barkley, R. A. & Cunningham, C. E. (1979). The effects of methylphenidate on the mother–child interactions of hyperactive children. Archives of General Psychiatry, 36, 201–8.
Barlow, D. H., Gorman, J. M., Shear, M. K. & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. Journal of the American Medical Association, 283(19), 2529–36.
Barnard, K. E., Magyary, D., Sumner, G., Booth, C. L., Mitchell, S. K. & Spieker, S. (1988). Prevention of parenting alterations for women with low social support. Psychiatry, 51, 248–53.
Barnett, S. D., Kramer, M. L., Casat, C. D., Connor, K. M. & Davidson, J. R. (2002). Efficacy of olanzapine in social anxiety disorder: a pilot study. Journal of Psychopharmacology, 16, 365–8.
Barrett, P. M., Dadds, M. R. & Rapee, R. M. (1996a). Family treatment of childhood anxiety: a controlled trial. Journal of Consulting and Clinical Psychology, 64, 333–42.
Barrett, P. M., Dadds, M. R. & Rapee, R. M. (1996b). Family management of childhood anxiety: a controlled trial. Journal of Consulting and Clinical Psychology, 65, 366–80.
Barrett, P., Healy-Farrell, L. & March, J. (2004). Cognitive-behavioural family treatment of childhood obsessive-compulsive disorder: a controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 46–62.
Barrows, K. A. & Jacobs, B. P. (2002). Mind-body medicine, an introduction & review of the literature. Medical Clinics of North America, 86, 11–31.
Barsky, A. J. & Ahern, D. K. (2004). Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. Journal of the American Medical Association, 291, 1464–70.
Bashir, K., King, M. & Ashworth, M. (1994). Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. British Journal of General Practice, 44, 408–12.
Basson, R. (2001). Female sexual response: the role of drugs in the management of sexual dysfunction. American College of Obstetricians and Gynecologists, 98, 350–3.
Bastian, H., Glasziou, P. & Chalmers, I. (2010). Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?PLoS Medicine, 7, e1000326.
Bateman, A. & Fonagy, P. (1999). The effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomised controlled trial. American Journal of Psychiatry, 156, 1563–9.
Bateman, A. & Fonagy, P. (2000) Effectiveness of psychotherapeutic treatment of personality disorder. British Journal of Psychiatry, 177, 138–43.
Bateman, A. & Fonagy, P. (2009). Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. American Journal of Psychiatry, 166, 1355–64.
Bauer, M. & Dopfmer, S. (1999). Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. Journal of Clinical Psychopharmacology, 19(5), 427–34.
Baumann, P., Nil, R. et al. (1996). A double-blind, placebo-controlled trial of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. Journal of Clinical Psychopharmacology, 16(4), 307–14.
Baxter, L. R., Jr., Liston, E. H. & Schwartz, J. M. et al. (1986). Prolongation of the antidepressant response to partial sleep deprivation by lithium. Psychiatry Research 19(1), 17–23.
Bayard, M., McIntyre, J., Hill, K. R. & Woodside, J., Jr. (2004). Alcohol withdrawal syndrome. American Family Physician, 69, 1443–50.
Beauchemin, K. M. & Hays, P. (1997). Phototherapy is a useful adjunct in the treatment of depressed inpatients. Acta Psychiatrica Scandinavica, 95(5), 424–7.
Beck, A. T. (2006). How an anomalous finding led to a new system of psychotherapy. Nature Medicine, 12, 1139–41.
Beckwith, L. (1988). Intervention with disadvantaged parents of sick preterm infants. Psychiatry, 51, 242–7.
Beidel, D. C., Turner, S. M. & Morris, T. L. (2000). Behavioural treatment of childhood social phobia. Journal of Consulting Clinical Psychology, 68, 1072–80.
Bellack, A. & DiClemente, C. (1999). Treating substance abuse among patients with schizophrenia. Psychiatric Services, 50, 75–80.
Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H. & Yang, Y. (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63, 426–32.
Benedetti, F., Barbini, B., Lucca, A., Campori, E., Colombo, C. & Smeraldi, E. (1997). Sleep deprivation hastens the antidepressant action of fluoxetine. European Archives of Psychiatry and Clinical Neuroscience, 247(2), 100–3.
Benedetti, F., Colombo, C., Barbini, B., Campori, E. & Smeraldi, E. (1999). Ongoing lithium treatment prevents relapse after total sleep deprivation. Journal of Clinical Psychopharmacology, 19(3), 240–5.
Benedetti, F., Colombo, C., Barbini, B., Campori, E. & Smeraldi, E. (2001). Morning sunlight reduces length of hospitalization in bipolar depression. Journal of Affective Disorders, 62(3), 221–3.
Benoit, D. & Coolbear, J. (1998). Post-traumatic feeding disorders in infancy: behavioral predicting treatment outcome. Infant Mental Health Journal, 19, 409–91.
Benson, H. & Klipper, M. Z. (2000). The Relaxation Response. New York: Harper Collins.
Berger, W., Mendlowicz, M. V., Marques-Portella, C. et al. (2009). Pharmacologic alternatives to antidepressants in post-traumatic stress disorder: a systematic review. Progress in Neuropsychopharmacology & Biological Psychiatry, 17, 169–80.
Bergeron, R., Ravindran, A. V., Chaput, Y. et al. (2002). Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study. Journal of Clinical Psychopharmacology, 22, 148–54.
Bergh, C., Brodin, U., Lindberg, G. & Södersten, P. (2002). Randomized controlled trial of a treatment for anorexia and bulimia nervosa. Proceedings of the National Academy of Sciences, 99(14), 9486–91.
Bernstein, G. A., Hektner, J. M., Borchardt, C. M. & McMillan, M. H. (2001). Treatment of school refusal: one-year follow-up. Journal of Child and Adolescent Psychiatry, 40, 206–13.
Bernstein, I. C. (1964). Anorexia nervosa treated successfully with electroshock therapy and subsequently followed by pregnancy. American Journal of Psychiatry, 120, 1021–5.
Beumont, P. J. V., Russell, J. D. & Touyz, S. (1993). Treatment of anorexia nervosa. Lancet 341, 1635–40.
Beumont, P. J., Arthur, B., Russel, J. D. & Touyz, S. W. & Stephen, W. (1994). Excessive physical activity in dieting disorder patients: proposals for a supervised exercise program. International Journal of Eating Disorders, 20(2), 211–13.
Beumont, P., Hay, P. & Beumont, D. (2004). Australian and New Zealand clinical practice guidelines for the treatment of anorexia nervosa. Australia and New Zealand Journal of Psychiatry, 38(9), 659–70.
Bickman, L. (1996). A continuum of care: more is not always better. American Psychologist, 51, 698–701.
Biederman, J. Newcorn, J. & Sprich, S. (1991). Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. American Journal of Psychiatry, 148, 564–77.
Bienvenu, O., Onyike, C. & Stein, M. et al. (2006). Agoraphobia in adults: incidence and longitudinal relationship with panic. British Journal of Psychiatry, 188, 432–8.
Birks, J. & Flicker, L. (2003). Selegiline for Alzheimer’s disease. Cochrane Database of Systematic Reviews, 1.
Birks, J., Grimley Evans, J. Iakovidou, V. & Tsolaki, M. (2000). Rivastigmine for Alzheimer’s disease. Cochrane Database of Systematic Reviews, 4.
Birks, J., Grimley, E. V. & Van Dongen, M. (2002). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, 4, CD00312.
Birmaher, B., Brent, D. A. & Benson, R. S. (1998). Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of American Academy of Child and Adolescent Psychiatry, 37, 1234–8.
Birmaher, B., Brent, D. A., Kolko, D. et al. (2000). Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Archives of General Psychiatry, 57, 29–36.
Birmaher, B., Axelson, D. A., Monk, K. et al. (2003). Fluoxetine for treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 415–23.
Birmingham, C. L., Guitierrez, E., Jonat, L. & Beumont, P. (2004). Randomized controlled trial of warming in anorexia nervosa. International Journal of Eating Disorders, 35(2), 234–8.
Bissada, H., Tasca, G. A., Barber, A. M. & Bradwin, J. (2008). Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind placebo-controlled trial. American Journal of Psychiatry, 165, 1281–8.
Bisson, J. I., Tavakoly, B., Witteveen, A. B. et al. (2010). TENTS guidelines: development of post-disaster psychosocial care guidelines through a Delphi process. British Journal of Psychiatry, 196, 69–74.
Black, B. & Uhde, T. W. (1994). Treatment of elective mutism with Fluoxetine: a double-blind placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1000–6.
Black,. L.Cullen,. C, Dicken,. P. & TurnbullJ. (1998). Anger control. British Journal of Hospital Medicine, 39, 325–9.
Black, M. M., Dubowitz, H., Hutcheson, J., Berenson-Howard, J. & Starr, R. H. (1995). A randomized clinical trial of home intervention for children with failure to thrive. Pediatrics, 95, 807–14.
Blagg, N. R. & Yule, W. (1984). The behavioural treatment of school refusal. Behavioural Research Therapy, 22, 119–27.
Blanchard, R. (1993). Varieties of autogynephilia and their relationship to gender dysphoria. Archives of Sexual Behavior, 22(3), 241–51.
Blanchard, R. & Steiner, B. W. (eds) (1990). Clinical Management of Gender Identity Disorders in Children and Adults. Washington DC: American Psychiatric Press.
Blanchard, R., Clemmensen, L. H. & Steiner, B. W. (1983). Gender reorientation and psychosocial adjustment in male-to-female transsexuals. Archives of Sexual Behavior, 12(6), 503–9.
Blanchard, R., Steiner, B. W., Clemmensen, L. H. & Dickey, R. (1989). Prediction of regrets in postoperative transsexuals. Canadian Journal of Psychiatry, 34, 43–5.
Blanco, C., Heimberg, R. G., Schneier, F. R. et al. (2010). A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Archives of General Psychiatry, 67, 286–95.
Blanco, C., Schneier, F. R., Schmidt, A. et al. (2003). Pharmacological treatment of social anxiety disorder: a meta-analysis. Depression and Anxiety, 18, 29–40.
Blondal, T., Franzon, M. & Westin, A. (1997). A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. European Respiratory Journal, 10, 1585–90.
Bloomquist, M. L. & Schnell, S. V. (2002). Helping Children with Aggression and Conduct Problems. New York: Guilford.
Blouin, A. G., Blouin, J. H. et al. (1996). Light therapy in bulimia nervosa: a double-blind, placebo-controlled study. Psychiatry Research, 60(1), 1–9.
Blum, N., St. John, D., Stuart, S. et al. (2008). Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. American Journal of Psychiatry, 165, 468–478.
Blumenthal, J. A., Babyak, M. A., Moore, K. A. et al. (1999). Effects of exercise training on older patients with major depression. Archives of Internal Medicine, 159(19), 2349–56.
Bodlund, O. & Kullgren, G. (1996). Transsexualism: general outcome and prognostic factors: a five-year follow-up study of nineteen transsexuals in the process of changing sex. Archives of Sexual Behavior, 25, 303–16.
Bolliger, C. T., Zellweger, J. P., Danielsson, T.et al. (2000). Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. British Medical Journal, 321, 329–33.
Bondy, A. & Frost, L. (1996). Educational approaches in pre-school: behavior techniques in a public school setting. In: E. Schopler & G. B. Mesibov, eds. Learning and Cognition in Autism, Current Issues in Autism. New York: Plenum Press.
Bora, R., Leaning, S., Moores, A. & Roberts, G. (2010). Life coaching for mental health recovery: the emerging practice of recovery coaching. Advances in Psychiatric Treatment, 16, 459–67.
Borduin, C. M., Mann, B. J., Cone, L. T. et al. (1995). Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence. Journal of Consulting and Clinical Psychology, 63, 569–78.
Bornovalova, M. A. & Daughters, S. B. (2007). How does Dialectical Behavior Therapy facilitate treatment retention among individuals with comorbid borderline personality disorder and substance use disorders?Clinical Psychology Review, 27, 923–43.
Bouza, C., Angeles, M., Munoz, A. & Amate, J. M. (2004). Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction, 99, 811–28.
Bowden-Jones, O., Iqbal, M. Z., Tyrer, P. et al. (2004). Prevalence of personality disorder in alcohol and drug services and associated co-morbidity. Addiction, 99, 1306–14.
Bowen, S., Witkiewitz, K., Dillworth, T. M. et al. (2006). Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors, 20, 343–7.
Bower, P. & Gilbody, S. (2005). Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. British Journal of Psychiatry, 186, 11–7.
Bradwejn, J., Ahokas, A., Stein, D. J., Salinas, E., Emilien, G., Whitaker, T. (2005). Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. British Journal of Psychiatry, 187, 352–9.
Brady, K. T. & Sonne, S. C. (1999). The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Research & Health, 23 (4), 263–71.
Brady, K., Pearlstein, T., Asnis, G. M. et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Journal of the American Medical Association, 283, 1837–44.
Braun, D. L., Sunday, S. R., Fornari, V. M. & Halmi, K. A. (1999). Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study. Comprehensive Psychiatry, 40(6), 442–8.
Breitbart, W., Marotta, R., Platt, M. et al., (1996). A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry, 153, 231–7.
Brent, D. A., Holder, D., Kolko, D. et al. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54, 877–85.
Brent, D. A., Kolko, D., Birmaher, B.et al. (1998). Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 906–14.
Brent, D., Emslie, G., Clark, G. et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. Journal of the American Medical Association, 299, 901–13.
Brestan, E. V. & Eyberg, S. M. (1998). Effective psychosocial treatments of conduct-disordered children and adolescents: 29 years, 82 studies, and 5272 kids. Journal of Clinical Child Psychology, 27, 180–9.
Brewer, J. A., Sinha, R., Chen, J. A. et al. (2009). Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Substance Abuse, 30, 306–17.
Bridge, J., Iyenar, S., Salary, C. et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297, 1583–96.
Britton, A. & Russell, R. (2004). Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment. Cochrane Database of Systematic Reviews, 2, CD000395.
Brodaty, H., Ames, D. & Snowdon, J. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134–43.
Bronskill, S. E., Anderson, G. M., Sykora, K. et al. (2004). Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. Journal of the American Geriatric Society, 52, 749–55.
Browder, D. M., Bambara, L. M. & Belfiore, P. J. (1997). Using a person-centred approach in community-based institutions for adults with developmental disabilities. Journal of Behavioral Education, 7, 519–28.
Brown, G. W., Birley, J. L. & Wing, J. (1972). Influence of family life on the course of schizophrenic disorders: a replication. British Journal of Psychiatry, 121, 241–58.
Brown, S. & Yalom, I. D. (1977). Interactional group therapy with alcoholics. Journal of Studies on Alcoholism, 38, 426–56.
Brownley, K. A., Berkman, N. D., Sedway, J. A., Lohr, K. N. & Bulik., C. M. (2007). Binge eating disorder treatment: a systematic review of randomized controlled trials. International Journal of Eating Disorders, 40, 337–48.
Bruce, S. E., Vasile, R. G., Goisman, R. M. et al. (2003). Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?American Journal of Psychiatry, 160(8), 1432–8.
Bryant, R. A., Mastrodomenico, J., Felmingham, K. L. et al. (2008). Treatment of acute stress disorder: a randomized controlled trial. Archives of General Psychiatry, 65, 659–67.
Bryant-Waugh, R., Markham, L., Kreipe, R. E. & Walsh, B. T. (2010). Feeding and eating disorders in childhood. The International Journal of Eating Disorders, 43(2), 98–111.
Brylewski, J. & Duggan, L. (2004). Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database of Systematic Reviews, 3, CD000377.
Budd, S. & Brown, W. (1974). Effect of reorientation technique on postcardiotomy delirium. Nursing Research, 23, 341–8.
Budney, A. J. & Higgins, S. T. (1998). A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. Rockville, MD: NIDA.
Budney, A. J. & Moore, B. A. (2002). Development and consequences of cannabis dependence. Journal of Clinical Pharmacology, 42, 28S–33S.
Budney, A. J., Radonovich, K. J., Higgins, S. T. & Wong, C. J. (1998). Adults seeking treatment for marijuana dependence: a comparison to cocaine-dependent treatment seekers. Experimental and Clinical Psychopharmacology, 6, 419–26.
Budney, A. J., Higgins, S. T., Radonovich, K. J. & Novy, P. L. (2000). Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology, 68, 1051–61.
Budney, A. J., Moore, B. A. & Vandrey, R. (2003). Health consequences of marijuana use. In: J. Brick, ed. Medical Consequences of Drug Abuse. London: Haworth Press, pp. 171–218.
Budney, A. J., Hughes, J. R., Moore, B. A. & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967–77.
Budney, A. J., Moore, B. A., Rocha, H. & Higgins, S. T. (2006). Voucher-based incentives and behavior therapy for adult marijuana dependence. Journal of Consulting and Clinical Psychology, 74, 307–16.
Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A. & Bahrenburg, B. (2007). Oral delta-9-tetrahydrocannabinol suppresses withdrawal symptoms. Drug and Alcohol Dependence, 86, 22–9.
Buitelaar, J. K., Van der Gaag, R. J., Cohen-Kettenis, P. & Melman, C. T. M. (2001). A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. Journal of Clinical Psychiatry, 62, 239–48.
Bullock, M. L., Kiresuk, T. J., Sherman, R. E. et al. (2002). A large randomized placebo controlled study of auricular acupuncture for alcohol dependence. Journal of Substance Abuse Treatment, 22, 71–7.
Burke, B. L., Arkowitz, H. & Menchola, M. (2003) The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. Journal of Consulting & Clinical Psychology, 71, 843–61.
Burns, B. J., Farmer, E. M. Z., Angold, A., Costello, E. J. & Behar, L. (1996). A randomized trial of case management for youths with serious emotional disturbance. Journal of Clinical Child Psychology, 25, 476–86.
Busato, W. & Galindo, C. C. (2004). Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU International, 93, 1018–21.
Butler, A. C., Chapman, J. E., Forman, E. M. & Beck, A. T. et al. (2006). The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clinical Psychology Review, 26, 17–31.
Butler, G., Fennell, M., Robson, P. & Gelder, M. (1991). Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 59, 167–75.
Bxarone, P., Poewe, W., Albrecht, S. et al. (2010). Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurology, 9, 573–80.
Byford, S., Barrett, B., Roberts, C. et al. (2007). Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents. British Journal of Psychiatry, 191, 436–40.
Bystritsky, A., Ackerman, D. L., Rosen, R. M. et al. (2004). Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. Journal of Clinical Psychiatry, 65, 565–8.
Cachelin, F. M., Striegel-Moore, R. H., Elder, K. A., Pike, K. M., Wilfley, D. E. & Fairburn, C. G. (1999). Natural course of a community sample of women with binge eating disorder. International Journal of Eating Disorders, 25, 45–54.
Caligiuri, M. R., Jeste, D. V. & Lacro, J. P. (2000). Antipsychotic-induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs Aging, 17, 363–84.
Candy, J., Cawley, R. H., Balfour, F. H. G. et al. (1972). Feasibility study for a controlled trial of formal psychotherapy. Psychological Medicine, 2, 345–8.
Carlbring, P., Nilsson-Ihrfelt, E., Waara, J. et al. (2005). Treatment of panic disorder: live therapy vs. self-help via the Internet. Behavior Research Therapy, 43(10), 1321–33.
Carlson, C. L., Pelham, W. E., Milich, R. & Dixon, J. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention-deficit hyperactivity disorder. Journal of Abnormal Child Psychology, 20, 213–32.
Carlson, L. E., Speca, M., Patel, K. D. & Goodey, E. (2004). Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology, 29, 448–74.
Carnwath, T. & Hardman, J. (1998). Randomised double-blind comparison of lofexdine and clonidine in the out-patient treatment of opiate withdrawal. Drug and Alcohol Dependence, 50, 251–4.
Caro, J., Getsios, D., Migliaccio-Walle, K., Ishak, J., El-Hadi, W. & the AHEAD Study Group (2003). Rational choice of cholinesterase inhibitor for the treatment of Alzheimer’s disease in Canada: a comparative economic analysis. BioMed Central Geriatrics, 3(1), 6.
Carpenter, L. L., Yasmin, S. & Price, L. H. (2002). A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biological Psychiatry, 51, 183–8.
Carr, A. (2004). The Easy Way to Stop Smoking. New York: Sterling.
Carrey, N., Mendella, P., McMaster, F. et al. (2002). Developmental psychopharmacology. In: S. Kutcher, ed. Practical Child and Adolescent Psychopharmacology. Cambridge: Cambridge University Press.
Carroll, K. C. (2000). Science-based therapies for drug dependence. The Economics of Neuroscience, 2, 41–7.
Carroll, K. M. (1997). Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. Journal of Addictive Behaviors, 22, 233–45.
Carroll, K. M. (1998). A Cognitive-Behavioural Approach: Treating Cocaine Addiction. Rockville, MD: National Institute on Drug Abuse.
Carroll, K. M., Ball, S. A., Nich, C. et al. (2001). Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Archives of General Psychiatry, 58(8), 755–61.
Carroll, K. M., Rounsaville, B. & Keller, D. (1991). Relapse prevention strategies for the treatment of cocaine abuse. American Journal of Drug and Alcohol Abuse, 17, 249–65.
Carroll, K. M., Nich, C., Ball, S. A., McCance, E. & Rounsaville, B. J. (1998). Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction, 93, 713–27.
Carroll, K. M., Fenton, L. R., Ball, S. A. et al. (2004). Efficacy of disulfiram and cognitive behavior therapy in a cocaine-dependent outpatient: a randomised placebo-controlled trial. Archives of General Psychiatry, 61, 264–72.
Carroll, K. M., Easton, C. J., Nich, C. et al. (2006). The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. Journal of Consulting & Clinical Psychology, 74, 955–66.
Carson, C. C., Rajfer, J., Eardley, I. et al. (2004). The efficacy and safety of Tadalafil: an update. BJU International, 93, 1276–81.
Caruso, S., Agnello, C., Intelisano, G., Farina, M., Di Mari, L. & Cianci, A. (2004). Placebo-controlled study of the efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology, 2004, 63, 955–9.
Casacalenda, N. & Boulenger, J. P. (1998). Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications. Canadian Journal of Psychiatry, 43, 722–30.
Casey, P. (2009). Adjustment disorder: epidemiology, diagnosis and treatment. CNS Drugs, 23, 927–38.
Casey, P. R., Tyrer, P. & Platt, S. (1985). The relationship between social functioning and psychiatric symptomatology in primary care. Social Psychiatry, 20, 5–9.
Casey, R. J. & Berman, J. S. (1985). The outcome of psychotherapy with children. Psychological Bulletin, 98, 388–400.
Casey, S. D., Perrin, C. J., Lesser, A. D., Perrin, S. H., Casey, C. L. & Reed, G. K. (2009). Using descriptive assessment in the treatment of bite acceptance and food refusal. Behavior Modification, 33(5), 537–58.
Chakos, M., Lieberman, J., Hoffman, E., Bradford, D. & Sheitman, B. (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. American Journal of Psychiatry, 158, 518–26.
Chamberlain, P. & Reid, J. B. (1998) Comparison of two community alternatives to incarceration for chronic juvenile offenders. Journal of Consulting and Clinical Psychology, 66, 624–33.
Chamberlain, P. & Rosicky, J. G. (1995). The effectiveness of family therapy in the treatment of adolescents with conduct disorders and delinquency. Journal of Marital and Family Therapy, 21, 441–59.
Chamberlain, P. (1990). Comparative evaluation of specialized foster-care for seriously delinquent youths: a first step. Community Alternatives: International Journal of Family Care, 2, 21–36.
Chamberlain, P. (2003). Treating Chronic Juvenile Offenders: Advances Made Through the Oregon Multidimensional Treatment Foster Care Model. Washington, DC: American Psychological Association.
Chan, A. W. (1985). Alcoholism and epilepsy. Epilepsia, 26, 323–33.
Chanen, A. M., Jackson, H. J., McCutcheon, L. K. et al. (2008). Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. British Journal of Psychiatry, 193, 477–84.
Channon, S., de Silva, P., Hemsley, D. & Perkins, R. (1989). A controlled trial of cognitive-behavioural and behavioural treatment of anorexia nervosa. Behaviour Research and Therapy, 27, 529–35.
Chanpattana, W., Chakrabhand, M. L., Sackeim, H. A. et al. (1999). Continuation ECT in treatment-resistant schizophrenia: a controlled study. Journal of ECT, 15, 178–92.
Chatham, M. A. (1978). The effect of family involvement on patients’ manifestations of postcardiotomy psychosis. Heart & Lung, 7, 995–9.
Chatoor, I. (2002). Feeding disorders in infants and toddlers: diagnosis and treatment. Child & Adolescent Psychiatric Clinics of North America, 11, 163–83.
Chatoor, I. (2003). Food refusal by infants and young children: diagnosis and treatment. Child and Adolescent Psychiatry Clinics of North America, 11, 163–83.
Chavira, D. A. & Stein, M. B. (2002). Phenomenology of social phobia. In: D. J. Stein & E. Hollander, eds. The American Psychiatric Publishing Textbook of Anxiety Disorders. Washington, DC: American Psychiatric Publishing, Inc., pp. 289–300.
Chesley, E. B. & Kreipe, R. E. (2003). Anorexia nervosa and the internet. Eating Disorder Review, July/August.
Chial, H. J., Camilleri, M., Williams, D. E., Litzinger, K. & Perrault, J. (2003). Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics, 111, 158–62.
Chick, J., Howlett, H., Morgan, M. Y. & Ritson, B. (2000). United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism, 35, 176–87.
Childress, A. R., Hole, A. V., Ehrman, R. N., Robbins, S. J., McLellan, A. T. & O’Brien, C. P. (1993). Cue reactivity and cue reactivity interventions in drug dependence. In: L. S. Onken, J. D. Blaine & J. J. Boren, eds. Behavioural Treatments for Drug Abuse and Dependence, pp. 73–95. Rockville, MD: National Institute on Drug Abuse.
Christie, D. (2007). Cognitive behavioural approaches. In: B. Lask & R. Bryant-Waugh, eds. Anorexia Nervosa and Related Eating Disorders in Childhood and Adolescence, 3rd edn. Hove, East Sussex: Psychology Press/Taylor and Francis Group, pp. 229–55.
Chung, M. Y., Min, K. H., Jun, Y. J. et al. (2004). Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Human Psychopharmacology, 19, 489–94.
Cicchetti, D., Toth, S. L. & Rogosch, F. A. (1999). The efficacy of toddler–parent psychotherapy to increase attachment security in off-spring of depressed mothers. Attachment and Human Development, 1, 34–66.
Cicchetti, D., Rogosch, F. A. & Toth, S. L. (2006). Fostering secure attachment in infants in maltreating families through preventive interventions. Development and Psychopathology, 18, 623–49.
Cipriani, A., Furukawa, T. A., Salanti, G. et al. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746–58.
Clare, L., Woods, R. T., Moniz Cook, E. D., Orrell, M. & Spector, A. (2003). Cognitive rehabilitation and cognitive training for early-stage Alzheimer’s disease and vascular dementia. Cochrane Database of Systematic Reviews, 4, CD003260.
Clark, A. (2004). Incidences of new prescribing by British child and adolescent psychiatrists: a prospective study over 12 months. Journal of Psychopharmacology, 18, 115–20.
Clark, D. M., Salkovskis, P. M., Hackmann, A., Wells, A., Ludgate, J. & Gelder, M. (1999). Brief cognitive therapy for panic disorder: a randomised controlled trial. Journal of Consulting & Clinical Psychology, 67, 583–9.
Clark, D. M., Ehlers, A., McManus, F. et al. (2003). Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. Journal of Consulting and Clinical Psychology, 71, 1058–67.
Clarke, G. N., Hawkins, W., Murphy, M. et al. (1995). Targeted prevention of unipolar depressive disorder in an at risk sample of high school adolescents: a randomized trial of a group cognitive interview. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 312–21.
Clarke, G. N., Rohde, P., Lewinsohn, P. M., Hops, H. & Seeley, J. R. (1999). Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. Journal of American Academy of Child and Adolescent Psychiatry, 38, 272–9.
Clarkin, J. F., Levy, K. N., Lenzenweger, M. F. & Kernberg, O. F. (2007). Evaluating three treatments for borderline personality disorder: a multiwave study. American Journal of Psychiatry, 164, 922–8.
Claudino, A. M., Hay, P., Lima, M. S., Bacaltchuk, J., Schmidt, U. & Treasure, J. (2006). Antidepressants for anorexia nervosa. Cochrane Database of Systematic Reviews, 1, CD004365.
Clausen, J. M., Landsverk, J., Ganger, W., Chadwick, D. & Litrownik, A. (1998). Mental health problems of children in foster care. Journal of Child & Family Studies, 7, 283–96.
Cloitre, M., Cohen, L. R., Koenen, K. C. & Han, H. (2002). Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. Journal of Consult Clinical Psychology, 70, 1067–74.
Clomipramine Collaborative Study Group (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 754–6.
Coffey, C. E., Carlin, J. B., Degenhardt, L., Lynskey, M. T., Sanci, L. & Patton, G. C. (2002). Cannabis dependence in young adults: an Australian population study. Addiction, 97, 187–94.
Cohen, J., Deblinger, E., Mannarino, A. P. & Steer, R. A. (2004). A multisite, randomised controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 393–402.
Cohen-Kettenis, P. T., Delemarre-van de Waal, H. A. & Gooren, L. J. (2008). The treatment of adolescent transsexuals: changing insights. Journal of Sexual Medicine, 5, 1892–7.
Cole, M. G., Primeau, F. & McCusker, J. (1996). Effectiveness of interventions to prevent delirium in hospitalized patients: a systematic review. Canadian Medical Association Journal, 155, 1263–8.
Colombo, C., Lucca, A., Benedetti, F., Barbini, B., Campori, E. & Smeraldi, E. (2000). Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Research, 95(1), 43–53.
Compton, S. N., March, J. S., Brent, D., Albano, A. M., Weersing, V. R. & Curry, J. (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 930–59.
Connor, D. F. & Rubin, J. (2010). Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents. Drugs Today, 46, 299–314.
Conners, K., Casat, C. D. & Gualtieri, C. et al. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314.
Connor, D. F., Glatt, S. J., Lopez, I. D., Jackson, D. & Melloni, R. H. (2002). Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 253–61.
Connors, G. J., Tonigan, J. S. & Miller, W. R. (2001). A longitudinal model of A.A. affiliation, participation, and outcome: retrospective study of the Project MATCH outpatient and aftercare samples. Journal of Studies on Alcohol, 62, 817–25.
Cook, C. C. H., Hallwood, P. M. & Thomson, A. D. (1998). B-vitamin deficiency and neuro-psychiatric syndromes in alcohol misuse. Alcohol & Alcoholism, 33, 317–36.
Cooke, R. A., Chambers, J. B, Singh, R. et al. (1994). QT interval in anorexia nervosa. British Heart Journal, 72(1), 69–73.
Cooper, P. J., Coker, S. & Fleming, C. et al. (1996). An evaluation of the efficacy of supervised cognitive behavioral self-help bulimia nervosa. Journal of Psychosomatic Research, 40, 281–7.
Cooper, P. J., Murray, L., Wilson, A. & Romaniuk, H. (2003). Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression. 1. Impact on maternal mood. British Journal of Psychiatry, 182, 412–19.
Copeland, J., Swift, W., Roffman, R. & Stephens, R. S. (2001). A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment, 21, 55–64.
Cordioli, A., Heldt, E., Bochi, D. B. et al. (2003). Cognitive-behavioural group therapy in obsessive-compulsive disorder: a randomised clinical trial. Psychotherapy and Psychosomatics, 72, 211.
Correll, C. (2008). Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 9–20.
Correll, C., Manu, P., Olshansky, V., Napolitano, B., Kane, J. M. & MalhortraA. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. Journal of the American Medical Association, 302, 1765–73.
Cosgrove, G. R. (2000). Surgery for psychiatric disorders. CNS Spectrums, 5(10), 43–52.
Costello, E. & Angold, A. (1995). Epidemiology. In: J. March, ed. Anxiety Disorders in Children and Adolescents. New York: Guilford Press, pp. 109–24.
Cottraux, J., Mollard, E., Bouvard, M. et al. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmacology, 5, 17–30.
Couturier, J. & Lock, J. (2007) A review of medication use for children and adolescents with eating disorders. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 16, 173–6.
Covey, L. S. & Glassman, A. H. (1991). A meta-analysis of double-blind placebo controlled trials of clonidine for smoking cessation. British Journal of Addiction, 86, 991–8.
Craft, M., Ismail, I. A., Krisnamurti, D. et al. (1987). Lithium in the treatment of aggression in mentally handicapped patients: a double-blind trial. British Journal of Psychiatry, 150, 685–9.
Craske, M. G. (1999). Anxiety Disorders: Psychological Approaches to Theory and Treatment. Boulder, CO: Westview Press.
Craske, M., DeCola, J., Sachs, A. & Pontillo, D. et al. (2003). Panic control treatment for agoraphobia. Journal of Anxiety Disorders, 17, 321–33.
Crisp, A. H., Callender, J. S., Halek, C. & Hsu, L. K. G. (1992). Long-term mortality in anorexia nervosa: a 20-year follow-up of the St. George’s and Aberdeen cohorts. British Journal of Psychiatry, 161, 104–7.
Crisp, A. H. and Kalucy, R. S. (1973). The effect of leucotomy in intractable adolescent weight phobia (primary anorexia nervosa). Postgraduate Medical Journal, 49, 883–93.
Crisp, A. H., Norton, K., Gowers, S. et al. (1991). A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. British Journal of Psychiatry, 159, 325–33.
Crits-Christoph, P., Siqueland, L., Blaine, J. et al. (1999). Psychosocial treatments for cocaine dependence: results of the National Institute on Drug Abuse Collaborative Cocaine Study. Archives of General Psychiatry, 56, 495–502.
Crow, S. & Schmidt, U. (2008). Complex treatments for eating disorders. In: P. Tyrer & K. R. Silk, eds. Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge: Cambridge University Press, pp. 647–55.
Crow, S. J., Mitchell, J. E., Roerig, J. D. & Steffen, K. (2009). What potential role is there for medication treatment in anorexia nervosa?International Journal of Eating Disorders, 42, 1–8.
Crumrine, P. K., Feldman, H. M., Teodori, J., Handen, B. L. & Alvin, R. M. (1987). The use of methylphenidate in children with seizures and attention deficit disorder. Annals of Neurology, B, 441–2.
Curran, H. V., Collins, R., Fletcher, S., Kee, S. C., Woods, B. & Iliffe, S. (2003). Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychological Medicine, 33, 1223–37.
Curtis, N. M., Ronan, K. R. & Borduin, C. M. (2004). Multisystemic therapy: a meta-analysis of outcome studies. Journal of Family Psychology, 18, 411–19.
D’Silva, K., Duggan, C. & Mccarthy, L. (2004). Does treatment really make psychopaths worse? A review of the evidence. Journal of Personality Disorders, 18, 163–77.
Daiuto, A., Baucom, D., Epstein, N. & Dutton, S. (1998). The application of behavioral couples therapy to the assessment and treatment of agoraphobia: implications of empirical research. Clinical Psychology Review, 18, 663–87.
Dam, M., Tonin, P., De Boni, A. et al. (1996). Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke, 27, 1211–14.
Dare, C., Eisler, I., Russell, G., Treasure, J. & Dodge, L. (2001). Psychological therapies for adults with anorexia nervosa: randomized controlled trial of out-patient treatments. British Journal of Psychiatry, 178, 216–21.
Daubenmier, J. J. (2003). A comparison of Hatha yoga and aerobic exercise on women’s body satisfaction. Dissertation Abstracts International: Section B: The Sciences & Engineering, 63(9-B).
Davenport, C. W. (1986). A follow-up study of 10 feminine boys. Archives of Sexual Behavior, 15, 511–7.
Davidson, J., Kudler, H., Smith, R. et al. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259–66.
Davidson, J. R., Potts, N., Richichi, E. et al. (1993). Treatment of social phobia with clonazepam and placebo. Journal of Clinical Psychopharmacology, 13, 423–8.
Davidson, J., Pearlstein, T., Londborg, P. et al. (2001). Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 1974–81.
Davidson, J. R. T., Foa, E. B., Huppert, J. D. et al. (2004). Fluoxetine comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Archives of General Psychiatry, 61, 1005–13.
Davidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I. & Musgnung, J. J. et al. (2006a). Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. Journal of Clinical Psychopharmacology, 26(3), 259–67.
Davidson, J., Baldwin, D., Stein, D. J. et al. (2006b). Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Archives of General Psychiatry, 63(10), 1158–65.
Davidson, K. & Tyrer, P. (1996). Cognitive therapy for antisocial and borderline personality disorders: single case study series. British Journal of Clinical Psychology, 35, 413–29.
Davidson, K., Norrie, J., Tyrer, P. et al. (2006). The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. Journal of Personality Disorders, 20, 450–65.
Davis, J., Barter, J. & Kane, J. M. (1989). Antipsychotic drugs. In: H. I. Kaplan & B. J. Sadock, eds. Comprehensive Textbook of Psychiatry V. Baltimore, Williams and Wilkins, pp. 1591–626.
Davis, J. M., Wang, Z. & Janicak, P. G. et al. (1993). A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacology Bulletin, 29, 175–81.
Davis, J. M., Chen, N. & Glick, I. D. (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry, 60, 553–64.
Davis, R., Olmsted, M. P., Rockert, W. (1990). Brief group psychoeducation for bulimia nervosa: assessing the clinical significance of change. Journal of Consulting and Clinical Psychology, 58(6), 882–5.
Davis, R., Olmsted, M., Rockert, W.Marques, T. & Dolhanty, J. (1997). Group psychoeducation for bulimia nervosa with and without additional psychotherapy process sessions. International Journal of Eating Disorders, 22(1), 25–34.
Davis, W. T., Campbell, L., Tax, J. & Lieber, C. S. (2002). A trial of “standard” outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment, 23, 9–19.
Dawson, G., Rogers, S., Munson, J. et al. (2010). Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver model. Pediatrics, 125, e7–e23.
de Beurs, E., Lange, A., van Dyck, R. & Koele, P. (1995). Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome. Australian and NZ Journal of Psychiatry, 29(1), 104–13.
De Deyn, P. P, Rabheru, K., Rasmussen, A. et al. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioural symptoms of dementia. Neurology, 53, 946–55.
De Deyn, P. P., Katz, I. R., Brodaty, H., Lyons, B., Greenspan, A. & Burns, A. et al. (2005). Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clinical Neurology and Neurosurgery, 107, 497–508.
de Lima, M. S., de Oliveira Soares, B. G., Reisser, A. A. & Farrell, M. (2002). Pharmacological treatment of cocaine dependence: a systematic review. Addiction, 97, 931–49.
DeRubeis, R., Hollon, S. D., Amsterdam, J. D. et al. (2005). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62(4), 409–16.
Deb, S., Lyons, I., Koutzoukis, C., Ali, I., & Mccarthy, G. et al. (1999). Rate of psychiatric illness one year after traumatic brain injury. American Journal of Psychiatry, 156, 374–8.
Deblinger, E., Steer, R. & Lippmann, J. (1999). Two-year follow-up study of cognitive behavioural therapy for sexually abused children suffering post-traumatic stress symptoms. Child Abuse and Neglect, 23, 1371–8.
Degun-Mather, M. (2003). Ego-state therapy in the treatment of a complex eating disorder. Contemporary Hypnosis, 20, 165–73.
Delate, T., Gelenberg, A. J., Simmons, V. A. & Motheral, B. R. (2004). Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatric Services, 55, 387–91.
DelBello, M., Schwiers, M. L., Rosenberg, H. L. & Strakowski, S. M. (2002). A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1216–23.
DelBello, M., Kowatch, R., Adler, C.et al. (2006). A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 305–13.
De Leon, G. (2004). Therapeutic communities. In: M. Galanter and H. D. Kleber, eds. Textbook of Substance Abuse Treatment, 3rd ed. Washington, D.C.: American Psychiatric Press, pp. 485–501.
Denis, C., Fatseas, M., Lavie, E. & Auriacombe, M. (2006a). Pharmacological interventions for benzodiazepine mono-dependence management in out patient settings. Cochrane Database of Systematic Reviews, 3, CD005194.
Denis, C., Lavie, E., Fatseas, M. & Auriacombe, M. (2006b). Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database of Systematic Reviews, 3, CD005336. doi: 10.1002/14651858.CD005336.
Department of Health (2002). Mental Health Policy Implementation Guide: Dual Diagnosis Good Practice Guide. London: Department of Health.
Diamond-Raab, L. & Orrell-Valente, J. K. (2002). Art therapy, psychodrama, and verbal therapy. An integrative model of group therapy in the treatment of adolescents with anorexia nervosa and bulimia nervosa. Child and Adolescent Psychiatry Clinics of North America, 11, 343–64.
Dibble, L. & Tandon, R. (1992). Post-ECT myoclonic jerks in a depressed patient with bulimia. Convulsive Therapy, 8(4), 285–9.
Dickerson Mayes, S., Calhoun, S. L., Krecko, V. F., Vesell, H. P. & Hu, J. (2001). Outcome following child psychiatric hospitalization. Journal of Behavioral Health Services & Research, 28, 96–103.
DiMascio, A., Weissman, M. M., Prusoff, B. A., Neu, C., Zwilling, M. & Klerman, G. L. (1979). Differential symptom reduction by drugs and psychotherapy in acute depression. Archives of General Psychiatry, 36, 1450–6.
Dimidjian, S., Hollon, S. D., Dobson, K. S. et al. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74, 658–70.
Dingemans, A. E., Bruna, M. J. & van FurthE. F. (2002). Binge eating disorder: a review. International Journal of Obesity, 26, 299–307.
Dodge, E., Hodes, M., Eisler, I. & Dare, C. (1995). Family therapy for bulimia nervosa in adolescents: an exploratory study. Journal of Family Therapy, 17, 59–77.
Doering, S., Horz, S., Rentrop, M. et al. (2010). Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. British Journal of Psychiatry, 196, 389–95.
Dolan, L. J., Kellam, S. G., BrownC. H.et al. (1993). The short-term impact of two classroom-based preventive interventions on aggressive and shy behaviors and poor achievement. Journal of Applied Developmental Psychology, 14, 317–45.
Doody, R. S., Geldmacher, D. S., Gordon, B., Perdomo, C. A., Pratt, R. D. & the Donepezil Study Group (2001). Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Archives of Neurology, 58, 427–33.
Dorey, G., Speakman, M., Feneley, R., Swinkels, A., Dunn, C. & Ewings, P. (2004). Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction. British Journal of General Practice, 54, 819–25.
Dozier, M., Stovall, K. C., Albus, K. & Bates, B. (2001). Attachment for infants in foster care: the role of caregiver state of mind. Child Development, 72, 1467–77.
Dozier, M., Peloso, E., Lindhiem, O. et al. (2006). Developing evidence-based interventions for foster children: an example of a randomized clinical trial with infants and toddlers. Journal of Social Issues, 62, 767–85.
Dubicka, B., Hadley, S. & Roberts, C. (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. British Journal of Psychiatry, 189, 393–8.
Dudley, W. H. & Williams, J. G. (1972). Electroconvulsive therapy in delirium tremens. Comprehensive Psychiatry, 13, 357–60.
Dula, E. S., Bukofzer, R., Perdok, R. J. & George, M. (2001). Apomorphine Study Group: double-blind, cross-over comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. European Urology, 39, 558–64.
Durlak, J. A., Fuhrman, T. & Lampman, C. (1991). Effectiveness of cognitive behaviour therapy for maladaptive children: a meta-analysis. Psychological Bulletin, 110, 204–14.
Dush, D. M., Hirt, M. L. & Schroeder, H. E. (1989). Self-statement modification in the treatment of child behavior disorders: a meta-analysis. Psychological Bulletin, 106, 97–106.
Eaden, J., Abrams, K., Shears, J. & Mayberry, J. (2006). Randomized controlled trial comparing the efficacy of a video and information leaflet versus information leaflet alone on patient knowledge about surveillance and cancer risk in ulcerative colitis. Inflammatory Bowel Diseases, 8, 407–12.
Ebmeier, K. P., Donaghey, C. & Steele, J. D. (2006). Recent developments and current controversies in depression. Lancet, 367, 153–67.
Eckerberg, B. (2002). Treatment of sleep problems in families with young children: effects of treatment on family well-being. Acta Paediatrica, 93, 126–34.
Eddy, J. M., Reid, J. B., Stoolmiller, M. & Fetrow, R. A. (2003). Outcomes during middle school for an elementary school-based preventive intervention for conduct problems: follow-up results from a randomized trial. Behavior Therapy, 34, 535–52.
Eisler, I. (2005). The empirical and theoretical base of family therapy and multiple family day therapy for adolescent anorexia nervosa. Journal of Family Therapy, 27, 104–31.
Eisler, I., Dare, C., Hodes, M., Russell, G. F. M., Dodge, E. & Le Grange, D. (2000). Family therapy for adolescent anorexia nervosa: the results of a controlled comparison of two family interventions. Journal of Child Psychology and Psychiatry, 41, 727–36.
Eisler, L., Simic, M., Russell, G. & Dare, C. (2007). A randomized controlled treatment trial of two forms of family therapy in adolescent anorexia nervosa: a five-year follow-up. Journal of Child Psychology Psychiatry, 48, 552–60.
Elkin, I., Shea, M. T., Watkins, J. T. et al. (1989). National Institute of Mental Health treatment of depression collaborative research program: general effectiveness of treatments. Archives of General Psychiatry, 46, 971–82.
Elsenga, S. & van den Hoofdakker, R. H. (1982). Clinical effects of sleep deprivation and clomipramine in endogenous depression. Journal of Psychiatric Research, 17(4), 361–74.
Emerson, E., Mason, H., Swarbrick, R., Mason, L. & Hatton, C. (2001) The prevalence of challenging behaviors: a total population study. Research in Developmental Disabilities, 22, 77–93.
Emmelkamp, P. M., Benner, A., Kuipers, A., Feiertag, G. A., Koster, H. C. & van Apeldoorn, F. J. (2006). Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder. British Journal of Psychiatry, 189, 60–4.
Emrick, C. D. & Tonigan, J. S. (2004). Alcoholics Anonymous and other 12-Step groups. In: M. Galanter & H. D. Kleber, eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 3rd edn. Washington, D.C.: American Psychiatric Press, pp. 485–501.
Emslie, G. J., Heiligenstein, J. H., Wagner, K. D. et al. (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205–15.
Eranti, S., Mogg, A., Pluck, G., Landau, S. et al. (2007). A randomized controlled trial with 6-month follow up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry, 164, 73–81.
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S. & DamarajuC. V. (2002). Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomized trial. The Lancet, 359, 1283–90.
Ernst, E. & Pittler, M. H. (1998). Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Journal of Urology, 159(2), 433–6.
Erzegovesi, S., Guglielmo, E., Siliprandi, F. & Bellodi, L. (2005). Low-dose in obsessive-compulsive risperidone augmentation of fluvoxamine treatment disorder: a double-blind, placebo-controlled study. European Neuropsychopharmacology, 15, 69–74.
European Monitoring Center for Drugs and Drug Addiction (2003). Annual Report 2003: The State of the Drugs Problem in the Acceding and Candidate Countries to the European Union. Luxembourg: Office of the Official Publications of the European Communities.
Evans, M. E., Armstrong, M. I., Kuppinger, A. D., Huz, S. & McNulty, T. L. (1998). Preliminary outcomes of an experimental study comparing treatment foster care and family-centered intensive case management. In: M. H. Epstein, K. Kutash & A. Duchnowski, eds. Outcomes for Children and Youth with Emotional and Behavioral Disorders and their Families: Programs and Evaluation Best Practices. Austin, TX: PRO-ED, pp. 543–80.
Evans, M. D., Hollon, S. D., DeRubeis, R. J. et al. (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 49, 802–8.
Eyberg, S. M. (1988). Parent–Child Interaction Therapy: Integration of traditional and behavioral concerns. Child and Family Behavior Therapy, 10, 33–48.
Faggiano, F., Vigna-Taglianti, F., Versino, E. & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. In: Cochrane Database Systematic Review, 3, CD002208. Oxford: Update Software Ltd.
Fahlen, T., Nilsson, H. L., Borg, K., Humble, M. & Pauli, U. et al. (1995). Social phobia: the clinical efficacy and tolerability of the monoamine-oxidase-A and serotonin uptake inhibitor brofaromine: a double-blind placebo-controlled study. Acta Psychiatrica Scandinavica, 92, 351–8.
Fairburn, C. G. (1981). A cognitive behavioral approach to the treatment of bulimia. Psychological Medicine, 11, 707–11.
Fairburn, C. (1997). Interpersonal psychotherapy for bulimia nervosa. In: D. M. Garner & P. E. Garfinkel, eds. The Handbook of Treatment for Eating Disorders, 2nd edn. New York: Guilford Press, pp. 278–94.
Fairburn, C. G. & Bohn, K. (2005). Eating Disorder Not Otherwise Specified (EDNOS): an example of the troublesome ‘Not Otherwise Specified (NOS)’ category in DSM-IV. Behaviour Research and Therapy, 43, 691–701.
Fairburn, C. & Cooper, Z. (2011). Eating disorders, DSM-5 and clinical reality. British Journal of Psychiatry, 198, 8–10.
Fairburn, C. G., Cooper, Z., Doll, H. A. et al. (2000). The natural course of bulimia nervosa and binge eating disorder in young women. Archives of General Psychiatry, 57, 659–65.
Fairburn, C. G., Cooper, Z. & Shafran, R. et al. (2003). Cognitive behaviour therapy for eating disorders: a “transdiagnostic” theory and treatment. Behaviour Research and Therapy, 41, 509–28.
Fairburn, C. G., Cooper, Z., Doll, H. A. et al. (2009). Transdiagnostic cognitive behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. American Journal of Psychiatry, 166, 311–9.
Fallon, B. A., Petkova, E., Skritskaya, N. et al. (2008). A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. Journal of Clinical Psychopharmacology, 28, 638–45.
Farre, M., Mas, A., Torrens, M., Moreno, V. & Cami, J. (2002). Retention rate and illicit opioid use during methadone maintenance intervention: a meta-analysis. Drug and Alcohol Dependence, 65, 283–90.
Farrell, J. M., Shaw, I. A. & Webber, M. A. (2009). A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder. Journal of Behavior Therapy & Experimental Psychology, 40, 317–28.
Fava, M., Alpert, J. et al. (2002). Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. Journal of Clinical Psychopharmacology, 22(4), 379–87.
Fedoroff, I. C. & Taylor, S. (2001). Psychological and pharmacological treatments of social phobia: a meta-analysis. Journal of Clinical Psychopharmacology, 21, 311–24.
Ferber, R. & Kryger, M. (1995). Principles and Practice of Sleep Medicine in the Child. Philadelphia: W. B.Saunders Company, pp. 79–89 & 99–106.
Ferreri, M., Lavergne, F., Berlin, I., Payan, C. & Puech, A. J. (2001). Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone. Acta Psychiatrica Scandinavica, 103, 66–72.
Field, T. (2002). Massage therapy. Medical Clinics of North America, 86(1), 163–171.
Field, T., Schanberg, S., Kuhn, C., Fierro, K., Henteleff, T., Mueller, C., Yando, R. & Burman, I. (1998). Bulimic adolescents benefit from massage therapy. Adolescence, 33, 554–63.
Fineberg, N. A. & Galem, T. M. (2005). Evidence-based pharmacotherapy of obsessive-compulsive disorder. International Journal of Neuropsychopharmacology, 8, 107–29.
Fink, H. A., MacDonald, R., Rutks-Indulis, R., Nelson, D. B. & Wilt, T. J. (2002). Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Archives of Internal Medicine, 162, 1349–60.
Fiore, M. C., Smith, S. S., Jorenby, D. E. & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. Journal of the American Medical Association, 271, 1940–7.
Fiore, M. C., Bailey, W. C., Cohen, S. J.et al. (2000). Clinical Practice Guideline: Treating Tobacco Use and Dependence. US Department of Health and Human Services. Rockville, MD: US Public Health Service.
Fisher, W. W., Adelinis, J. D., Volkert, V. M., Keeney, K. M., Neidert, P. L. & Hovanetz, A. (2005). Assessing preferences for positive and negative reinforcement during treatment of destructive behavior with functional communication training. Research in Developmental Disabilities, 26, 153–68.
Fleming, M. F., Mundt, M. P., French, M. F.et al. (2002). Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis. Alcoholism, Clinical and Experimental Research, 26, 36–43.
Foa, E. B., Kozak, M. J., Steketee, G. S. & McCarthy, P. R. (1992). Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy. British Journal of Clinical Psychology, 31 ( Pt 3), 279–92.
Foa, E. B., Dancu, C. V., Hembree, E. A. et al. (1999). A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. Journal of Consulting and Clinical Psychology, 67, 194–200.
Foa, E. B., Liebowitz, M. R., Kozak, M. J. et al. (2005). Randomized placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obssessive–compulsive disorder. American Journal of Psychiatry, 162, 151–61.
Folkerts, H. W., Michael, N., Tolle, R. et al. (1997). Electroconvulsive therapy vs. paroxetine in treatment-resistant depression: a randomized study. Acta Psychiatrica Scandinavica, 96, 334–42.
Fontaine, C. S., Hynan, L. S., Koch, K., Martin-Cook, K., Svetlik, D. & Weiner, M. F. (2003). A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. Journal of Clinical Psychiatry, 64, 726–30.
Forbes, D., Creamer, M., Bisson, J. I. et al. (2010). A guide to guidelines for the treatment of PTSD and related conditions. Journal of Traumatic Stress, 23, 537–52.
Foxcroft, D. R., Ireland, D., Lister-Sharp, D. J., Lowe, G. & Breen, R. (2003). Longer-term primary prevention for alcohol misuse in young people: a systematic review. Addiction, 98, 397–411.
Frangou, S., Lewis, M. & McCrone, P. (2006). Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised, double-blind, placebo-controlled study. British Journal of Psychiatry 188, 46–50.
Frank, E., Kupfer, D. J., Perel, T. M. et al. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093–9.
Frankel, F., Cantwell, D. P. & Myatt, R. (1996). Helping ostracized children: social skills training and parent support for socially rejected children. In: E. D. Hibbs & P. S. Jensen, eds. Psychosocial Treatments for Child and Adolescent Disorders: Empirically Based Strategies for Clinical Practice. Washington, DC: American Psychological Association, pp. 595–617.
Franzen, U., Backmund, H. & Gerlinghoff, M. (2004). Day treatment group programme for eating disorders: reasons for drop-out. European Eating Disorders Review, 12, 153–8.
Freestone, M. H., Ladouceur, R., Gagnon, F. et al. (1997). Cognitive-behavioral treatment of obsessive thoughts: a controlled study. Journal of Consulting and Clinical Psychology, 65, 405–13.
Fridell, M. (2003). Psychosocial treatment for drug dependence. In: M. Berglund, S. Thelander & E. Jonsson, eds. Treating Alcohol and Drug Abuse: An Evidence Based Review. Berlin: Wiley-VCH GmbH & Co.
Friedman, J. H. (2010). Parkinson’s disease psychosis 2010: a review article. Parkinsonism and Related Disorders, 16, 553–60.
Fruehwald, S., Gatterbauer, E., Rhak, P. & Baumhackl, U. (2003). Early fluoxetine treatment of post-stroke depression: a 3-month double-blind, placebo-controlled study with an open-label long-term follow up. Journal of Neurology, 250, 347–51.
Furukawa, T. A., Watanabe, N. & Churchill, R. (2007). Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews, 1, CD004364.
Gagiano, C., Read, S., Thorpe, L. et al. (2005). Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders. Psychopharmacology (Berlin), 179, 629–36.
Galanter, M., Dermatis, H., Glickman, L. et al. (2004). Network therapy: decreased secondary opioid use during buprenorphine maintenance. Journal of Substance Abuse Treatment, 26, 313–18.
Gallagher-Heather, M., Rabbin, B. A. & McCloskey, M. S. (2004). A brief group cognitive-behavioural intervention for social phobia in childhood. Journal of Anxiety Disorders, 18, 459–79.
Gamberini, M., Bolliger, D., Lurati Buse, G. A. et al. (2009). Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery: a randomized controlled trial. Critical Care Medicine, 37, 762–8.
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N. & Crews, F. T. (1999). Pharmacological treatment of alcohol dependence: a review of the evidence. Journal of the American Medical Association, 281, 1318–25.
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S. et al. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. Journal of the American Medical Association, 293, 1617–25.
Garcia-Palacios, A., Hoffman, H., Carlin, A., Furness, T. A., III & Botella, C. (2002). Virtual reality in the treatment of spider phobia: a controlled study. Behaviour Research and Therapy, 40(9), 983–93.
Gareri, P., Cotroneo, A., Lacava, R. et al. (2004). Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Archives of Gerontology Geriatric Supplement, 9, 207–15.
Garety, P. A., Fowler, D.G., Freeman, D., Bebbinton, P., Dunn, G. & Kuipers, E. (2008). Cognitive-behavioural therapy and family intervention for relapse Prevention and symptom reduction in psychosis: randomised controlled trial. British journal of psychiatry, 192, 412–23.
Garner, D. M. & Needleman, L. D. (1997). Sequencing and integration of treatments. In: D. M. Garner & P. E. Garfinkel, eds. Handbook of Treatment for Eating Disorders. New York: Guilford Press, pp. 50–66.
Garner, D. M. & Vitousek, P. K. M. (1997). Cognitive-behavioral therapy for anorexia nervosa. In: D. M. Garner & P. E. Garfinkel, eds. The Handbook of Treatment for Eating Disorders, 2nd edn. New York: Guilford Press, pp. 94–144.
Garnok-Jones, K. P. & Keating, G. M. (2010). Spotlight on atomoxetine in attention deficit hyperactivity disorder in children and adolescents. CNS Drugs, 24, 85–8.
Garrett, C. J. (1997). Recovery from anorexia nervosa: a sociological perspective. International Journal of Eating Disorders, 21, 261–72.
Garssen, B., de Ruiter, C. & Van Dyck, R. (1992). Breathing retraining: a rational placebo?Clinical Psychology Review, 12(2), 141–53.
Geddes, J., Freemantle, N., Harrison, P. & Bebbington, P. (2000). Atypical antispychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. British Medical Journal, 321, 1371–6.
Geddes, J. R., Rendell, J. M. & Goodwin, G. M. et al. (2003). BALANCE: a large simple trial of maintenance treatment for bipolar disorder. World Psychiatry, 1, 48–51.
Geddes, J. R., Goodwin, G. M., Huffman, R., Paska, W., Evoniuk, G. & Leadbetter, R. (2009). Additional clinical trail data and a retrospective pooled analysis of response rates across all randomized trials conducted by GSK. Bipolar Disorders, 8 (Suppl. 1), 32.
Geddes, J. R., Goodwin, G. M., Rendell, J. et al. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet, 375, 385–95.
Geist, R., Heinmaa, M., Stephens, D., Davis, R. & Katzman, D. K. (2000). Comparison of family therapy and family group psychoeducation in adolescents with anorexia nervosa. Canadian Journal of Psychiatry, 45, 173–8.
Gelernter, C. S., Uhde, T. W., Cimbolic, P. et al. (1991). Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Archives of General Psychiatry, 48, 938–45.
Geller, D., Biederman, J., Stewart, E. et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in paediatric obsessive compulsive disorder. American Journal of Psychiatry, 160, 1919–28.
George, M. S., Lisanby, S. H. & Sackeim, H. A. et al. (1999). Transcranial Magnetic Stimulation: applications in neuropsychiatry. Archives of General Psychiatry, 56, 300–11.
George, M. S., Nahas, Z., Kozel, F. A. et al. (2003). Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectrums, 8(7), 496–514.
George, M. S., Rush, A. J., Marangell, L. B. et al. (2005). A one year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry, 58(5), 364–73.
George, T. P., Verrico, C. D. & Roth, R. H. (1998). Effects of repeated nicotine pre-treatment on mesoprefontal dopaminergic and behavioral responses to acute footshock stress. Brain Research, 801, 36–49.
George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R. & Schottenfeld, R. S. (2000). Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biological Psychiatry, 47, 1080–6.
Gevensleben, H., Holl, B., Albrecht, B. et al. (2010). Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial. European Child & Adolescent Psychiatry, 19, 715–24.
Ghazi-Noori, S., Chung, T. H., Deane, K. H. O. et al. (2003). Therapies for depression in Parkinson’s disease. Cochrane Database of Systematic Reviews, 3, CD003465. Oxford: Update Software Ltd.
Ghaziuddin, N., Kutcher, S. P., Knapp, P. & American Academy of Child and Adolescent Psychiatry Work Group on Quality Issues (2004). Summary of the practice parameter for the use of electroconvulsive therapy with adolescents. Journal of American Academy of Child Adolescent Psychiatry, 43, 119–22.
Gibbons, M. B., Crits-Christoph, P., Levinson, J. et al. (2002). Therapist interventions in the interpersonal and cognitive therapy sessions of the Treatment of Depression Collaborative Research Program. American Journal of Psychotherapy, 56, 3–26.
Gibbons, R. D., Brown, C. H., Hur, K. et al. (2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164, 1356–63.
Giesen-Bloo, J., van Dyck, R., Spinhoven, P. et al. (2006). Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs. transference-focused psychotherapy. Archives of General Psychiatry, 63, 649–58.
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A. & Goodwin, G. M. (2004). Antidepressants for bipolar depression: a systematic review of randomized controlled trials. American Journal of Psychiatry, 161, 1537–47.
Giovino, G. A. (2002). Epidemiology of tobacco use in the United States. Oncogene, 21, 7326–40.
Gleeson, J., Cotton, S., Alvarez-Jimenez, M. et al. (2009.) A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. Journal of Clinical Psychiatry, 70, 477–86.
Gogtay, N. & Rapoport, J. (2008). Clozapine use in children and adolescents. Expert Opinion in Pharmacotherapy, 9, 459–65.
Goldberg, S. C., Halmi, K. A., Eckert, E. D., Casper, R. C. & Davis, J. M. (1979). Cyproheptadine in anorexia nervosa. British Journal of Psychiatry, 134, 67–70.
Goldner, E. M., Birmingham, C. L. & Smye, V. (1997). Addressing treatment refusal in anorexia nervosa: clinical, ethical and legal considerations. In: D. M. Garner & P. E. Garfinkel, eds. Handbook of Treatment for Eating Disorders, 2nd edn. New York: Guilford Press.
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., Wicker, P. A., for the Sildenafil Study Group (1998). Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine, 338, 1397–404.
Goldstein, M., Peters, L., Baillie, A., McVeigh, P., Minshall, G. & Fitzjames, D. (2010). The effectiveness of a day program for the treatment of adolescent anorexia nervosa. International Journal of Eating Disorders. doi: 10.1002/eat.20789.
Gonzalez, G., Sevarino, K., Sofuoglu, M. et al. (2003). Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction, 98, 1625–32.
Goodwin, F. K., Murphy, D. L., Bunney Jr., W. E. et al. (1969). Lithium-carbonate treatment in depression and mania: a longitudinal double-blind study. Archives of General Psychiatry, 21(4), 486–96.
Goodyer, I. M., Herbert, J. & Tamplin, A. (2003). Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychological Medicine, 33, 601–10.
Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D. & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–7.
Gossop, M., Marsden, J., Stewart, D. & Kidd, T. (2003). The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction, 98, 291–303.
Gould, R. A., Otto, M. W., Pollack, M. H. & Yap, L. (1997a). Cognitive behavioural and pharmacological treatment of generalised anxiety disorder: a preliminary meta-analysis. Behavior Therapy, 28, 285–305.
Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. & Yap, L. (1997b). Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clinical Psychology: Science and Practice, 4, 291–306.
Gowers, S. & Bryant-Waugh, R. (2004). Management of child and adolescent eating disorders: the current evidence base and future directions. Journal of Child Psychology and Psychiatry, 45, 63–83.
Gowers, S., Norton, K., Halek, C., & Crisp, A. H. (1994). Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders, 15, 65–77.
Gowers, S. G., Clark, A., Roberts, C. et al. (2007). Clinical effectiveness of treatments for anorexia nervosa in adolescents: randomised controlled trial. British Journal of Psychiatry, 191, 427–35.
Gowers, S., Claxton, M., Rowlands, L. et al. (2010). Drug prescribing in child and adolescent eating disorder services. Child and Adolescent Mental Health, 15, 18–22.
Graham, A. W. & Fleming, M. S. (1998). Brief interventions. In: A. W. Graham, T. K. Schultz & B. B. Wilford, eds. Principles of Addiction Medicine, 2nd edn. Chevy Chase, MD: American Society of Addiction Medicine, Inc, pp. 615–30.
Graham, P. (1998). Cognitive-Behaviour Therapy for Children and Adolescents. Cambridge: Cambridge University Press.
Grandison, M. K. & Boudinot, F. D. (2000). Age related changes in protein binding of drugs: implications for therapy. Clinical Pharmacokinetics, 38, 271–90.
Grandmaison, E. & Simard, M. (2003). Critical review of memory stimulation programs in Alzheimer’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 130–44.
Grant, B. F., Stinson, F. S., Dawson, D. A. et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807–16.
Gray, C. A. (1995). Teaching children with autism to ‘read’ social situations. In: A. Quill, ed. Teaching Children with Autism: Strategies to Enhance Communication and Socialization. New York: Delmar, pp. 219–42.
Gray, R., Leese, M., Bindman, J. et al. (2006). Adherence therapy for people with schizophrenia: European multicentre randomized controlled trial. British Journal of Psychiatry, 189, 508–14.
Greater London Alcohol and Drug Alliance (2004). An evidence base for the London crack cocaine strategy: a consultation document prepared for the Greater London Alcohol and Drug Alliance. London: Greater London Authority.
Green, J. M. (2003). Are attachment disorders best seen as social impairment syndromes?Attachment and Human Development, 5, 259–64.
Green, J. M. & Goldwyn, R. (2002). Annotation: Attachment disorganisation and psychopathology: new findings in attachment research and their potential implications for developmental psychopathology in childhood. Journal of Child Psychology and Psychiatry, 43, 835–46.
Green, J., Jacobs, B., Beecham, J. et al. (2007). Inpatient treatment in child and adolescent psychiatry: a prospective study of health gain and costs. Journal of Child Psychology and Psychiatry, 48, 1259–67.
Green, J., Charman, T., McConachie, H. et al. and the PACT Consortium (2010). Parent-mediated communication-focused treatment for preschool children with autism (MRC Pact); a randomised controlled trial. The Lancet, 375(9732), 2152–60.
Green, R. (1978). Sexual identity of 37 children raised by homosexual or transsexual parents. American Journal of Psychiatry, 135, 692–7.
Green, R. (1998). Sexual functioning in post-operative transsexuals: male-to-female and female-to-male. International Journal of Impotence Research, 10 (Suppl 1), S22–4.
Greenberg, B. D., George, M. S., Martin, J. D. et al (1997). Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. American Journal of Psychiatry, 154, 867–9.
Greenberg, P. E., Sisitsky, T., Kessler, R. C. et al. (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry, 60(7), 427–35.
Greenblatt, M., Grosser, G. H., Wechsler, H. et al. (1964). Differential response of hospitalized depressed patients to somatic therapy. American Journal of Psychology, 120, 935–43.
Gregory, S., Shawcross, C. R. & Gill, D. et al. (1985). The Nottingham ECT Study: a double-blind comparison of bilateral, unilateral and stimulated ECT in depressive illness. British Journal of Psychiatry, 146, 520–4.
Greist, J. H., Jefferson, J. W., Kobak, K. A. et al. (1995). A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology, 10, 57–65.
Greist, J. H., Marks, I. M., Baer, L. et al. (2002) Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. Journal of Clinical Psychiatry, 63, 138–45.
Grella, C. E., Anglin, M. D. & Wugalter, S. E. (1997). Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 23, 15–42.
Gresham, F. M. & Nagle, R. J. (1980). Social skills training with children: Responsiveness to modelling and coaching as a function of peer orientation. Journal of Consulting and Clinical Psychology, 48, 718–29.
Griffiths, R. A., Hadzi-Pavlovic, D. & Channon-Little, L. (1996). The short-term follow-up effects of hypnobehavioural and cognitive behavioural treatment for bulimia nervosa. European Eating Disorder Review, 4(1), 12–31.
Grigoriadis, D., Kennedy, S. H. et al. (2003). A comparison of anti-depressant response in younger and older women. Journal of Clinical Psychopharmacology, 23(4), 405–7.
Gros, D. F. & Antony, M. M. (2006). The assessment and treatment of specific phobias: a review. Current Psychiatry Reports, 8(4), 298–303.
Grossman, P., Niemann, L., Schmidt, S. & Walach, H. (2004). Mindfulness-based stress reduction and health benefits: a meta-analysis. Journal of Psychosomatic Research, 57, 35–43.
Guastella, A. J., Dadds, M. R., Lovibond, P. F., Mitchell, P. & Richardson, R. (2007). A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research, 41, 466–71.
Gurney, V. W. & Halmi, K. A. (2001). An eating disorder curriculum for primary care providers. International Journal of Eating Disorder, 30, 209–12.
Haessler, F., Glaser, T. & Beneke, L. J. et al. (2007). Zuclopenthixol in aggressive challenging behaviour in learning disability: discontinuation study. British Journal of Psychiatry, 190, 447–8.
Haigh, R. & Treasure, J. L. (2003). Investigating the Needs of Carers in the Area of Eating Disorders: Development of the Carers’ Needs Assessment Measure (CaNAM). European Eating Disorder Review, 11, 125–41.
Hajak, G., Muller, W. E., Wittchen, H. U., Pittrow, D. & Kirch, W. (2003). Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction, 98, 1371–8.
Hall, A. & Crisp, A. H. (1987). Brief psychotherapy in the treatment of anorexia nervosa: outcome at one year. British Journal of Psychiatry, 151, 185–91.
Hallstrom, C., Treasaden, I., Edwards, J. G. & Lader, M. (1981). Diazepam, propranolol and their combination in the management of chronic anxiety. British Journal of Psychiatry, 139, 417–21.
Halmi, K. A., Eckert, E., LaDu, T. J. & Cohen, J. (1986). Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Archives of General Psychiatry, 43(2), 177–81.
Hampson, R. B. & Beavers, R. W. (1996). Family therapy and outcome: relationships between therapist and family styles. Contemporary Family Therapy, 18, 345–70.
Han, C. & Kim, Y. (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics, 45, 297–301.
Han, J. S., Trachtenberg, A. I. & Lowinson, J. H. (2004). Acupuncture. In: J. H. Lowinson, P. Ruiz, R. B. Millman & J. G. Langrod, eds. Substance Abuse: A Comprehensive Textbook, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins.
Handen, B. L., Sahl, R. & Hardan, A. Y. (2008). Guanfacine in children with autism and/or intellectual disabilities. Journal of Developmental and Behavioral Pediatrics, 29, 303–8.
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W. & Fischman, M. W. (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology, 14, 395–404.
Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J., Bennett, A., Zubaran, C. & Foltin, R. W. (2004). Marijuana withdrawal in humans: effects of oral THC or Divalproex. Neuropsychopharmacology, 29, 158–70.
Hansen, V., Lund, E. & Smith-Sivertsen, T. (1998). Self-reported mental distress under the shifting daylight in the high north. Psychological Medicine, 28, 447–52.
Harmon, R. J. & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–9.
Hart, S., Field, T., Hernandez-Reif, M. & Nearing, G. (2001). Anorexia nervosa symptoms are reduced by massage therapy. Eating Disorders, 9, 289–99.
Hawley, C. J., Tattersall, M., Dellaportas, C. & Hallstrom, C. (1994). Comparison of long-term benzodiazepine users in three settings. British Journal of Psychiatry, 165, 792–6.
Haug, T. T., Blomhoff, S., Hellstrøm, K., et al. (2003). Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial. British Journal of Psychiatry, 182, 312–18.
Hay, P. J. & Bacaltchuk, J. (2008). Bulimia nervosa. Clinical Evidence (Online) June 12, pii: 1009.
Hay, P. P., Bacaltchuk, J., Stefano, S. & Kashyap, P. (2009). Psychological treatments for bulimia nervosa and binging. Cochrane Database of Systematic Reviews, 7(4), CD000562.
Hazell, P. (2006). Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. Journal of Paediatrics and Child Health, 43, 19–24.
Hazell, P. L. & Stuart, J. E. (2003). A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 886–94.
Hazell, P., O’Connell, D., Heathcote, D. & Henry, D. A. (2009). Tricyclic drugs for depression in children and adolescents. Cochrane Depression, Anxiety and Neurosis Group Cochrane Database of Systematic Reviews, 1, 2009.
Health Technology Board for Scotland (2002). Health Technology Assessment Advice 3: Prevention of Relapse in Alcohol Dependence. HTBS.
Heather, N., Bowie, A., Ashton, H. et al. (2004). Randomized controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addiction Research Theory, 12, 141–54.
Hedges, D. W., Reimherr, F. W., Hoopes, S. P. et al. (2003). Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. Journal of Clinical Psychiatry, 64(12), 1449–54.
Heim, C., Newport, D. J., Bonsall, R., Miller, A. H. & Nemeroff, C. B. (2001). Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. American Journal of Psychiatry, 158, 575–81.
Heimberg, R. G. (2002). Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Biological Psychiatry, 51, 101–8.
Heimberg, R. G., Liebowitz, M. R., Hope, D. A. et al. (1998). Cognitive behavioral group therapy vs. phenelzine for social phobia. Archives of General Psychiatry, 55, 1133–41.
Heldt, E. M., Gisele, G., Kipper, L., Blaya, C., Isolan, L. & Otto, M. W. (2006). One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behaviour Research and Therapy, 44(5), 657–65.
Hellstrom, K., Fellenius, J. & Ost, L. G. (1996). One versus five sessions of applied tension in the treatment of blood phobia. Behaviour Research and Therapy, 34(2), 101–12.
Henggeler, S. W., Melton, G. B. & Smith, L. A. (1992). Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. Journal of Consulting and Clinical Psychology, 60, 953–61.
Henggeler, S. W., Schoenwald, S. K., Borduin, C. M., Rowland, M. D. & Cunningham, P. B. (1998). Multisystemic Treatment of Antisocial Behavior in Children and Adolescents. New York: Guilford.
Herbert, J. D., Gaudiano, B. A., Rheingold, A. A. et al. (2009). Cognitive behavior therapy for generalized social anxiety disorder in adolescents: a randomized controlled trial. Journal of Anxiety Disorders, 23, 167–77.
Herpertz, S. C., Zanarini, M., Schulz, C. S. et al. (2007). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders. The World Journal of Biological Psychiatry, 8, 212–44.
Herpetz-Dahlmann, B. & Remschmidt, H. (1993). Depression and psychosocial adjustment in adolescent anorexia nervosa: a controlled 3-year follow-up study. European Child and Adolescent Psychiatry, 2, 146–54.
Herrmann, N. & Lanctôt, K. (2006). Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Drug Safety, 29, 833–43.
Herrmann, N. & Lanctôt, K. L. (2007). Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease. Canadian Journal of Psychiatry, 52, 630–46.
Herrmann, N., Lanctot, K. L., Eryavec, G. & Khan, L. R. (2004a). Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer’s disease patients. Journal of Psychopharmacology, 18, 215–20.
Herrmann, N., Mamdani, M. & Lanctôt, K. L. et al. (2004b). Atypical antipsychotics and risk of cerebrovascular accidents. American Journal of Psychiatry, 161, 1113–15.
Herzog, T., Hartmann, A. & Falk, C. (1996). Total symptom-oriented and psychodynamic concept in inpatient treatment of anorexia nervosa: a quasi-experimental comparative study of 40 admission episodes. Psychotherapie Psychosomatische Medizin und Psychologie, 46, 11–22.
Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone: a systematic review of the published literature. BMC Psychiatry, 9, 6.
Hetrick, S. E., Purcell, R., Garner, B. & Parslow, R. (2010). Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews, 7, CD007316.
Higgins, S. T., Wong, C. J., Badger, G. J., Haug-Ogden, D. E. & Dantona, R. L. (2000). Contingent reinforcement increases cocaine abstinence during outpatient treatment and one year follow-up. Journal of Consulting and Clinical Psychology, 68, 64–72.
Hill, K. P. & Sofuoglu, M. (2007). Biological treatments for amfetamine dependence: recent progress. CNS Drugs, 21, 851–69.
Hirsch, S. & Leff, J. (1971). Parental abnormalities of verbal communication in the transmission of schizophrenia. Psychological Medicine, 1(2), 118–27.
Hoffman, K. T., Marvin, R. S., Cooper, G. & Powell, B. (2006). Changing toddlers’ and preschoolers’ attachment classifications: The Circle of Security intervention. Journal of Consulting and Clinical Psychology, 74, 1017–26.
Hofmann, S. G. (2004). Cognitive mediation of treatment change in social phobia. Journal of Consulting and Clinical Psychology, 72, 393–9.
Hofmann, S. G., Meuret, A. E., Smits, J. A. et al. (2006). Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298–304.
Hogarty, G. E., Ulrich, R. F., Mussare, F. & Aristigueta, N. (1976). Drug discontinuation among long term, successfully maintained schizophrenic outpatients. Diseases of the Nervous System, 37, 494–500.
Hogervorst, E., Williams, J., Budge, M., Riedel, W. & Jolles, J. (2000). The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience, 101, 485–512.
Hohagen, F., Winkelmann, G., Rasche-Ruchle, H. et al. (1998). Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: results of a multicentre study. British Journal of Psychiatry, Suppl 35, 71–8.
Hohman, C., Hamon, R., Batshaw, M. L. et al. (1988). Transient postnatal elevation of serotonin levels in mouse neocortex. Brain Research, 47, 163–6.
Holder, H., Longabaugh, R., Miller, W. R. & Rubonis, A. V. (1991) The cost-effectiveness of treatment for alcoholism: a first approximation. Journal of Studies on Alcohol, 52, 517–40.
Holder, H. D., Cisler, R. A., Longabaugh, R., Stout, R. L., Treno, A. J. & Zweben, A. (2000). Alcoholism treatment and medical care costs from Project MATCH. Addiction, 95, 999–1013.
Hollander, E., Baldini Rossi, N., Sood, E. & Pallanti, S. (2003). Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. International Journal of Neuropsychopharmacology, 6, 397–401.
Hollander, E., Phillips, A., Chaplin, W. et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30, 582–9.
Hollon, S. D., DeRubeis, R., Shelton, C. et al. (2005). Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Archives of General Psychiatry, 62(4), 417–22.
Honer, W. G., Thornton, A. E., Chen, E. Y. et al. (2006). Clozapine alone versus clozapine and risperid one with refractory schizophrenia. New England Journal of Medicine, 354, 472–82.
Hoopes, S. P., Reimherr, F. W., Hedges, D. W. et al. (2003). Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. Journal of Clinical Psychiatry, 64(11), 1335–41.
Hope, D. A., Heimberg, R. G. & Bruch, M. A. (1995). Dismantling cognitive-behavioral group therapy for social phobia. Behaviour Research and Therapy, 33, 637–50.
Horikawa, N., Yamazaki, T., Miyamoto, K. et al. (2003). Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. General Hospital Psychiatry, 25, 289–92.
Horowitz, J., Wolitzky, K. & Powers, M. (2005). Psychosocial Treatments for Specific Phobias: A Meta-analysis. Washington, DC.
Howard, R. J., Juszczak, Ballard, C. G., et al. (2007). Donezepil for the treatment of agitation in Alzheimer’s disease. New England Journal of Medicine, 357, 1382–92.
Howard, R. J., Juszczak, E., Ballard, C. G. et al. (2008). Donepezil for the treatment of agitation in Alzheimer’s disease. New England Journal of Medicine, 357, 1382–92.
Howlin, P. & Rutter, M. (1987). Treatment of Autistic Children. Chichester: Wiley.
Howlin, P. (2010). Evaluating psychological treatments for children with autism-spectrum disorders. Advances in Psychiatric Treatment, 16, 133–40.
Howlin, P., Gordon, K., Pasco, G. & Charman, T. (2007). A group randomised, controlled trial of the Picture Exchange Communication System for children with autism. Journal of Child Psychology and Psychiatry, 48, 473–8.
Howlin, P., Magiati, I. & Charman, T. (2009). Systematic review of early intensive behavioural interventions for children with autism. American Journal on Mental Retardation, 114, 23–41.
Hughes, J. R. (1991). Long-term use of nicotine-replacement therapy. In: S. M. Henningfield, ed. New Developments in Nicotine-Delivery Systems. New York: Carlton, pp. 64–71.
Hughes, J. R. (1994). An algorithm for smoking cessation. Archives of Family Medicine, 3, 280–5.
Humphreys, K. (2003). Alcoholics Anonymous and 12-Step alcoholism treatment programs. In: M. Galanter, ed. Recent Developments in Alcoholism, Vol 16: Research on Alcoholism Treatment. New York: Kluwer Academic/Plenum, pp. 149–64.
Humphreys, K. & Moos, R. H. (2001). Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research, 25, 711–16.
Humphreys, K., Mankowski, E. S., Moos, R. H. & Finney, J. W. (1999). Do enhanced friendship networks and active coping mediate the effect of self-help groups on substance abuse?Annals of Behavioral Medicine, 21, 54–60.
Humphreys, K., Wing, S., McCarty, D. et al. (2004). Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy. Journal of Substance Abuse Treatment, 26, 151–8.
Huppert, J. D. & Franklin, M. E. (2006). Cognitive behavioral therapy for obsessive-compulsive disorder: an update. Current Psychiatry Reports, 7, 268–73.
Hurt, R. D., Sachs, D. P. L., Glover, E. D.et al. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195–202.
Hymel, S., Wagner, E. & Butler, L. J. (1990). Reputational bias: view from the peer group. In: S. R. Asher & J. D. Coie, eds. Peer Rejection in Childhood. Cambridge: Cambridge University Press, pp. 156–88.
Illich, I. (1975). Medical Nemesis. The Expropriation of Health. London: Marion Boyars.
Ingenhoven, T., Lafay, P., Rinne, T., Passchier, J. & Duivenvoorden, H. (2010). Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. Journal of Clinical Psychiatry, 71, 14–25.
Insel, T. (1995). The development of brain and behavior. In: F. Bloom & D. Kupfer, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press.
Institute of Medicine (
1990).
Broadening the Base of Treatment for Alcohol Problems.
Washington, D.C.:
National Academy Press (retrieved from
http://www.nap.edu).
International Psychogeriatric Association (1998). Behavioural and Psychological Symptoms of Dementia. Chicago: International Psychogeriatric Association.
Ipser, J. C., Kariuki, C. M. & Stein, D. J. (2008). Pharmacotherapy for social anxiety disorder: a systematic review. Expert Reviews in Neurotherapeutics, 8, 235–57.
Irvin, J. E., Bowers, C. A., Dunn, M. E. & Wang, M. C. (1999). Efficacy of relapse prevention: a meta-analytic review. Journal of Consulting and Clinical Psychology, 67, 563–70.
Izzo, A. A. (2004). Drug interactions with St. John’s Wort (Hypericum perforatum): a review of the clinical evidence. International Journal of Clinical Pharmacology Therapy, 42, 139–48.
Jackson, H. J., McGorry, P. D., Killackey, E. et al. (2008). Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus befriending for first-episode psychosis: the ACE project. Psychological Medicine, 38, 725–35.
Jacobi, C., Hayward, C., DeZwann, M., Karemer, H. C. & Agras, W. S. (2004). Coming to terms with risk factors for eating disorders: application of risk terminology and suggestions for a general taxonomy. Psychological Bulletin, 130(1), 19–65.
Jacobs, B., Green, J., Kroll, L., Tobias, C., Dunn, G. & Briskman, J. (2009). The effect of inpatient care on measured Health Needs in children and adolescents. Journal of Child Psychology and Psychiatry, 50, 1273–81.
Jacobson, N. D., Dobson, K. S., Truax, P. A. et al. (1996). A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology, 64, 295–304.
Jacobson, N. S., Martell, C. R. & Dimidjian, S. et al. (2001). Behavioral activation treatment for depression: returning to contextual roots. Clinical Psychology: Science and Practice, 8(3), 255–68.
Jacobson, S. W. & Frye, K. F. (1991). Effects of maternal social support on attachment: experimental evidence. Child Development, 62, 572–82.
Jäger, B., Liedke, R., Künsebeck, H.-W., Lempa, W., Kersting, A. & Seide, L. (1996). Psychotherapy and bulimia nervosa: evaluation and long-term follow-up of two conflict-orientated treatment conditions. Acta Psychiatrica Scandinavica, 93, 268–78.
Janowsky, D. S., Kraus, J. E., Barnhill, L. J. et al. (2003). Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study. Journal of Clinical Psychopharmacology, 23, 500–4.
Janowsky, D. S., Shetty, M., Barnhill, L. J. et al. (2005). Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial. International Journal of Neuropsychopharmacology, 8, 37–48.
Jarrett, R. B., Schaffer, M., McIntire, D. et al. (1999). Treatment of atypical depression with cognitive therapy or phemelzein: a double-blind placebo-controlled trial. Archives of General Psychiatry, 56, 431–7.
Jenike, M. A. (1998). Neurosurgical treatment of obsessive-compulsive disorder. British Journal of Psychiatry, 35 (Suppl), 79–90.
Jeste, D. V., Caligiuri, M. P., Paulsen, J. S. et al. (1995). Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Archives of General Psychiatry, 52, 756–65.
John, U., Veltrup, C., Driessen, M., Wetterling, T. & Dilling, H. (2003). Motivational intervention: an individual counselling vs. a group treatment approach for alcohol-dependent inpatients. Alcohol & Alcoholism, 38, 263–9.
Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A. & Bigelow, G. E. (1995). A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence, 40, 17–25.
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L. & Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343, 1290–7.
Johnson, R. E., Strain, E. C. & Amass, L. (2003). Buprenorphine: how to use it right. Drug and Alcohol Dependence, 70 (2 Suppl), S59–77.
Johnston, L. D., O’Malley, P. M. & Bachman, J. G. (2002). Monitoring the Future National Survey Results on Adolescent Drug Use: Overview of Key Findings (NIH Publication No. 03–5374). Bethesda, MD: National Institute on Drug Abuse. 56.
Jones, C., Cormac, I., Silveira da Mota Neto, J. I. & Campbell, C. (2004). Cognitive behaviour therapy for schizophrenia. The Cochrane Database of Systematic Reviews, 4, CD000524. pub2.doi: 10.1002/14651858.CD000524.pub2. Oxford: Update Software Ltd.
Jones, P. B., Barnes, T. R., Davies, L. et al. (2006). Randomized controlled trial of the effect on Quality of Life of second- vs. first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry, 63, 1079–87.
Jorenby, D. E., Leischow, S. J., Nides, M. A. et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, 685–91.
Jorenby, D. E., Hays, J. T., Rigotti, N. A. et al. (2006). Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Journal of the American Medical Association, 296, 56–63.
Josiassen, R. C., Joseph, A., Kohegyi, E. et al. (2005). Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 162, 130–6.
Joyce, P. R., Mulder, R. T. et al. (2003). A differential response to nortriptyline and fluoxetine and melancholic depression: the importance of age and gender. Acta Psychiatrica Scandinavica, 108, 20–3.
Joyce, P. R., McKenzie, J. M., Carter, J. D. et al. (2007). Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive behaviour therapy for depression. British Journal of Psychiatry, 190, 503–8.
Juffer, F., Hoksbergen, A. C., Riksen-Walraven, J. M. & Kohnstamm, G. A. (1997). Early intervention in adoptive families: supporting maternal sensitive responsiveness, infant–mother attachment, and infant competence. Journal of Child Psychology and Psychiatry, 38, 1039–50.
Juffer, F., Bakermans-Kranenburg, M. J. & van Ijzendoorn, M. H. (2005). The importance of parenting in the development of disorganized attachment: evidence from a preventative intervention study in adoptive families. Journal of Child Psychology and Psychiatry, 46, 263–74.
Jureidini, J. N., Doecke, C. J., Mansefield, P. R. et al. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal, 328, 879–83.
Kabat-Zinn, J. (1990). Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York: Delacorte.
Kächele, H., Kordy, H., Richard, M. & Research Group TR-EAT (2001). Therapy amount and outcome of inpatient psychodynamic treatment of eating disorders in Germany: Data from a multicenter study. Psychotherapy Research, 11, 239–57.
Kadden, R. M. & Conney, N. L. (2005). Treating alcohol problems. In: G. A. Marlatt & D. M. Donovan, eds. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press, pp. 65–91.
Kadden, R., Carroll, K., Donovan, D.et al. (1994). Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence (Project Match Monograph Series Vol. 3; NIH Publication No. 94–3724). Rockville, MD: National Institute on Alcohol and Alcoholism.
Kadden, R. M., Litt, M. D., Kabela-Cormier, E. & Petry, N. M. (2007). Abstinence rates following behavioral treatments for marijuana dependence. Addictive Behaviors, 32, 1220–36.
Kafantaris, V., Coletti, D., Dicker, R., Padula, G. & Kane, J. M. (2003). Lithium treatment of acute mania in adolescents: a large open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1038–45.
Kafantaris, V., Coletti, D., Dicker, R. et al. (2004). Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 984–93.
Kahn, C. & Pike, K. (2001). In search of predictors of dropout from inpatient treatment for anorexia nervosa. International Journal of Eating Disorders, 30, 237–44.
Kahn, R. J., McNair, D. M., Lipman, R. S. et al. (1986). Imipramine and chordiazepoxide in depressive and anxiety disorders: II. Efficacy in anxious out-patients. Archives of General Psychiatry, 43, 79–85.
Kakko, J., Svanborg, K. D., Kreek, M. J. & Heilig, M. (2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet, 361, 662–8.
Kaminer, Y., Burleson, J. A. & Goldberger, R. (2002). Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. Journal of Nervous & Mental Disease, 190, 737–45.
Kampman, K. M., Alterman, A. I. & Volpicelli, J. R. (2001a). Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychology of Addictive Behavior, 15, 52–9.
Kampman, K. M., Volpicelli, J. R. & Mulvaney, F. (2001b). Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug and Alcohol Dependence, 63, 69–78.
Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L. & Hendriks, G.-J. (2002). A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. Journal of Clinical Psychiatry, 63(9), 772–7.
Kane, J. M., Honigfeld, G., Singer, J., Meltzer, H. & Group tCCS (1988). Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine/benztropine. Archives of General Psychiatry, 45, 789–96.
Kaplan, H. S. (1974). The New Sex Therapy: Active Treatment of Sexual Dysfunctions. New York: Brunner Mazel.
Kasari, C., Freeman, S. & Paparella, T. (2006). Joint attention and symbolic play in young children with autism: a randomized controlled intervention study. Journal of Child Psychology and Psychiatry, 47, 611–20.
Kasari, C., Paparella, T., Freeman, S. & Jahromi, L. B. (2008). Language outcome and autism: randomized comparison of joint attention and play interventions. Journal of Consulting and Clinical Psychology, 76, 125–37.
Kasper, S., Gastpar, M., Müller, W. E. et al. (2008). Efficacy of St. John’s wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 258, 59–63.
Katon, W. J., Roy-Byrne, P., RussoJ. & Cowley, D. (2002). Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Archives of General Psychiatry, 95, 1098–104.
Katona, C. L., Abou-Saleh, M. T. et al. (1995). Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. British Journal of Psychiatry, 166(1), 80–6.
Katz, R. J., De Veaugh-Geiss, J. & Landau, P. (1990). Clomipramine in obsessive-compulsive disorder. Biological Psychiatry, 28, 401–14.
Katz, R. J., Lott, M. H., Arbus, P. et al. (1995). Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety, 1, 169–74.
Kaye, W. H., Nagata, T., Weltzin, T. E. et al. (2001). Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry, 49(7), 644–52.
Kazanjian, A. & Rothon, D. A. (2002). Acupuncture in the Management of Alcohol and Drug Dependence. Vancouver, BC: British Columbia Office of Health Technology Assessment, University of British Columbia.
Kazdin, A. E. (1996). Dropping out of child therapy: issues for research and implications for practice. Clinical Child Psychology and Psychiatry, 1, 133–56.
Kazdin, A. E. (2000). Psychotherapy for Children and Adolescents: Directions for Research and Practice. Oxford: Oxford University Press.
Kazdin, A. E. & Wassel, G. (1999). Barriers to treatment participation and therapeutic change among children referred for conduct disorder. Journal of Clinical Child Psychology, 28, 160–72.
Kazdin, A. E., Bass, D., Ayers, W. A. & Rodgers, A. (1990). Empirical and clinical focus of child and adolescent psychotherapy research. Journal of Consulting and Clinical Psychology, 58, 729–40.
Kearns, G. L. & Reed, M. D. (1989). Clinical pharmacokinetics in infants and children: a reappraisal. Clinical Pharmacokinetics, 17, 29–67.
Keel, P. K., Fichter, M., Quadflieg, N. et al. (2004). Application of a latent class analysis to empirically define eating disorder phenotypes. Archives of General Psychiatry, 61, 192–200.
Keller, M. B., McCullough, J. P., Klein, D. N. et al. (2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462–70.
Kellner, C. H., Knapp, R., Husain, M. M et al. (2010). Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomized trial. British Journal of Psychiatry, 196, 226–34.
Kelly, D. & Mitchell-Heggs, N. (1973). Stereotactic limbic leucotomy: a follow-up study of thirty patients. Postgraduate Medical Journal, 49, 852–65.
Kenardy, J. A., Dow, M. G., Johnston, D. W., Newman, M. G., Thomson, A. & Taylor, C. B. (2003). A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial. Journal of Consulting and Clinical Psychology, 71(6), 1068–75.
Kenardy, J. R. S. & Dob, R. (2005). Cognitive behaviour therapy for panic disorder: long-term follow-up. Cognitive Behaviour Therapy, 2003, 34(2), 75–8.
Kendall, P. C. (ed.) (2000). Child & Adolescent Therapy: Cognitive-Behavioral Procedures. New York: Guilford Press.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M. et al. (1997). Therapy for youths with anxiety disorders: a second randomised clinical trial. Journal of Consulting and Clinical Psychology, 65, 366–80.
Kennedy, E. (2004). Child and Adolescent Psychotherapy: A Systematic Review of Psychoanalytic Approaches. London: North Central London Strategic Health Authority.
Kennedy, E., Kumar, A. & Datta, S. S. (2007). Antipsychotic medication for childhood-onset schizophrenia. Cochrane Database of Systematic Reviews, 3, CD004027. doi: 10.1002/14651858.CD004027.pub2.
Kenwright, M. & Marks, I. (2004). Computer-aided self-help for phobia/panic: feasibility study. British Journal of Psychiatry, 179, 456–9.
Kerwin, M. E. (1999). Empirically supported treatments in pediatric psychology: severe feeding problems. Journal of Pediatric Psychology, 24, 193–214.
Keso, L. & Salaspuro, M. (1990). Inpatient treatment of employed alcoholics: a randomized clinical trial of Hazelden-type and traditional treatment. Alcoholism: Clinical and Experimental Research, 14, 584–9.
Kessler, R. C., Stang, P., Wittchen, H. U., Stein, M. & Walters, E. E. (1999). Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychological Medicine, 29, 555–67.
Kessler, R. C., Berglund, P., DemlerO. (2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593–602.
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–27.
Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K. & Walters, E. E. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415–24.
Kho, K. H., Vreeswijk, M. F., Simpson, S. & Zwinderman, A. H. (2003). A meta-analysis of electroconvulsive therapy efficacy in depression. Journal of ECT, 19(3), 139–47.
Kiefer, F., Jahn, H., Tarnaske, T. et al. (2003). Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Archives of General Psychiatry, 60, 92–99.
Kim, K. Y., Bader, G. M., Kotlyar, V. et al. (2003). Treatment of delirium in older adults with quetiapine. Journal of Geriatric Psychiatry and Neurology, 16, 29–31.
King, B. H., Hollander, E., Sikich, L. et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry, 66, 583–90.
King, M., Holt, V. & Nazareth, I. (2007). Women’s views of their sexual difficulties: agreement and disagreement with clinical diagnoses. Archives of Sexual Behavior, 36, 281–8.
King, N., Tonge, B., Heyne, D. et al. (1998). Cognitive behavioural treatment of school-refusing children: a controlled evaluation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 395–403.
King, V. L., Stoller, K. B., Hayes, M. et al. (2002). A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence, 65, 137–48.
Kingdon, D. G. & Turkington, D. (1995). Cognitive Behavioral Therapy of Schizophrenia. Psychology Press.
Kingdon, D., Tyrer, P., Seivewright, N., Ferguson, B. & Murphy, S. (1996). The Nottingham Study of Neurotic Disorder: influence of cognitive therapists on outcome. British Journal of Psychiatry, 169, 93–97.
Kinsey, A. C., Pomeroy, W. B. & Martin, C. E. (1948). Sexual Behaviour in the Human Male. Philadelphia: Saunders.
Kirchmayer, U., Davoli, M., Verster, A. D., Amato, L., Ferri, M. & Perucci, C. A. (2002). A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction, 97, 1241–9.
Klein Velderman, M., Bakermans-Krenenburg, M. J., Juffer, F. & van Ijzendoorn, M. H. (2006). Effects of attachment-based interventions on maternal sensitivity and infant attachment: differential susceptibility of highly reactive infants. Journal of Family Psychology, 20, 266–74.
Klein, R. G., Abikoff, H., Klass, E., Ganeles, D., Seese, L. M. & Pollack, S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry, 54, 1073–9.
Klerman, G. L., Weissman, M. M., Rousaville, B. J. & Chevron, E. S. (1984). Interpersonal Psychotherapy of Depression. New York: Basic Books.
Klinkvan der J. J., Blonk, R. W., Schene, A. H.& van Dijk, F. J. (2003). Reducing long term sickness absence by an activating intervention in adjustment disorders: a cluster randomised controlled design. Occupational & Environmental Medicine, 60, 429–37.
Kobak, K. A., Greist, J. H., Jefferson, J. W., Katzelnick, D. J. & Henk, H. J. (1998). Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology (Berlin), 136, 205–16.
Kockott, G. & Fahrner, E. M. (1987). Transsexuals who have not undergone surgery: a follow-up study. Archives of Sexual Behavior, 16, 511–22.
Kocsis, J. H., Gelenberg, A. J., Rothbaum, B. O. et al. (2009). Cognitive Behavioral Analysis System of Psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression. Archives of General Psychiatry, 66, 1178–88.
Kodak, T. & Piazza, C. C. (2008). Assessment and behavioral treatment of feeding and sleeping disorders in children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 17(4), 887–905.
Koenigsberg, H. W., Reynolds, D. & Goodman, L. (2003). Risperidone in the treatment of schizotypal personality disorder. Journal of Clinical Psychiatry, 64, 628–34.
Kolb, L. C., Burris, B. C. & Griffiths, S. (1984). Propranolol and clonidine in the treatment of the chronic post-traumatic stress disorders of war. In: B. A. Van der Kolk, ed. Post-traumatic Stress Disorder: Psychological and Biological Sequelae. Washington, DC: American Psychiatric Press, pp. 98–105.
Kolevzon, A., Mathewson, K. A. & Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. Journal of Clinical Psychiatry, 67, 407–14.
Kollins, S. H. (2008). A qualitative review of issues arising in the use of psycho stimulant medications in patients with ADHD and comorbid substance use disorders. Current Medical Research and Opinion, 24, 1345–57.
Koran, L. M., Hanna, G. L., Hollander, E., Nestadt, G., Simpson, H. B., on behalf of the American Psychiatric Association (2007). Practice guideline for the treatment of patients with obsessive-compulsive disorder. American Journal of Psychiatry, 164 (7 Suppl), 5–53.
Kornstein, S. G., Schatzberg, A. F. et al. (2000). Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry, 157(9), 1445–52.
Kosten, T. R. & O’Connor, P. G. (2003). Management of drug and alcohol withdrawal. New England Journal of Medicine, 348, 1786–95.
Kosten, T. R. (2002). Pathophysiology and treatment of cocaine dependence. In C. Nemeroff, ed. Neuropsychopharmacology: The Fifth Generation of Progress. Baltimore, MD: Lippincott Williams & Wilkins, pp. 1461–73.
Kosten, T. R. (2003). Buprenorphine for opioid detoxification: a brief review. Addictive Disorders and Their Treatment, 2, 107–12.
Kosten, T. R., Frank, J. B., Dan, E., McDougle, C. J. & Giller, E. L. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366–70.
Kosten, T., Oliveto, A., Feingold, A. et al. (2003). Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug & Alcohol Dependence, 70, 315–25.
Kotler, L. A., Cohen, P., Davies, M., Pine, D. S. & Walsh, B. T. (2001). Longitudinal relationships between childhood, adolescent, and adult eating disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1434–40.
Kotler, L. A., Devlin, M. J., Davies, M. & Walsh, B. T. (2003). An open trial of fluoxetine for adolescents with bulimia nervosa. Journal of Child and Adolescent Psychopharmacology, 13, 329–35.
Kovacs, M., Rush, A. J., Beck, A. T. & Hollon, S. T. (1981). Depressed outpatients treated with cognitive therapy or pharmacotherapy. Archives of General Psychiatry, 38, 33–9.
Kowatch, R. A., Fristad, M., Birmaher, B. et al. and the Child Psychiatric Workgroup on Bipolar Disorder (2005). Treatment guidelines for children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 213–35.
Kranzler, H. R. & Van Kirk, J. (2001). Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism: Clinical and Experimental Research, 25, 1335–41.
Kranzler, H. R., Armeli, S., Tennen, H. et al. (2003). Targeted naltrexone for early problem drinkers. Journal of Clinical Psychopharmacology, 23, 294–304.
Krauth, C. (2002). How high are the costs of eating disorders – anorexia nervosa and bulimia nervosa – for German Society?European Journal of Health Economics, 3, 244–50.
Krijn, M., Emmelkamp, P. M., Biemond, R., de Wilde, L. C., Schuemie, M. J. & van der Mast, C. A. (2004). Treatment of acrophobia in virtual reality: the role of immersion and presence. Behaviour Research and Therapy, 42(2), 229–39.
Kripke, D. F., Mullaney, D. J., Klauber, M. R., Risch, S. C. & Gillin, J. C. (1992). Controlled trial of bright light for nonseasonal major depressive disorders. Biological Psychiatry 31(2), 119–34.
Kristeller, J. L. & Hallett, C. B. (1999). An exploratory study of a meditation-based intervention for binge eating disorder. Journal of Health Psychology 4(3), 357–63.
Kroenke, K. & Swindle, J. (2000). Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychotherapy and Psychosomatics, 69, 205–15.
Kuiper, B. & Cohen-Kettenis, P. (1988). Sex reassignment surgery: a study of 141 Dutch transsexuals. Archives of Sexual Behavior, 17, 439–57.
Kumar, V., Anand, R., Messina, J., Hartman, R. & Veach, J. (2000). An efficacy and safety analysis of Exelon in Alzheimer’s disease patients with concurrent vascular risk factors. European Journal of Neurology, 7, 159–69.
Kumra, S., Frazier, J. A., Jacobsen, L. K. et al. (1996). Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison. Archives of General Psychiatry, 53, 1090–7.
Kumra, S., Kranzler, H., Gerbino-Rosen, G. et al. (2007). Clozapine and “high-dose” olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biological Psychiatry, 63, 524–9.
Kurlan, R., Cummings, J., Raman, R. & Thal, L. (2007). Quetiapine for agitation or psychosis in patients with dementia and parkinsonism: Alzheimer’s Disease Cooperative Study Group. Neurology, 68, 1356–63.
Kusel, A. B. (1999). Primary prevention of eating disorders through media literacy training of girls. Dissertation Abstracts International B: The Sciences & Engineering, 60(4-B), 1859.
Kypri, K., Langley, J. D., Saunders, J. B., Cashell-Smith, M. L. & Herbison, P. (2008). Randomized controlled trial of web-based alcohol screening and brief intervention in primary care. Archives of Internal Medicine, 168, 530–6.
Kypri, K., Sitharthan, T., Cunningham, J. A., Kavanagh, D. J. & Dean, J. I. (2005). Innovative approaches to intervention for problem drinking. Current Opinion in Psychiatry, 18, 229–34.
Lacroix, I., Berrebi, A., Chaumerliac, C., Lapeyre-Mestre, M., Montastruc, J. L. & Damase-Michel, C. (2004). Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction, 99, 209–14.
Laederach-Hofmann, K., Graf, C., Horber, F. et al. (1999). Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. International Journal of Eating Disorders, 26(3), 231–44.
Lam, R. W., Goldner, E. M. & Grewal, A. K. (1996). Seasonality of symptoms in anorexia and bulimia nervosa. International Journal of Eating Disorders, 19, 35–44.
Lam, R. W., Lee, S. K., Tam, E. M., Grewal, A. & Yatham, L. N. (2001). An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa. Journal of Clinical Psychiatry, 62(3), 164–8.
Lambourn, J. & Gill, D. (1978). A controlled comparison of simulated and real ECT. British Journal of Psychiatry, 133, 514–19.
Lancaster, T. & Stead, L. F. (1999). Self help interventions for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.
Lanctôt, K. L., Best, T. S., Mittmann, N. et al. (1998). Efficacy and safety of neuroleptics in behavioural disorders associated with dementia. Journal of Clinical Psychiatry, 59, 550–61; quiz 562–3.
Landen, M., Walinder, J. & Lundstrom, B. (1996). Prevalence, incidence and sex ratio of transsexualism. Acta Psychiatrica Scandinavica, 93, 221–3.
Landen, M., Walinder, J., Hambert, G. & Lundstrom, B. (1998). Factors predictive of regret in sex reassignment. Acta Psychiatrica Scandinavica, 97, 284–9.
Larimer, M. E. & Cronce, J. M. (2002). Identification, prevention and treatment: a review of individual-focused strategies to reduce problematic alcohol consumption by college students. Journal of Studies on Alcohol, Suppl. 14, 148–63.
Lask, B. & Bryant-Waugh, R. (2007). Anorexia Nervosa and Related Eating Disorders in Childhood and Adolescence, 3nd edn. Hove, East Sussex: Psychology Press, Taylor and Francis Group.
Lasser, K., Boyd, J. W., Woolhandler, S. et al. (2000). Smoking and mental illness: a population-based prevalence study. Journal of the American Medical Association, 284, 2606–10.
Laumann, E. O., Paik, A. & Rosen, R. C. (1999). Sexual dysfunction in the United States: prevalence and predictors. Journal of the American Medical Association, 281, 537–44.
Laundreville, P., Bordes, M., DicaireL. & Verrault, R. (1998). Behavioral approaches for reducing agitation in residents of long-term-care facilities: critical review and suggestions for future research. International Psychogeriatrics, 10, 397–419.
Law, M. & Tang, J. L. (1995). An analysis of the effectiveness of interventions intended to help people stop smoking. Archives of Internal Medicine, 155, 1933–41.
Le Grange, D., Crosby, R., Rathouz, P. & Leventhal, B. (2007). A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa. Archives of General Psychiatry, 64, 1049–56.
LeBlanc, L. A., Piazza, C. C. & Krug, M. A. (1997). Comparing methods for maintaining the safety of a child with pica. Research in Developmental Disabilities, 18, 215–20.
Leggio, L., Kenna, G. A. & Swift, R. M. (2008). New developments for the pharmacological treatment of alcohol withdrawal syndrome: a focus on non-benzodiazepine GABAergic medications. Progress in Neuropsychopharmacology and Biological Psychiatry, 32, 1106–17.
Lehman, A. F., Lieberman, J. A. & Dixon, L. B. (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry, 161 (Suppl. 2), 1–56.
Leichsenring, F. & Leibing, E. (2003). The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: a meta-analysis. American Journal of Psychiatry, 160, 1223–32.
Lejoyeux, M., Solomon, J. & Ades, J. (1998). Benzodiazepine treatment for alcohol-dependent patients. Alcohol and Alcoholism, 33, 563–75.
Letemendia, J. F., Delva, N. J., Rodenberg, M. et al. (1993). Therapeutic advantage of bifrontal electrode placement in ECT. Psychological Medicine, 23, 349–60.
Leucht, S., Pitschel-Walz, G., Abraham, D. & Kissling, W. (1999). Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trials. Schizophrenia Research, 35, 51–68.
Leucht, S., Barnes, T. R., Kissling, W., Engel, R. R., Correll, C. & Kane, J. M. (2003). Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry, 160, 1209–22.
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C. & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet, 373, 31–41.
Levine, M. D., Marcus, M. D. & Moulton, P. (1996). Exercise in the treatment of binge-eating disorder. International Journal of Eating Disorders, 19, 171–7.
Levine, S. B. & Shumaker, R. E. (1983). Increasingly Ruth: toward understanding sex reassignment. Archives of Sexual Behavior, 12, 247–61.
Lewinsohn, P. M. & Clarke, G. N. (1999). Psychosocial treatments for adolescent depression. Clinical Psychology Review, 19, 329–42.
Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R. & Andrew, J. A. (1993). Adolescent psychopathology, I: prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology, 103, 133–44.
Lewis, S. W., Barnes, T. R., Davies, L. et al. (2006). Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia Bulletin, 32, 715–23.
Licht, R. W & Quitzau, S. (2002). Treatment strategies in patients with major depression not responding to first-line sertraline treatment. Psychopharmacology, 161, 143–51.
Liddle, H. A. (2004). Family-based therapies for adolescent alcohol and drug use: research contributions and future research needs. Addiction, 99 (Suppl. 2), 76–92.
Lidz, T., Flack, S. & Cornelison, A. (1965). Schizophrenia and the Family. New York: International Press.
Lieberman, A., Weston, D. & Pawl, J. (1991). Preventive intervention and outcome with anxiously attached dyads. Child Development, 62, 199–209.
Lieberman, J. A., Stroup, T. S. & McEvoy, J. P. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209–23.
Liebowitz, M. R., Heimberg, R. G., Schneier, F. R. et al. (1999). Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depression and Anxiety, 10, 89–98.
Liebowitz, M. R., Schneier, F., Campeas, R. et al. (1992). Phenelzine vs. atenolol in social phobia: a placebo-controlled comparison. Archives of General Psychiatry, 49, 290–300.
Liebowitz, M. R., Gelenberg, A. J. & Munjack, D. (2005). Venlafaxine extended release vs. placebo and paroxetine in social anxiety disorder. Archives of General Psychiatry, 62, 190–8.
Liebrenz, M., Boesch, L., Stohler, R. et al. (2010). Benzodiazepine dependence: when abstinence is not an option. Addiction, 105, 1877–8.
Lief, H. I. & Hubschman, L. (1993). Orgasm in the postoperative transsexual. Archives of Sexual Behavior, 22, 145–55.
Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W. & Melchart, D. (1996). St John’s wort for depression: an overview and meta-analysis of randomised clinical trials. British Medical Journal, 313(7052), 253–8.
Linde, K., Berner, M., Egger, M. & Mulrow, C. (2005). St John’s wort for depression: meta-analysis of randomised controlled trials. British Journal of Psychiatry, 186, 99–107.
Lindemalm, G., Korlin, D. & Uddenberg, N. (1986). Long-term follow-up of “sex change” in 13 male-to-female transsexuals. Archives of Sexual Behavior, 15, 187–210.
Lindemalm, G., Korlin, D. & Uddenberg, N. (1987). Prognostic factors vs. outcome in male-to-female transsexualism: a follow-up study of 13 cases. Acta Psychiatrica Scandinavica, 75, 268–74.
Linehan, M. M., Armstrong, H., Suarez, A, Allmon, D. & Heard, H. L. (1991). Cognitive-behavioural treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–64.
Linehan, M. M., Schmidt, H. 3rd., Dimeff, L. A., Craft, J. C., Kanter, J. & Comtois, K. A. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions, 8, 279–92.
Linehan, M. M., Comtois, K. A., Murray, A. M. et al. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs. therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757–66.
Ling, W., Wesson, D. R., Charuvastra, C. & Klett, C. J. (1996). A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53, 401–7.
Lingford-Hughes, A. R., Welch, S. & Nutt, D. J. (2004). Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 18, 293–335.
Linscheid, T. R. & Murphy, L. B. (1999). Feeding disorders of infancy and early childhood. In: S. D. Nether, ed. Child and Adolescent Psychological Disorders: A Comprehensive Textbook. New York: Oxford University Press, pp. 139–55.
Lochman, J. E. & Wells, K. C. (1996). A social-cognitive intervention with aggressive children: prevention effects and contextual implementation issues. In: R. Peters & R. J. Mcmahon, eds. Prevention and Early Intervention: Childhood Disorders, Substance Use and Delinquency. Thousand Oaks, CA: Sage, pp. 111–43.
Lock, J. & Fitzpatrick, K. K. (2009). Advances in psychotherapy for children and adolescents with eating disorders. American Journal of Psychotherapy, 63, 287–303.
Lock, J., Le Grange, D., Agras, W. S. & Dare, C. (2001). Treatment Manual for Anorexia Nervosa: A Family-Based Approach. New York: Guilford Publications, Inc.
Loeb, K. L., Walsh, B. T., Lock, J. et al. (2007). Open trial of family-based treatment for full and partial anorexia nervosa in adolescence: evidence of successful dissemination. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 792–800.
Lonergan, E. T., Cameron, M. & Luxenberg, J. et al. (2004). Valproic acid for agitation in dementia. Cochrane Database of Systematic Reviews, CD003945. Oxford: Update Software Ltd.
Lonergan, E., Luxenberg, J., Areosa Sastre, A. (2009). Benzodiazepines for delirium. Cochrane Database of Systematic Reviews, Oct 7(4), CD006379.
Lorig, K. R. & Holman, H. (2003). Self-management education: history, definition, outcomes, and mechanisms. Annals of Behavior Medicine, 26, 1–7.
Lovaas, O. I. (2002). Teaching Individuals with Developmental Delays: Basic Intervention Techniques. Austin, Texas: Pro-Ed.
Loy, C. & Schneider, L. (2006). Galantamine for Alzheimer’s disease and mild cognitive impairment. Cochrane Database of Systematic Reviews, 1.
Luty, S. E., Carter, J. D., McKenzie, J. M. et al. (2007). Christchurch Psychotherapy of Depression Study: a randomised controlled trial of interpersonal psychotherapy and cognitive behaviour therapy. British Journal of Psychiatry, 190, 496–502.
Lyketsos, C. G., DelCampo, L., Steinberg, M. et al. (2003). Treating depression in Alzheimer’s disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Archives of General Psychiatry, 60, 737–46.
Lyons-Ruth, K., Connell, D. B., Grunebaum, H. U. & Botein, S. (1990). Infants at social risk: maternal depression and family support services. Child Development, 61, 85–98.
Ma, H. & Teasdale, J. D. (2004). Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology, 72(1), 31–40.
Macey, M. L., Thompson, M., Santosh, P. J & Wong, I. C. K. (2005). Effects of the committee on safety of medicines advice on antidepressant prescribing to children and adolescents in the UK. Drug Safety, 28, 1151–7.
Mackenzie, A., Funderburk, F. R. & Allen, R. P. (1999). Sleep, anxiety, and depression in abstinent and drinking alcoholics. Substance Use and Misuse, 34, 347–61.
Mackin, P., Bishop, D., Watkinson, H., Gallagher, P. & Ferrier, I. N. (2007). Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. British Journal of Psychiatry, 191, 23–9.
Maggioni, A. & Lifschitz, F. (1995). Nutritional management of failure to thrive. Pediatric Clinics of North America, 42, 791–810.
Mains, J. A. & Scogin, F. R. (2003). The effectiveness of self-administered treatments: a practice-friendly review of the research. Journal of Clinical Psychology, 59, 237–46.
Malouf, R. & Birks, J. (2004). Donepezil for vascular cognitive impairment. Cochrane Database of Systematic Reviews, 1, CD004395.
Manassis, K., Mendlowitz, S. L., Scapillato, D. et al. (2002). Group and individual cognitive-behavioural therapy for childhood anxiety disorders: a randomised trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1423–30.
Mancini, C., Van-Ameringen, M., Oakman, R. & Farvolden, P. (1999). Serotonergic agents in the treatment of social phobia in children and adolescents: a case series. Depression and Anxiety, 10(1), 33–9.
Mann, K., Lehert, P. & Morgan, M. Y. (2004). The efficacy of acamprosate in the maintenance of abstinence in alcohol-depending individuals: results of a meta-analysis. Alcoholism: Clinical Experimental Research, 28, 51–63.
Mantovani, A., Stanford, A. D., Bulow, P. & Lisanby, S. H. (2008). Focal brain stimulation approaches to psychiatric treatment. In: P. Tyrer & K. R. Silk, eds. Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge: Cambridge University Press, pp. 83–97.
Marcaurelle, R., Belanger, C. & Marchand, A. (2003). Marital relationship and the treatment of panic disorder with agoraphobia: a critical review. Clinical Psychology Review, 23, 247–76.
March, J. S., Amaya-Jackson, L., Murray, M. D., Cathryn, M. & Schulte, A. (1998). Cognitive behavioural psychotherapy for children and adolescents with posttraumatic stress disorder after a single incident stressor. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 585–93.
Marcus, R. N., Owen, R., Kamen, L. et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1110–19.
Marder, S. R., Essock, S. M., Miller, A. L. et al. (2002). The Mount Sinai conference on the pharmacology of schizophrenia. Schizophrenia Bulletin, 28, 5–16.
Marder, S. R., Essock, S. M., Miller, A. L. et al. (2004). Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161, 1334–49.
Margolese, H. C. (2000). The male menopause and mood: testosterone decline and depression in the aging male: is there a link?Journal of Geriatric Psychiatry and Neurology, 13(2), 93–101.
Mariani, J. & Levin, F. (2007). Treatment strategies for co-occurring ADHD and substance use disorders. American Journal on Addictions, 16, 45–56.
Marks, I. M., Swinson, R. P. & Basoglu, M. et al. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. British Journal of Psychiatry, 162, 776–87.
Marks, I. M., Kenwright, M., McDonough, M., Whittaker, M. & Mataix-Cols, D. (2004). Saving clinicians’ time by delegating routine aspects of therapy to a computer: a randomized controlled trial in phobia/panic disorder. Psychological Medicine, 34(1), 9–17.
Marks, L. S. (2003). Editorial comment 1. Urology, 62, 125–6.
Marlatt, G. A. (2002). Buddhist philosophy and the treatment of addictive behavior. Cognitive & Behavioral Practice, 9(1), 44–50.
Marlatt, G. A. & Gordon, J. R. (1985). Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford.
Marlatt, G. A. & Witkiewitz, K. (2002). Harm reduction approaches to alcohol use: health promotion, prevention, and treatment. Addictive Behaviors, 27, 867–86.
Marlatt, G. A., Pagano, R., Rose, D. & Marques, J. (1984). Effect of meditation and relaxation training upon alcohol use in male social drinkers. In: D. Shapiro & R. Walsh, eds. Meditation: Classic and Contemporary Perspectives. New York: Aldine, pp. 105–120.
Marrazzi, M. A., Bacon, J. P., Kinzie, J. & Luby, E. D. (1995). Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. International Clinical Psychopharmacology, 10, 163–72.
Marshall, R. D., Beebe, K. L., Oldham, M. & Zaninelli, R. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. American Journal of Psychiatry, 158(12), 1982–8.
Martell, C. R., Dimidjian, S., Mulick, P. S., Roberts, L. J. & Wagner, A. (2003). Clinical applications of behavioral discussion. Panel Discussion, 37th Annual Convention, Association for Advancement of Behavior Therapy, Reno, Nevada.
Martin, J. L. R., Barbanoj, M. J., Schlaepfer, T. E. et al. (2003). Repetitive transcranial magnetic stimulation for the treatment of depression: systematic review and meta-analysis. British Journal of Psychiatry, 182, 480–91.
Martin, J. L. R., Barbanoj, M. J., Schlaepfer, T. E. et al. (2004). Transcranial magnetic stimulation for treating depression [Review]. The Cochrane Database of Systematic Reviews, 1. Oxford: Update Softward Ltd.
Martins, J. G. (2009). EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. Journal of the American College of Nutrition, 28, 525–42.
Marziali, E. & Monroe-Blum, H. (1995). An interpersonal approach to group psychotherapy with borderline personality disorder. Journal of Personality Disorders, 9, 179–89.
Mason, B. J., Goodman, A. M., Chabac, S. & Lehert, P. (2006). Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. Journal of Psychiatric Research, 40, 383–93.
Masters, W. H. & Johnson, V. E. (1970). Human Sexual Inadequacy. Boston: Little Brown.
Mataix-Cols, D. & Marks, I. M. (2006). Self-help with minimal therapist contact for obsessive-compulsive disorder: a review. European Psychiatry, 21, 75–80.
Mate-Kole, C., Freschi, M. & Robin, A. (1988). Aspects of psychiatric symptoms at different stages in the treatment of transsexualism. British Journal of Psychiatry, 152, 550–3.
Mate-Kole, C., Freschi, M. & Robin, A. (1990). A controlled study of psychological and social change after surgical gender reassignment in selected male transsexuals. British Journal of Psychiatry, 157, 261–4.
Mather, A. S., Rodriguez, C., Guthrie, M. F., McHarg, A. M., Reid, I. C. & McMurdo, M. E. (2002). Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. British Journal of Psychiatry, 180, 411–5.
Mattick, R. P., Breen, C., Kimber, J. & Dovoli, M. (2002a). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Systematic Reviews, 4, CD002209. Oxford: Update Software Ltd.
Mattick, R. P., Kimber, J., Breen, C. & Davoli, M. (2002b). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 4. Oxford: Update Software Ltd.
Mayberg, H. S., Lozano, A. M., Voon, V. et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45, 651–60.
Mayo-Smith, M. F. (1997). Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Journal of the American Medical Association, 278, 144–51.
Mayou, R., Kirmayer, L. J., Simon, G., Kroenke, K. & Sharpe, M. (2005). Somatoform disorders: time for a new approach in DSM-V. American Journal of Psychiatry, 162, 847–55.
McBride, N., Farringdon, F., Midford, R., Meuleners, L. & Phillips, M. (2004). Harm minimization in school drug education: final results of the School Health and Alcohol Harm Reduction Project (SHAHRP). Addiction, 99, 278–91.
McCambridge, J. & Strang, J. (2004). The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction, 99, 39–52.
McCann, J., Stein, A., Fairburn, C. G. & Dunger, D. B. (1994). Eating habits and attitudes of mothers of children with non-organic failure to thrive. British Medical Journal, 70, 234–6.
McCann, U. D. & Agras, W. S. (1990). Successful treatment of non-purging bulimia nervosa with desipramine: a double-blind placebo-controlled study [see comments]. American Journal of Psychiatry, 147(11), 1509–13.
McCarney, R., Fisher, P., Iliffe, S. et al. (2008). Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial. International Journal of Geriatric Psychiatry, 23, 1222–30.
McCarthy, O. & Carr, A. (2002). Prevention of bullying. In: A. Carr, ed. Prevention: What Works with Children and Adolescents? A Critical Review of Psychological Prevention Programmes for Children, Adolescents and their Families. Hove, East Sussex: Brunner-Routledge, pp. 205–21.
McCracken, J. T., McGough, J., Shah, B. et al. and Research Units on Pediatric Psychopharmacology Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314–21.
McCrady, B. S., Epstein, E. E. & Hirsch, L. S. (1999). Maintaining change after conjoint behavioral alcohol treatment for men: outcomes at 6 months. Addiction, 94, 1381–96.
McCullough, J. P. (2000). Treatment of Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy. New York: Guilford Press.
McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R. & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–8.
McElroy, S. L., Casuto, L. S., Nelson, E. B. et al. (2000). Placebo-controlled trial of sertraline in the treatment of binge eating disorder. American Journal of Psychiatry, 157(6), 1004–6.
McElroy, S. L., Hudson, J. I., Capece, J. A. et al. (2007). Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biological Psychiatry, 61, 1039–48.
McEvoy, J. P., Lieberman, J. A., Stroup, T. S. et al. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163, 600–10.
McGuire, H. & Hawton, K. (2003). Interventions for vaginismus. Cochrane Database of Systematic Reviews, 1, P:CD001760.
McGurk, S. R., Twamley, E. W., Sitzer, D. I. et al. (2007). A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry, 164, 1791–802.
McIver, S., McGartland, M. & O’Halloran, P. (2009). ‘Overeating is not about the food’: women describe their experience of a yoga treatment for binge eating. Qualitative Health Research, 19, 1234–45.
McKay, J. R., Alterman, A. I., Cacciola, J. S., O’Brien, C. P., Koppenhave, J. M. & Shepard, D. S. (1999). Continuing care for cocaine dependence: comprehensive 2-year outcomes. Journal of Consulting and Clinical Psychology, 67, 420–7.
McKeehan, M. B. & Martin, D. (2002). Assessment and treatment of anxiety disorders and co-morbid alcohol/other drug dependency. Alcoholism Treatment Quarterly, 20, 45–59.
McKeith, I. G. (2006). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Journal of Alzheimer’s Disease, 9 (3 Suppl), 417–23.
McKeith, I. G., Galasko, D., Kosaka, K. et al. (1996). Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology, 47, 1113–24.
McKeith, I., Del Ser, T., Spano, P. et al. (2000). Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 356, 2031–6.
McKellar, J., Stewart, E. & Humphreys, K. (2003). Alcoholics Anonymous involvement and positive alcohol-related outcomes: cause, consequence, or just a correlate? A prospective 2-year study of 2,319 alcohol-dependent men. Journal of Consulting and Clinical Psychology, 71, 302–8.
McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E. & O’Brien, C. P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953–9.
McMain, S. F., Links, P. S., Gnam, W. H. et al. (2009). A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry, 166, 1365–74.
McShane, R., Areosa Sastre, A. & Minakaran, N. (2006). Memantine for dementia. Cochrane Database of Systematic Reviews, 2.
Medical Research Council (1985). Clinical trial of the treatment of depressive illness. British Medical Journal, 5439, 881–6.
Meehan, K. M., Wang, H., David, S. R. et al. (2002). Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology, 26, 494–504.
Mehler, P. S. & Weiner, K. L. (1993). Anorexia nervosa and total parenteral nutrition. International Journal of Eating Disorders, 14, 297–304.
Meltzer, H., Gatward, R., Goodman, R. & Ford, T. (2003). Mental health of children and adolescents in Great Britain. International Review of Psychiatry, 15, 185–7.
Melvin, G. A., Tonge, B. J., King, N. J., Heyne, D., Gordon, M. S. & Klimkeit, E. D. (2006). A comparison of cognitive-behavioural therapy, sertraline, and their combination for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1151–61.
Menza, M. A., Murray, G. B., Holmes, V. F. et al. (1998). Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart and Lung, 17, 238–41.
Menza, M. A., Murray, G. B., Holmes, V. F. & Rafuls, W. A. (1988). Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung, 17, 238–41.
Meuleman, E. J. H. (2003). Investigations in erectile dysfunction. Current Opinions in Urology, 13, 411–16.
Meythaler, J. M., Bruner, R. C., Johnson, A. & Thomas, A. (2002). Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. Journal of Head Trauma Rehabilitation, 17, 300–13.
Michelson, D., Allen, A. J., Busner, J. et al. (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896–901.
Miklowitz, D. J. (2008). Adjunctive psychotherapy for bipolar disorder: state of the evidence. American Journal of Psychiatry, 165, 1408–19.
Miklowitz, D. J., Axelson, D. A., Birmaher, B. et al. (2008). Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Archives of General Psychiatry, 65, 1053–61.
Milano, W., Siano, C., Putrella, C. & Capasso, A. (2005). Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Advances in Therapeutics, 22, 278–83.
Milisen, K., Foreman, M. D., Abraham, I. L. et al. (2001). A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. Journal of the American Geriatrics Society, 49, 523–32.
Miller, W. R., Zweben, A., DiClemente, C. C. & Rychtarik, R. G. (1992). Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence (NIAA Project Match Monograph Series Vol. 2). Rockville, MD: National Institute on Alcohol and Alcoholism.
Miller, D.D., Caroff, S.N., Davis, S.M. et.al. (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial. British Journal of Psychiatry, 198, 279–88.
Miller, A. L., Hall, C. S., Buchanan, R. W. et al. (2004). The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. Journal of Clinical Psychiatry, 65, 500–8.
Miller, W. R. & Rollnick, S. (1991). Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press.
Miller, W. R. & Sanchez, V. C. (1993). Motivating young adults for treatment and life-style change. In: G. Howard, ed. Issues in Alcohol Use and Misuse by Young Adults. South Bend, IN, University of Notre Dame Press.
Miller, W. R. & Wilbourne, P. L. (2002). Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction, 97, 265–77.
Milsap, R. L. & Szefler, S. J. (1986). Special pharmacokinetic considerations in children. In: W. E. Evans, J. J. Schentag & W. J. Jusko, eds. Applied Pharmacokinetic Principles of Therapeutic Drug Monitoring. Spokane, WA: Applied Therapeutics Inc., pp. 294–330.
Mindell, J. A. & Owens, J. A. (2010). A Clinical Guide to Pediatric Sleep: Diagnosis and Management of Sleep Problems, 2nd edn. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins.
Mindell, J. A., Kuhn, B., Lewin, D. S., Meltzer, L. J. & Sadeh, A. (2006). Behavioral treatment of bedtime problems and night waking in infants and young children. Journal of Sleep and Sleep Disorders Research, 29(10), 1263–76.
Minnis, H., Green, J., O’Connor, T. & Liew, A. (2009). Reactive Attachment Disorder and Attachment Patterns: evidence for the overlap. Journal of Child Psychology & Psychiatry, 50(8), 931–42.
Minuchin, S., Rosman, B. I. & Baker, T. (1978). Psychosomatic Families: Anorexia Nervosa in Context. Cambridge, MA: Harvard University Press.
Mitchell, J. E., Fletcher, L., Hanson, K. et al. (2001). The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa. Journal of Clinical Psychopharmacology, 21(3), 298–304.
Mitte, K., Noack, P., Steil, R. & Hautzinger, M. (2005). A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. Journal of Clinical Psychopharmacology, 25, 141–50.
Montague, D. K., Jarow, J., Broderick, G. A. et al. (2004). AUA guideline on the pharmacologic management of premature ejaculation. Journal of Urology, 172, 290–4.
Monteiro, W. O., Noshirvani, H. F., Marks, I. M. & Lelliott, P. T. (1987). Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. British Journal of Psychiatry, 151, 107–12.
Montgomery, S. A., McIntyre, A., Osterheider, M. et al. (1993). A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder: The Lilly European OCD Study Group. European Neuropsychopharmacology, 3, 143–52.
Montgomery, S. A., Kasper, S., Stein, D. J., Bang Hedegaard, K. & Lemming, O. M. (2001). Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. International Clinical Psychopharmacology, 16, 75–86.
Montgomery, S. A., Nil, R., Durr-Pal, N., Loft, H. & Boulenger, J. P. (2005). A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. Journal of Clinical Psychiatry, 66, 1270–8.
Montgomery, S. A., Chatamra, K., Pauer, L., Whalen, E. & Baldinetti, F. (2008). Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. British Journal of Psychiatry, 193, 389–94.
Monti, P. M., Abrams, D. B., Kadden, R. M. & Cooney, N. L. (1989). Treating Alcohol Dependence: A Coping Skills Training Guide. New York: Guilford Press.
Moore, B. A. & Budney, A. J. (2001). Tobacco smoking in marijuana dependent outpatients. Journal of Substance Abuse, 13, 585–98.
Moore, B. A. & Budney, A. J. (2003). Relapse in outpatient treatment for marijuana dependence. Journal of Substance Abuse Treatment, 25, 85–9.
Moos, R. H. & Moos, B. S. (2004). Long-term influence of duration and frequency of participation in Alcoholics Anonymous on individuals with alcohol use disorders. Journal of Consulting and Clinical Psychology, 72, 81–90.
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G. & Bava, A. (2003). Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation. Drugs and Aging, 20, 1035–40.
Morgan, H. G., Purgold, J. & Welbourne, J. (1983). Management and outcome in anorexia nervosa: a standardized prognostic study. British Journal of Psychiatry, 143, 282–7.
Morgan, J. F. & Crisp, A. H. (2002). Use of leucotomy for intractable anorexia nervosa: a long-term follow-up study. International Journal of Eating Disorders, 27(3), 249–58.
Morgenstern, J. & Longabaugh, R. (2000). Cognitive behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction, 95, 1475–90.
Morgenstern, J., Labouvie, E., McCrady, B. S., Kahler, C. W. & Frey, R. M. (1997). Affiliation with Alcoholics Anonymous after treatment: a study of its therapeutic effects and mechanism of action. Journal of Consulting and Clinical Psychology, 65, 768–77.
Morgentaler, A. (1999). Male impotence. Lancet, 354, 1713–18.
Morgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B., Brown, T. M. et al. (2006). Practice parameters for behavioral treatment of bedtime problems and night waking in infants and young children. Sleep, 29(10), 1277–81.
Morishita, S. (2000). Treatment of anorexia nervosa with Naikan therapy. International Medical Journal, 7(2), 151.
Morriss, R., Dowrick, C., Salmon, P. et al. (2007). Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. British Journal of Psychiatry, 191, 536–42.
Morselli, P. L., Franco-Morselli, R., Bossi, L. et al. (1980). Clinical pharmacokinetics in newborn and infants: age related differences and therapeutic implications. Clinical Pharmacokinetics, 5, 485–527.
Morton, I. & Bleathman, C. (1991). The effectiveness of validation therapy in dementia: a pilot study. International Journal of Geriatric Psychiatry, 6, 327–30.
Moyer, A., Finney, J. W., Swearingen, C. E. & Vergun, P. (2002). Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction, 97, 279–92.
Moynihan, R. & Mintzes, B. (2010). Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction. Greystone Books.
MTA Cooperative Group (1999). A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry, 56, 1073–85.
Muehlbacher, M., Nickel, M. K. & Nickel, C. (2005). Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 25, 580–3.
Mueller, M. M., Piazza, C. C., Moore, J. W. & Kelley, M. E. (2003). Training parents to implement pediatric feeding protocols. Journal of Applied Behavior Analysis, 36, 545–62.
Mufson, L. & Fairbanks, J. (1996). Interpersonal psychotherapy for depressed adolescents: a one year naturalistic follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1145–55.
Mufson, L., Moreau, M., Weissman, M. M. & Garfinkel, R. (1999). Efficacy of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 56, 573–9.
Mufson, L., Dorta, K. P., Wickramarante, P., Nomura, Y., Olfson, M. & Weissman, M. (2004). A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 61, 577–84.
Mukaddes, N. M., Kaynak, F. N., Kinali, G., Besikci, H. & Issever, H. (2004). Psychoeducational treatment of children with autism and reactive attachment disorder. Autism, 8, 101–9.
Mukherjee, S., Sackeim, H. A. & Schnur, D. B. (1994). Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. American Journal of Psychiatry, 151, 169–76.
Mullen, P. D., Simons-Morton, D. G., Ramirez, G., Frankowski, R. F., Green, L. W. & Mains, D. A. (1997). A meta-analysis of trials evaluating patient education and counselling for three groups of preventive health behaviors. Patient Educational Counseling, 32, 157–73.
Mundo, E., Bareggi, S. R., Pirola, R., Bellodi, L. & Smeraldi, E. (1997). Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study. Journal of Clinical Psychopharmacology, 17, 4–10.
Murphy, S. & Tyrer, P. (1991). A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry, 158, 511–16.
Murphy, T. J., Pagano, R. R. & Marlatt, G. A. (1986). Life-style modification with heavy alcohol drinkers: effects of aerobic exercise and meditation. Addictive Behaviors, 11, 175–86.
Murphy, S. M., Owen, R. & Tyrer, P. (1989). Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks’ treatment with diazepam or buspirone. British Journal of Psychiatry, 154, 529–34.
Murray, L., Cooper, P. J., Wilson, A. & Romaniuk, H. (2003). Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression. 2. Impact on the mother–child relationship and child outcome. British Journal of Psychiatry, 182, 420–27.
Nakamura, J., Uchimura, N., Yamada, S. et al. (1997). Mianserin suppositories in the treatment of post-operative delirium. Human Psychopharmacology, 12, 595–9.
National Clinical Guideline Centre for Acute and Chronic Conditions (2010). Delirium: Diagnosis, Prevention and Management. London: Royal College of Physicians.
National Collaborating Centre for Mental Health (2004). Eating Disorders: Core Interventions in the Treatment and Management of Anorexia Nervosa, bulimia Nervosa and Related Eating Disorders. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2005a). Depression in Children and Young People: Identification and Management in Primary, Community and Secondary care. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2005b). Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2006a). Obsessive Compulsive Disorder: Core Interventions in the Treatment of Obsessive Compulsive Disorder and Body Dysmorphic Disorder. London:British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2006b). Post-traumatic Stress Disorder (PTSD): The Management of PTSD in Adults and Children in Primary and Secondary Care. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2007). Dementia: The NICE-SCIE Guideline on Supporting People with Dementia and their Carers in Health and Social Care. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2009a). Depression: The Treatment and Management of Depression in Adults (Update). London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2009a). Borderline Personality Disorder: The NICE Guideline on Treatment and Management. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2009b). Antisocial Personality Disorder: Treatment, Management and Prevention. London: British Psychological Society and Royal College of Psychiatrists.
National Collaborating Centre for Mental Health (2010). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (updated edition). London: British Psychological Society and Royal College of Psychiatrists.
National Institute for Clinical Excellence (2004). Guideline on the use of zaleplon, zolpidem and zopiclone for the short term management of insomnia. Technology appraisal 77. London: NICE.
National Institute for Health and Clinical Excellence (2007). Management of anxiety (panic disorder with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. 2004 (amended 2007). London: NICE.
National Institute on Alcohol Abuse and Alcoholism (2000a). Tenth Special Report to the U.S. Congress on Alcohol and Health, 2000. Washington, DC: US Department of Health and Human Services.
National Institute on Alcohol Abuse and Alcoholism (2000b). Alcohol Alert No. 49: New Advances in Alcoholism Treatment. Rockville, MD: Author.
National Institute on Drug Abuse (2004). Scientifically based approaches to drug addiction treatment. In: Principle of Drug Addiction Treatment: A Research Based Guide. Rockville, MD: National Institute on Drug Abuse, pp. 1–7.
National Research Council (2001). Educating Children with Autism. Committee on Educational Interventions for Children with Autism. Division of Behavioral and Social Sciences and Education. National Research Council. Washington, DC: National Academy Press.
National Treatment Agency for Substance Misuse (2002). Models of care for treatment of adult drug misusers: framework for developing local systems of effective drug misuse treatment in England. London: National Treatment Agency for Substance Misuse.
Nazareth, I., Boynton, P. & King, M. (2003). Problems with sexual function in people attending London general practitioners: a cross sectional study. British Medical Journal, 327, 423–6.
Nchito, M., Geissler, P. W., Mubila, L., FriisH. & Olsen, A. (2004). Effects of iron and multimicronutrient supplementation on geophagy: a two-by-two factorial study among Zambian schoolchildren in Lusaka. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98, 218–27.
Neal, L. A., Shapland, W. & Fox, C. et al. (1997). An open trial of moclobemide in the treatment of post-traumatic stress disorder. International Clinical Psychopharmacology, 12, 231–7.
Neiderman, M., Zarody, M., Tattersall, M. & Lask, B. (2000). Enteric feeding in severe adolescent anorexia nervosa: a report of four cases. International Journal of Eating Disorders, 28, 470–5.
Neiderman, M., Zarody, M., Tattersall, M. & Lask, B. (2000). Enteric feeding in severe adolescent anorexia nervosa: A report of four cases. International Journal of Eating Disorders, 28, 470–475.
Nelson III, W. M. & Finch, A. J. (2000). Managing anger in youth: a cognitive-behavioral intervention approach. In: P. C. Kendall, ed. Child & Adolescent Therapy: Cognitive-Behavioral Procedures, 2nd edn. New York: Guilford Press, pp. 129–170.
Neumark-Sztainer, D., Sherwood, N., Coller, T. & Hannan, P. (2000). Primary prevention of disordered eating among preadolescent girls: Feasibility and short-term effect of a community-based intervention. Journal of the American Dietetic Association, 100 (12), 1466–73.
Newton-Howes, G., Weaver, T. & Tyrer, P. (2008). Attitudes of staff towards patients with personality disorder in community health teams. Australian and New Zealand Journal of Psychiatry, 42, 572–7.
Nierenberg, A. A., McLean, N. E. et al. (1995). Early non-response to fluoxetine as a predictor of poor eight-week outcome. American Journal of Psychiatry, 152, 1500–3.
Nixon, R. D., Sweeney, L., Erickson, D. B. & Touyz, S. W. (2003). Parent–child interaction therapy: a comparison of standard and abbreviated treatments for oppositional defiant preschoolers. Journal of Consulting & Clinical Psychology, 71, 251–60.
Norton, C. R., Cox, B. J. & Malan, J. (1992). Nonclinical panickers: a critical review. Clinical Psychology Review, 12, 121–39.
Nosé, M., Cipriani, A., Biancosino, B., Grassi, L. & Barbui, C. (2006). Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. International Journal of Clinical Psychopharmacology, 21, 345–53.
Novaco, R. W. (1976). The functions and regulation of the arousal of anger. American Journal of Psychiatry, 133, 1124–8.
Nowinski, J., Baker, S. & Carroll, K. (1992). Twelve Step Facilitation Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence (DHHS Publication No. ADM 92–1893). Rockville, MD: US Department of Health and Human Services.
Nowinski, J., Baker, S. & Carroll, K. (1994). Twelve Step Facilitation Therapy Manual (Project Match Monograph Series, Vol. 1; NIH Publication No. 94–3722). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
Nunes, E. V. & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. Journal of the American Medical Association, 291, 1887–96.
O’Connor, P. G. & Kosten, T. R. (1998). Rapid and ultrarapid opioid detoxification techniques. Journal of the American Medical Association, 279, 229–34.
O’Connor, T. G., Bredenkamp, D. & Rutter, M., The English and Romanian Adoptees (ERA) Study Team (1999). Attachment disturbances and disorders in children exposed to early severe deprivation. Infant Mental Health Journal, 20, 10–29.
O’Farrell, T. J. & Fals-Stewart, W. (2000). Behavioral couples therapy for alcoholism and drug abuse. Journal of Substance Abuse Treatment, 18, 51–4.
O’Herlihy, A., Worrall, A., Lelliott, P., Jaffa, T., Hill, P. & Banerjee, S. (2003). Distribution and characteristics of inpatient child and adolescent mental health services in England and Wales. British Journal of Psychiatry, 183, 847–51.
O’Malley, J. E., Anderson, W. H. & Lazare, A. (1972). Failure of outpatient treatment of drug abuse. I. Heroin. American Journal of Psychiatry, 128, 865–8.
O’Neill, R. E., Horner, R. H., Albin, R. W. et al. (1997). Functional Analysis of Problem Behavior: A Practical Assessment Guide, 2nd edn. Pacific Grove, CA: Brooks/Cole.
Oden, S. & Asher, S. R. (1977). Coaching children in social skills for friendship making. Child Development, 48, 495–506.
Olatunji, B. O., Deacon, B. J. & Abramowitz, J. S. (2009). Is hypochondriasis an anxiety disorder?British Journal of Psychiatry, 194, 481–2.
Oldham, J., Phillips, K., Gabbard, G. et al. (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. American Journal of Psychiatry, 158, 1–52.
Oliver-Africano, P., Murphy, D. & Tyrer, P. (2009). Aggressive behavior in adults with intellectual disability: defining the role of drug treatment. CNS Drugs, 23, 903–13.
Oliveto, A. H., Feingold, A., Schottenfeld, R., Jatlow, P. & Kosten, T. R. (1999). Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs. methadone. Archives of General Psychiatry, 56, 812–20.
Olmsted, M. P., Davis, R., Rockert, W., Irvine, M. J., Eagle, M. & Garner, D. M. (1991). Efficacy of a brief group psychoeducational intervention for bulimia nervosa. Behavior Research Therapy, 29(1), 71–83.
Olmsted, M. P., Daneman, D., Rydall, A. C., Lawson, M. L. & Rodin, G. (2002). The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. International Journal of Eating Disorders, 32, 230–9.
Olweus, D., Limber, S. & Mihalic, S. (2000). Blueprints for Violence Prevention: Bullying Prevention Program. Boulder, CO: Center for Study and Prevention of Violence.
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J. & Forette, F. (2002). Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke, 33, 1834–9.
Öst, L. G. & Sterner, U. (1987). Applied tension: a specific behavioral method for treatment of blood phobia. Behaviour Research and Therapy, 25(1), 25–9.
Öst, L., Salkovskis, P. & Hellstrom, K. et al. (1991). One-session therapist-directed exposure vs. self-exposure in the treatment of spider phobia. Behavior Therapy, 22, 407–22.
Öst, L. G., Brandberg, M. & Alm, T. (1997). One versus five sessions of exposure in the treatment of flying phobia. Behaviour Research and Therapy, 35(11), 987–96.
Öst, L. G., Svensson, L., Hellstrom, K. & Lindwall, R. (2001). One-session treatment of specific phobias in youths: a randomized clinical trial. Journal of Consulting Clinical Psychology, 69(5), 814–24.
Ostafin, B. D. (2008). Surfing the urge: experiential acceptance moderates the relation between automatic alcohol motivation and hazardous drinking. Journal of Social and Clinical Psychology, 27, 404–18.
Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S. & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: efficacy of cognitive behavioural therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485–90.
Otto, M. W., Pollack, M. H., Gould, R. A., Worthington, J. J., McArdle, E. T. & Rosenbaum, J. F. (2000). A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. Journal of Anxiety Disorders, 14, 345–58.
Otto, M. W., Tuby, K. S., Gould, R. A., McLean, R. Y. & Pollack, M. H. (2001). An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. American Journal of Psychiatry, 158(12), 1989–92.
Ottolini, M. C., Hamburger, E. K., Loprieato, J. O. et al. (2001). Complementary and alternative medicine use among children in the Washington, DC area. Ambulatory Pediatrics, 1, 122–5.
Oude-Voshaar, R. C., Gorgels, W. J. & Mol, A. J. J. (2003). Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. British Journal of Psychiatry, 182, 498–504.
Oude-Voshaar, R. C., Gorgels, W. J., Mol, A. J. et al. (2006a). Long-term outcome of two forms of randomised benzodiazepine discontinuation. British Journal of Psychiatry, 188, 188–9.
Oude-Voshaar, R. C., Couvée, J. E., van Balkom, A. J. L. M., Mulder, P. G. H. & Zitman, F. G. (2006b). Strategies for discontinuing long-term benzodiazepine use: meta-analysis. British Journal of Psychiatry, 189, 213–20.
Ouimette, P. C., Finney, J. W. & Moos, R. H. (1997). Twelve-step and cognitive behavioral treatment for substance abuse: a comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology, 65, 230–40.
Overshott, R., Vernon, M., Morris, J. & Burns, A. (2010). Rivastigmine in the treatment of delirium in older people: a pilot study. International Psychogeriatrics, 22, 812–8.
Owen, P. L., Slaymaker, V., Tonigan, J. S. et al. (2003). Participation in Alcoholics Anonymous: intended and unintended change mechanisms. Alcoholism: Clinical and Experimental Research, 27, 524–32.
Owen, R., Sikich, L., Marcus, R. N. et al. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124, 1533–40.
Oyebode, F. (2004). Invited commentary on: The rediscovery of recovery. Advances in Psychiatric Treatment, 10, 48–9.
Palinkas, L. A., Atkins, C. J., Miller, C. & Ferreira, D. (1996). Social skills training for drug prevention in high-risk female adolescents. Preventative Medicine, 25, 692–701.
Palmer, R. L., Birchall, H., McGrain, L. & Sullivan, V. (2002). Self-help for bulimic disorders: a randomized controlled trial comparing minimal guidance with face-to-face or telephone guidance. British Journal of Psychiatry, 181, 230–5.
Pande, A. C., Davidson, J. R, Jefferson, J. W. et al. (1999). Treatment of social phobia with gabapentin: a placebo-controlled study. Journal of Clinical Psychopharmacology, 19, 341–8.
Pande, A. C., Feltner, D. E., Jefferson, J. W. et al. (2004). Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology, 24, 141–9.
Parellada, E., Baeza, I., de Pablo, J. et al. (2004). Risperidone in the treatment of patients with delirium. Journal of Clinical Psychiatry, 65, 348–53.
Parker, G. (2002). Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression. Acta Psychiatrica Scandinavica, 106(3), 168–70.
Parker, G., Parker, K. et al. (2003). Gender differences in response to differing antidepressant drug classes: two negative studies. Psychological Medicine, 33(8), 1473–7.
Parkinson Study Group (1999). Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. New England Journal of Medicine, 340, 757–63.
Parr, J. M., Kavanagh, D. J., Cahill, L., Mitchell, G. & Young, R. (2008). Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction, 104, 13–24.
Paton, C. (2008). Prescribing in pregnancy. British Journal of Psychiatry, 192, 321–22.
Patterson, G. R. & Gullion, M. E. (1968). Living With Children: New Methods for Parents and Teachers. Champaign, IL: Research Press.
Peck Peterson, S. M., Caniglia, C., RoysterA. J., Macfarlane, E., Plowman, K., Baird, S. J. & Wu, N. (2005). Blending functional communication training and choice making to improve task engagement and decrease problem behaviour. Educational Psychology, 25, 257–74.
Pediatric OCD Treatment Study (POTS) Team (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the pediatric OCD treatment study (POTS) randomised controlled trial. Journal of the American Medical Association, 292(16), 1969–76.
Pekkala, E. & Merinder, L. (2002). Psychoeducation for schizophrenia. The Cochrane Database of Systematic Reviews, 2, CD002831. doi: 10.1002/14651858.CD002831. Oxford: Update Software Ltd.
Pelham, W. E., Vodde-Hamiliton, M., Murphy, D. A., Greenstein, J. & Vallano, G. (1991). The effects of methylphenidate on ADHD adolescents in recreational, peer group and classroom settings. Journal of Clinical Child Psychology, 20, 293–300.
Pendleton, V. R., Goodrick, G. K., Poston, W. S., Reeves, R. & Foreyt, J. P. (2002). Exercise augments the effects of cognitive-behavioral therapy in the treatment of binge-eating. International Journal of Eating Disorders, 31(2), 172–84.
Perimentis, P., Gyftopoulos, K., Giannitsas, K. et al. (2004). A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction. International Journal of Impotency Research, 16, 2–7.
Perry, J. C., Banon, E. & Ianni, F. (1999). Effectiveness of psychotherapy for personality disorder. American Journal of Psychiatry, 156, 1312–21.
Perry, P. J., Stambaugh, R. L., Tsuang, M. T. & Smith, R. E. (1981). Sedative-hypnotic tolerance testing and withdrawal comparing diazepam to barbiturates. Journal of Clinical Psychopharmacology, 1, 289–96.
Pertschuk, M. J., Forster, J., Buzby, G. & Mullen, J. L. (1981). The treatment of anorexia nervosa with total parenteral nutrition. Biological Psychiatry, 16(6), 539–50.
Pesenti, F., Mavrotheris, S., Serra, C., Lucchio, P. & Pucciarelli, S. (1999). Use of percutaneous endoscopic gastrostomy in anorexia nervosa: case report. Rivista Italiana di Nutrizione Parenterale ed Enterale, 17(1), 24–7.
Peskind, E. R., Tsuang, D. W., Bonner, L. T. et al. (2005). Propranolol for disruptive behaviours in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study. Alzheimer’s Disease and Associated Disorders, 19, 23–8.
Petitjean, S., Stohler, R., Deglon, J. et al. (2001). Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence, 62, 97–104.
Petrakis, I., Carroll, K., Nich, C. et al. (2000). Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction, 95, 219–28.
Petry, N. (2006). Contingency management treatments: a uniquely American approach, or perhaps even better suited for European drug abuse treatment?British Journal of Psychiatry, 189, 97–8.
Petry, N., Tedford, J., Austin, M., Nich, C., Carroll, K. C. & Rounsaville, B. J. (2004). Prize reinforcement contingency management for treating cocaine users: how long can we go, and with whom. Addiction, 99, 349–60.
Petry, N. M., Peirce, J. M., Stitzer, M. L. et al. (2005). Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry, 62, 1148–56.
Pharoah, F. M., Rathbone, J., Mari, J. J. & Streiner, D. (2003). Family intervention for schizophrenia. The Cochrane Database of Systematic Reviews, 3, CD000088. doi: 10.1002/14651858.CD000088. Oxford: Update Software Ltd.
Pigott, T. A. & Seay, S. M. (1999). A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Journal of Clinical Psychiatry, 60, 101–6.
Pike, K. M., Walsh, B. T., Vitousek, K., Wilson, G. T. & Bauer, J. (2003). Cognitive behaviour therapy in the posthospitalization treatment of anorexia nervosa. American Journal of Psychiatry, 160, 2046–9.
Pilling, D., Bebbington, P., Kuipers, E. et al. (2002a). Psychological treatments in schizophrenia II: meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychological Medicine, 32, 783–91.
Pilling, D., Bebbington, P., Kuipers, E. et al. (2002b). Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763–82.
Pollack, M. H., Allgulander, C., Bandelow, B. et al. (2003). WCA recommendations for the long-term treatment of panic disorder. CNS Spectrums, 8(8) Suppl. 1, 17–30.
Pollak, P., Tison, F., Rascol, O. et al. (2004). Clozapine in drug induced psychosis in Parkinson’s disease: a randomized, placebo controlled study with open follow up. Journal of Neurology, Neurosurgery and Psychiatry, 75, 689–95.
Pollock, B. G., Mulsant, B. H., Rosen, J. et al. (2002). Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized demented patients. American Journal of Psychiatry, 159, 460–5.
Pomeranz, B. (1989). Acupuncture research related to pain, drug addiction and nerve regeneration. In: B. Pomeranz, G. Stux, eds. Scientific Bases of Acupuncture. Berlin, Germany: Springer-Verlag, pp. 35–52.
Porst, H. (1989). Prostaglandin E in erectile dysfunction (German language article). Urologe A, 28, 94–8.
Powers, P. S. & Santana, C. A. (2002). Eating disorders: a guide for the primary care physician. Primary Care, 29, 81–98.
Powers, P. S. & Bannon, Y. (2004). Medical co-morbidity of anorexia nervosa, bulimia nervosa, and binge eating disorder. In: T. Brewerton ed. Clinical Handbook of Eating Disorders: An Integrated Approach (Medical Psychiatry 26). Marcel Dekker. New York:
Pratt, B. M. & Woolfenden, S. R. (2002). Interventions for preventing eating disorders in children and adolescents. Cochrane Database of Systematic Reviews, 2, CD002891.
Price, J., Cole, V. & Goodwin, G. M. (2009). Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. British Journal of Psychiatry, 195, 211–17.
Prochazka, A. V., Weaver, M. J., Keller, R. T., Fryer, G. E., Licari, P. A. & Lofaso, D. (1998). A randomized trial of nortriptyline for smoking cessation. Archives of Internal Medicine, 158, 2035–9.
Project Match Research Group (1997). Matching alcoholism treatments to client heterogeneity: Project MATCH post-treatment drinking outcomes. Journal of Studies on Alcoholism, 58, 7–29.
Project MATCH Research Group (1998). Matching alcoholism treatments to client heterogeneity: Project MATCH three year drinking outcomes. Alcoholism: Clinical and Experimental Research, 22, 1300–11.
Pull, C. B. (2006). Current status of virtual reality therapy in anxiety disorders. Current Opinion in Psychiatry, 18, 7–14.
Pusey, H. (2000). Dementia care: interventions with people with dementia and their informal caregivers. Mental and Health Care, 3, 204–7.
Rabey, J. M., Prokhorov, T., Miniovitz, A., Dobronevsky, E. & Klein, C. (2007). Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Movement Disorders, 22, 313–18.
Rabkin, J. G., Wagner, G. J. & Rabkin, R. (1999). Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. Journal of Clinical Psychopharmacology, 19(1), 19–27.
Rabkin, J. G., Wagner, G. J. & Rabkin, R. (2000). A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Archives of General Psychiatry, 57(2), 141–7; discussion 155–6.
Raine, A., Mellingen, K., Liu, J., Venables, P. & Mednick, S. A. (2003). Effects of environmental enrichment at ages 3–5 years on schizotypal personality and antisocial behavior at ages 17 and 23. American Journal of Psychiatry, 196, 1627–35.
Raistrick, D., Hodgson, R. & Ritson, B. (1999). Tackling Alcohol Together. London: Free Association Books.
Rakic, Z., Starcevic, V., Maric, J. & Kelin, K. (1996). The outcome of sex reassignment surgery in Belgrade: 32 patients of both sexes. Archives of Sexual Behavior, 25(5), 515–25.
Rangecroft, M. E. H., Tyrer, S. P. & Berney, T. P. (1997). The use of seclusion and emergency medication in a hospital for people with learning disability. British Journal of Psychiatry, 170, 273–7.
Ranger, M., Tyrer, P., Milošeska, K., Fourie, H., Khaleel, I., North, B. & Barrett, B. (2009). Cost-effectiveness of nidotherapy for comorbid personality disorder and severe mental illness: randomized controlled trial. Epidemiologia e Psichiatria Sociale, 18, 128–36.
Ravndal, E. (2001). An outcome study of a therapeutic community based in the community: a five-year prospective study of drug abusers in Norway. In: B. Rawlings & R. Yates, eds. Therapeutic Communities, 4th edn. Philadelphia: Jessica Kingsley Publishers, pp. 224–40.
Rawson, R. A., Huber, A., McCann, M. J. et al. (2002). A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Archives of General Psychiatry, 59, 817–24.
Rawson, R. A., Marinelli-Casey, P., Anglin, M. D. et al. & Methamphetamine Treatment Project Corporate Authors (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99, 708–17.
Reas, D. L. & Grilo, C. M. (2008). Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring), 16, 2024–38.
Reau, N. R., Senturia, Y. D., Lebailly, S. A. & Christoffel, K. K. (1996). Infant and toddler feeding patterns and problems: normative data and a new direction. Developmental and Behavioral Pediatrics, 17, 149–53.
Rehman, J., Lazer, S., Benet, A. E., Schaefer, L. C. & Melman, A. (1999). The reported sex and surgery satisfactions of 28 postoperative male-to-female transsexual patients. Archives of Sexual Behavior, 28, 71–89.
Reich, D. B., Winternitz, S., Hennen, J., Watts, T. & Stanculescu, C. (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. Journal of Clinical Psychiatry, 65, 1601–6.
Reichow, B. & Wolery, M. (2009). Comprehensive synthesis of early intensive behavioral interventions for young children with autism based on the UCLA young autism project model. Journal of Autism and Developmental Disorders, 39, 23–41.
Reid, M. J., Webster-Stratton, C. & Hammond, M. (2003). Follow-up of children who received the Incredible Years intervention for Oppositional-Defiant Disorder: maintenance and prediction of 2-year outcome. Behavior Therapy, 34, 471–91.
Reinecke, M. A., Ryan, N. E. & DuBois, D. L. (1998). Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: a review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 26–34.
Research Unit on Paediatric Psychopharmacology Anxiety Study Group (RUPPS) (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344, 1279–85.
Resick, P. A., Nishith, P., Weaver, T. L., Astin, M. C. & Feuer, C. A. (2002). A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. Journal of Consulting Clinical Psychology, 70, 867–79.
Resnick, S. G., Rosenheck, R. A. & Lehman, A. F. (2004). An exploratory analysis of correlates of recovery. Psychiatric Services, 55, 540–7.
Resnick, S. G., Fontana, A., Lehman, A. F. & Rosenheck, R. A. (2005). An empirical conceptualization of the recovery orientation. Schizophrenia Research, 75, 119–28.
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L. et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives in General Psychiatry, 61(11), 1136–44.
Ricca, V., Mannucci, E., Mezzani, B. et al. (1997). Cognitive-behavioral therapy versus combined treatment with group psychoeducation and fluoxetine in bulimic outpatients. Eating Weight Disorders, 2(2), 94–9.
Richters, J. E., Arnold, L. E., Jensen, P. S. et al. (1995). NIMH Collaborative Multisite Multimodal Treatment Study of Children with ADHD: background and rationale. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 987–1000.
Rickels, K., Schweizer, E., Case, W. G. & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Archives of General Psychiatry, 47, 899–907.
Rickels, K., Schweizer, E., Weiss, S.Zavodnick, S. (1993). Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Archives of General Psychiatry, 50, 61–8.
Rigotti, N. A. (2002). Treatment of tobacco use and dependence. New England Journal of Medicine, 346, 506–12.
Riper, H., Kramer, J., Smit, F., Conijn, B., Schippers, G. & Cuijpers, P. (2008). Web-based self-help for problem drinkers: a pragmatic randomized trial. Addiction, 103, 218–27.
Risse, S. C., Whitters, A., Burke, J., Chen, S., Scurfield, R. M. & Raskind, M. A. (1990). Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. Journal of Clinical Psychiatry, 51, 206–9.
Ritchie, C. W., Ames, D., Clayton, T. & Lai, R. (2004). Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. American Journal of Geriatric Psychiatry, 12(4), 358–69.
Robb, A. S., Silber, T. J., Orrell-Valente, J. K. et al. (2002). Supplemental nocturnal nasogastric refeeding for better short term outcome in hospitalized adolescent girls with anorexia nervosa. The American Journal of Psychiatry, 159(8), 1347–53.
Roberts, G. & Wolfson, P. (2004). The rediscovery of recovery: open to all. Advances in Psychiatric Treatment, 10, 37–48.
Robertson, B., Karlsson, I., Eriksson, L. et al. (1996). An atypical neuroleptic drug in the treatment of behavioural disturbances and psychotic symptoms in elderly people. Dementia, 7, 142–6.
Robin, A. L., Gilroy, M. & Dennis, A. B. (1998). Treatment of eating disorders in children and adolescents. Clinical and Psychological Reviews, 18, 421–6.
Robin, A. L., Siegel, P. T., Moye, A. W., Gilroy, M., Dennis, A. B. & Sikand, A. (1999). A controlled comparison of family versus individual therapy for adolescents with anorexia nervosa. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1482–9.
Robinson, G. M., Sellers, E. M. & Janacek, E. (1981). Barbiturate and hypnosedative withdrawal by a multiple oral Phenobarbital loading dose technique. Clinical and Pharmacological Therapy, 30, 71–6.
Rodebaugh, T. L., Holaway, R. M. & Heimberg, R. G. (2004). The treatment of social anxiety disorder. Clinical Psychology Review, 24, 883–908.
Roerig, J. L., Mitchell, J. E., deZwaan, M. et al. (2003). The eating disorders medicine cabinet revisited: A clinician’s guide to appetite suppressants and diuretics. International Journal Of Eating Disorders, 33, 443–57.
Rogers, S. L., Doody, R. S., Mohs, R. C., Friedhoff, L. T. & the Donepezil Study Group (1998a). Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Archives of Internal Medicine, 158, 1021–31.
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T. & the Donepezil Study Group (1998b). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology, 50, 136–45.
Rohde, L. A., Barbosa, G., Polanczyk, G. et al. (2001). Factor and latent class analysis of DSM-IV ADHD symptoms in a school sample of Brazilian adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 711–18.
Romeo, R., Knapp, M., Tyrer, P., Crawford, M. & Oliver-Africano, P. (2009). The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis. Journal of Intellectual Disabilities Research, 53, 633–43.
Roozen, H. G., Boulogne, J. J., van Tulder, M. W., van den Brink, W., De Jong, C. A. & Kerkhof, A. J. (2004). A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug and Alcohol Dependence, 74, 1–13.
Rose, S., Bisson, J. & Wessely, S. (2003). A systematic review of single-session psychological interventions (‘debriefing’) following trauma. Psychotherapy and Psychosomatics, 72, 176–84.
Rosen, G. M., Lilienfeld, S. O., Frueh, C., McHugh, P. R. & Spitzer, R. L. (2010). Reflections on PTSD’s future in DSM-V. British Journal of Psychiatry, 197, 343–4.
Rosenberg, P. B., Drye, L. T., Martin, B. K., et al.; DIADS-2 Research Group (2010). Sertraline for the treatment of depression in Alzheimer disease. American Journal of Geriatric Psychiatry, 18, 136–45.
Rosenvinge, J. H. & Klusmeier, A. K. (2000). Treatment for eating disorders from a patient satisfaction perspective: a Norwegian replication of a British study. European Eating Disorders Review, 8, 293–300.
Ross, M. W. & Need, J. A. (1989). Effects of adequacy of gender reassignment surgery on psychological adjustment: a follow-up of fourteen male-to-female patients. Archives of Sexual Behavior, 18, 145–53.
Rosselló, J. & Bernal, G. (1999). The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. Journal of Consulting & Clinical Psychology, 67, 734–45.
Rothbaum, B. O., Astin, M. C. & Marsteller, F. (2005). Prolonged exposure therapy versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. Journal of Traumatic Stress, 18, 607–16.
Rotunda, R. J., O’Farrell, T. J., Murphy, M. & Babey, S. H. (2008). Behavioral couples therapy for comorbid substance use disorders and combat-related posttraumatic stress disorder among male veterans: an initial evaluation. Addictive Behaviors, 33, 180–7.
Rounsaville, B. J. & Carroll, K. M. (1997). Individual psychotherapy. In: J. H. Lowinsohn, P. Ruiz & R. B. Millman, eds. Comprehensive Textbook of Substance Abuse, 3rd edn. New York: Williams and Wilkins, pp. 430–9.
Royal College of Psychiatrists (2005). Third Report of the Royal College of Psychiatrists’ Special Committee on ECT. London: Royal College of Psychiatrists.
Roy-Byrne, P. P. & Cowley, D. (2002). Pharmacologic treatments for panic disorder, generalized anxiety disorder, specific phobia and social anxiety disorders. In: P. E. Nathan & J. Gorman, eds. A Guide to Treatments That Work. New York: Oxford University Press, pp. 337–65.
Rubin, E. H., Drevets, W. C. & Burke, W. J. et al. (1988). The nature of psychotic symptoms in senile dementia of the Alzheimer type. Journal of Geriatric Psychiatry and Neurology, 1, 16–20.
Rubio, G., Manzanares, J., Lopez-Munoz, F. et al. (2002). Naltrexone improves outcome of a controlled drinking program. Journal of Substance Abuse Treatment, 23, 361–6.
Rudnick, A. (2001). Ethics of ECT for children. Journal of the American Academy of Child and Adolescence Psychiatry, 40, 387.
Ruggiero, G. M., Laini, V, Mauri, M. C., et al (2001). A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectis. Progress in Neuropsychopharmaclolgy & Biological Psychiatry, 25, 1049–59
Ruma, P. R., Burke, R. V. & Thompson, R. W. (1996). Group parent training: is it effective for children of all ages?Behavior Therapy, 27, 159–69.
Rund, B. R. (1994). The relationship between psychosocial and cognitive functioning in schizophrenic patients and expressed emotion and communication deviance in their parents. Acta Psychiatrica Scandinavica, 90,133–40.
Rush, A. J., Marangell, L. B., Sackeim, H. A. et al. (2005). Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biological Psychiatry, 58, 347–54.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R. et al. (2006a). Bupropion-Sr, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine, 354(12), 1231–42.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R.A. A. et al. (2006b). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry, 2006, 163, 1905–17.
Russell, G. F., Szmukler, G. L., Dare, C. & Eisler, I. (1987). An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Archives of General Psychiatry, 44, 1047–56.
Ruttenber, A. J., Lawler-Heavner, J., Yin, M., Wetli, C. V., Hearn, W. L. & Mash, D. C. (1997). Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. Journal of Forensic Science, 42, 25–31.
Rutter, M. & Sonuga-Barke, E. J. (2010). Overview of findings from the ERA study, inferences, and research implications. Monographs of the Society for Research in Child Development, 75, 212–29.
Rutter, M. and the English and Romanian Adoptees (ERA) study team (1998). Developmental catch-up, and deficit, following adoption after severe global early privation. Journal of Child Psychology and Psychiatry, 39, 465–76.
Rynn, M. A., Siqueland, L. & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. The American Journal of Psychiatry, 158, 2008–14.
Sachdev, P. S., McBride, R., Loo, C. K. et al. (2001). Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. Journal of Clinical Psychiatry, 62, 981–4.
Sackeim, H. A., Rush, A. J., George, M. S. et al. (2001). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 25(5), 713–28.
Sajaniemi, N., Mäkelä, J., Salokorpi, T., von Wendt, L., Hämäläinen, T. & Hakamies-Blomqvist, L. (2001). Cognitive performance and attachment patterns at four years of age in extremely low birth weight infants after early intervention. European Child and Adolescent Psychiatry, 10, 122–9.
Salzer, M. S., Bickman, L. & Lambert, E. W. (1999). Dose–effect relationship in children’s psychotherapy services. Journal of Consulting and Clinical Psychology, 67, 228–38.
SAMHSA, National Survey On Drug Use And Health (2002). [Computer file]. 2nd ICPSR version. 2004, Research Triangle Institute [producer]. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor]: Research Triangle Park, NC.
SAMHSA (2003). SAMHSA Report to Congress on the Prevention and Treatment of Co-occurring Substance Abuse Disorders and Mental Disorders. Washington DC: US Department of Health and Human Services.
Sanchez-Craig, M., Cappell, H., Busto, U. & Kay, G. (1987). Cognitive-behavioural treatment for benzodiazepine dependence: a comparison of gradual versus abrupt cessation of drug intake. British Journal of Addiction, 82, 1317–27.
Sanders, M. R., Markie-Dadds, C., Tully, L. A. & Bor, W. (2000). The Triple P-Positive Parenting Program: a comparison of enhanced, standard, and self-directed behavioral family intervention for parents of children with early onset conduct problems. Journal of Consulting and Clinical Psychology, 68, 624–40.
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R. et al. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease: The Alzheimer’s Disease Cooperative Study. New England Journal of Medicine, 336, 1216–22.
Satel, S. L. & Edell, W. S. (1991). Cocaine-induced paranoia and psychosis proneness. American Journal of Psychiatry, 148, 1708–11.
Satterfield, J. H., Satterfield, B. & Cantwell, D. P. (1981). Three-year multi-modality study of 100 hyperactive boys. Journal of Pediatrics, 98, 650–5.
Saunders, B., Wilkinson, C. & Phillips, M. (1995). The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction, 90, 415–24.
Schachar, R., Tannock, R., Cunningham, C. & Corkum, P. (1997). Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 754–63.
Schachter, H. M., Pham, B., King, J., Langford, S. & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475–88.
Schaeffer, C. M. & Borduin, C. M. (2005). Long-term follow-up to a randomized clinical trial of multisystemic therapy with serious and violent juvenile offenders. Journal of Consulting & Clinical Psychology, 73, 445–53.
Schmidt, P. J., Nieman, L., Danaceau, M. A. et al. (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. American Journal of Obstetrics & Gynecology, 183(2), 414–20.
Schmidt, U., Lee, S., Beecham, J. et al. (2007). A randomized controlled trial of family therapy and cognitive behavior therapy guided self-care for adolescents with bulimia nervosa and related conditions. American Journal of Psychiatry, 164, 591–8.
Schmidt, U., Andiappan, M., Gover, M. et al. (2008). Randomised controlled trial of CD-ROM-based cognitive-behavioural self-care for bulimia nervosa. British Journal of Psychiatry, 193, 493–500.
Schneider, L. S. & Dagerman, K. S. (2004). Psychosis of Alzheimer’s disease: clinical characteristics and history. Journal of Psychiatric Research, 38, 105–11.
Schneider, L. S., Pollock, V. E. & Lyness, S. A. (1990). A meta-analysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatrics Society, 38, 553–63.
Schneider, N. G., Olmstead, R., Mody, F. V.et al. (1995). Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction, 90, 1671–82.
Schneider, N. G., Olmstead, R., Nilsson, F., Mody, F. V., Franzon, M. & Doan, K. (1996). Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo controlled trial. Addiction, 91, 1293–306.
Schneider, W. N., Drew-Cates, J., Wong, T. M. et al. (1999). Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Injury, 13, 863–72.
Schopler, E. (1997). Implementation of TEACCH philosophy. In: D. J. Cohen & F. R. Volkmar, eds. Handbook of Autism and Pervasive Developmental Disorders, 2nd edn. New York: John Wiley, pp. 767–98.
Schottenfeld, R. S., Pakes, J. R., Oliveto, A., Ziedonis, D. & Kosten, T. R. (1997). Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives in General Psychiatry, 54, 713–20.
Schover, L. R. & Leiblum, S. R. (1994). Commentary: the stagnation of sex therapy. Journal of Psychology and Human Sexuality, 6, 5–30.
Schwartz, T. L. & Masand, P. D. (2000). Treatment of delirium with quetiapine. Primary Care Companion. Journal of Clinical Psychiatry, 2, 10–12.
Schweizer, E., Rickels, K., Case, W. G. & Greenblatt, D. J. (1991). Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and outcome. Archives of General Psychiatry, 48, 448–52.
Scott, J. & Clare, L. (2003). Do people with dementia benefit from psychological interventions offered on a group basis?Clinical Psychology and Psychotherapy, 10, 186–96.
Scott, S., Spender, Q., Doolan, M., Jacobs, B. & Aspland, H. (2001). Multicentre controlled trial of parenting groups for childhood antisocial behaviour in clinical practice. British Medical Journal, 323, 1–7.
Scotti, J. R., Evans, I. M., Meyer, L. H. et al. (1991). A meta-analysis of intervention research with problem behavior: treatment validity and standards of practice. American Journal on Mental Retardation, 93, 233–56.
Scottish Intercollegiate Guidelines Network (2003). The Management of Harmful Drinking and Alcohol Dependence in Primary Care, a National Clinical Guideline. Edinburgh: Royal College of Physicians.
Segal, R. (2001). Hypnosis in the treatment of an eating disorder. Australian Journal of Clinical & Experimental Hypnosis, 29(1), 26–36.
Segal, Z. V., Williams, J. M. G. & Teasdale, J. D. (2002). Mindfulness-Based Cognitive Therapy for Depression. New York: Guilford Press.
Seida, J. K., Ospina, M. B., Karkhaneh, M., Hartling, L., Smith, V. & Clark, B. (2009). Systematic reviews of psychosocial interventions for autism: an umbrella review. Developmental Medicine and Child Neurology, 51, 95–104.
Seidman, S. N., Spatz, E., Rizzo, C. & Roose, S. P. (2001). Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. Journal of Clinical Psychiatry, 62(6), 406–12.
Seifer, R., Sameroff, A. J., Baldwin, C. P. & Baldwin, A. L. (1992). Child and family factors that ameliorate risk between 4 and 13 years of age. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 893–903.
Seivewright, H., Green, J., Salkovskis, P., Barrett, B., Nur, U. & Tyrer, P. (2008). Randomised controlled trial of cognitive behaviour therapy in the treatment of health anxiety in a genitourinary medicine clinic. British Journal of Psychiatry, 192, 332–7.
Selvini-Palazzoli, M. (1974). Self Starvation: From the Intrapsychic to the Transpersonal Approach to Anorexia Nervosa. London: Chaucer Publishing.
Serfaty, M. & McCluskey, S. (1998). Compulsory treatment of anorexia nervosa and the moribund patient. European Eating Disorders Review, 6(1), 27–37.
Serfaty, M. A., Turkington, D., Heap, M., Ledsham, L. & Jolley, E. (1999). Cognitive therapy versus dietary counseling in the outpatient treatment of anorexia nervosa: effects of the treatment phase. European Eating Disorders Review, 7, 334–50.
Shaner, A., Eckman, T., Roberts, L. & Fuller, T. (2003). Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psychiatric Services, 54, 1287–9.
Shanti, C. M. & Lucas, C. E. (2003). Cocaine and the critical care challenge. Critical Care Medicine, 31, 1851–9.
Shapiro, D. A., Barkham, M., Rees, A., Hardy, G. E., Reynolds, S. & Startup, M. (1994). Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy. Journal of Consulting and Clinical Psychology, 62(3), 522–34.
Shapiro, J. R., Berkman, N. D., Brownley, K. A. et al. (2007). Bulimia nervosa treatment: a systematic review of randomized controlled trials. International Journal of Eating Disorders, 40, 321–36.
Shaw, P., Sporn, A., Gogtay, N. et al. (2006). Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison. Archives of General Psychiatry, 63, 721–30.
Shea, S., Turgay, A., Carroll, A. et al. (2004). Risperidone in the treatment of disruptive behavioural symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114, 634–41.
Sheehan, D. V., Ballenger, J. & Jacobsen, G. (1980). Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Archives of General Psychiatry, 37, 51–9.
Shelton, R. C., Williamson, D. J., Corya, S. A. et al. (2005). Olanzapine/Fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. Journal of Clinical Psychiatry, 66, 1289–97.
Shiffman, S., Dresler, C. M., Hajek, P., Gilburt, S. J. A., Targett, D. A. & Strahs, K. R. (2002). Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine, 162, 1267.
Shifren, J. L. (2004). The role of androgens in female sexual dysfunction. Mayo Clinic Proceedings, 79 (4 Suppl), S19–24.
Shifren, J. L., Braunstein, G. D., Simon, J. A. et al. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine, 434, 682–8.
Shirk, S. R. (2001). Development and cognitive therapy. Journal of Cognitive Psychotherapy, 15, 155–63.
Sikich, L., Frazier, J., McClellan, J. et al. (2008). Findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. American Journal of Psychiatry, 165, 1420–31.
Silagy, C., Mant, D., Fowler, G. & Lodge, M. (1994). Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet, 343, 139–42.
Silagy, C., Lancaster, T., Stead, L., Mant, D. & Fowler, G. (2002). Nicotine replacement for smoking cessation. Cochrane Database of Systematic Reviews. Oxford: Update Software Ltd.
Silk, K. R. & Jibson, M. D. (2010). Personality disorders. In: A. J. Rothschild, ed. The Evidence-Based Guide to Antipsychotic Medications. Washington, DC: American Psychiatric Publishing, Inc., pp. 101–24.
Silva, R. R., Dinohra, M. D., Munoz, M. D. & Alpert, M. (1996). Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 352–8.
Silverman, K., Higgins, S. T., Brooner, R. K. et al. (1996). Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Archives of General Psychiatry, 53, 409–15.
Simons, A. D., Murphy, G. E., Levine, J. L. & Wetzel, R. D. (1986). Cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 43, 43–8.
Sienaert, P. (2011). What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist. Canadian Journal of Psychiatry, 56, 5–12.
Sipahimalani, A. & Masand, P. S. (1998). Olanzapine in the treatment of delirium. Psychosomatics, 39, 422–30.
Slattery, J., Chick, J., Cochrane, M. et al. (2003). Prevention of Relapse in Alcohol Dependence. Health Technology Assessment Report 3. Glasgow: Health Technology Board for Scotland.
Small, J. G., Klapper, M. H., Kellams, J. J. et al. (1988). Electroconvulsive treatment compared with lithium in the management of manic states. Archives in General Psychology, 45, 727–32.
Smelson, D. A., Dixon, L., Craig, T., Remolina, S., Batki, S., Niv, N. & Owen, R. (2008). Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs, 22, 903–16.
Smelson, D., Kalman, D., Losonczy, M. F. et al. (2010). A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Mental Health Journal. DOI:10.1007/s10297-010-9346-9
Smith, B. H., Waschbusch, D. A., Willoughby, M. T. & Evans, S. (2000). The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD). Clinical Child and Family Psychology Review, 3, 243–67.
Smith, D. E. & Wesson, D. R. (1971). A phenobarbital technique for the withdrawal of barbiturate abuse. Archives of General Psychiatry, 24, 56–60.
Smith, D. E. & Wesson, D. R. (1985). Benzodiazepine dependence syndromes. In: D. E. Smith & D. R. Wesson, eds. The Benzodiazepines: Current Standards for Medical Practice. Lancaster, UK: MTP Press, pp. 235–48.
Smith, G. J., Amner, G., Johnsson, P. & Franck, A. (1997). Alexithymia in patients with eating disorders: an investigation using a new projective technique. Perceptual and Motor Skills, 85, 247–56.
Smits, J., Conall, M. & Otto, M. W. (2006). Combining cognitive-behavioral therapy and pharmacotherapy for the treatment of panic disorder. Journal of Cognitive Psychotherapy, 20(1), 75–84.
So, C. C. & Wong, K. F. (2002). The Brain and the Inner World: An Introduction to Neuroscience of Subjective Experience. London:Karnac Press.
Soares, B. F. O., Lima, M. S., Reisse, R. A. A. P. & FarrellM. (2002). Dopamine agonists for cocaine dependence (Cochrane Review). In: The Cochrane Library, 2. Oxford: Update Software.
Soares, C. N., Almeida, O. P., Joffe, H. & Cohen, L. S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry, 58(6), 529–34.
Sobell, M. B. & Sobell, L. C. (2000). Stepped care as a heuristic approach to the treatment of alcohol problems. Journal of Consulting and Clinical Psychology, 68, 573–9.
Sofuoglu, M. & Kosten, T. R. (2006). Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion on Emerging Drugs, 11(1), 91–8.
Sofuoglu, M., Dudish-Poulsen, S., Brown, S. B. & Hatsukami, D. K. (2003). Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug and Alcohol Dependence, 69, 273–82.
Sokolski, K. N., Conney, J. C. et al. (2004). Once-daily high-dose pindolol for SSRI-refractory depression. Psychiatry Research, 125(2), 81–6.
Solomon, S. M. & Kirby, D. F. (1990). The refeeding syndrome: a review. Journal of Parenteral and Enteral Nutrition, 14, 90–7.
Sorenson, J. L. & Copeland, A. L. (2000). Drug abuse treatment as an HIV prevention strategy: a review. Drug and Alcohol Dependence, 59, 17–31.
Spector, A., Orrell, M., Davies, S. & Woods, R. T. (2000). Reminiscence therapy for dementia. Cochrane Database of Systematic Reviews, 2, CD001120.
Spector, A., Orrell, M., Davies, S. & Woods, R. (2003). Reminiscence therapy for dementia. Cochrane Database of Systematic Reviews, 3. Oxford: Update Softward Ltd.
Spence, S. H., Donovan, C. & Brechman-Toussaint, M. (2000). The treatment of childhood social phobia: the effectiveness of a social skills training-based cognitive-behavioural intervention, with and without parental involvement. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 41, 713–26.
Spencer, S.-J., Rutter, D. & Tyrer, P. (2010). Integration of nidotherapy into the management of mental illness and antisocial personality: a qualitative study. International Journal of Social Psychiatry, 56, 50–9.
Spencer, T., Biederman, J., Wilens, T., Harding, M., O’Donnell, D. & Griffin, S. (1996). Pharmacotherapy of attention deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409–32.
Spencer, T., Heiligenstein, J. H., Biederman, J. et al. (2002). Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63, 1140–7.
Spiegel, D. A., Bruce, T. J., Gregg, S. F. & Nuzzarello, A. (1994). Does cognitive behaviour therapy assist slow-taper alprazolam discontinuation in panic disorder?American Journal of Psychiatry, 151, 876–81.
Spivak, K., Sanchez-Craig, M. & Davila, R. (1994). Assisting problem drinkers to change on their own: effect of specific and non-specific advice. Addiction, 89, 1135–42.
Srisurapanont, M. & Jarusuraisin, N. (2003). Opioid antagonists for alcohol dependence. In: The Cochrane Library. Chichester: John Wiley & Sons Ltd.
Srisurapanont, M., Jarusuraisin, N. & Kittirattanapaiboon, P. (2002). Treatment for amphetamine dependence and abuse (Cochrane Review). In: The Cochrane Library, 2. Oxford: Update Software.
Stams, G. -J. J. M., Juffer, F., van Ijzendoorn, M. H. & Hoksbergen, R. A. C. (2001). Attachment-based intervention in adoptive families in infancy and children’s development at age 7: two follow-up studies. British Journal of Developmental Psychology, 19, 159–80.
Stangier, U., Heidenreich, T., Peitz, M., Lauterbach, W. & Clark, D. M. (2003). Cognitive therapy for social phobia: individual versus group treatment. Behaviour Research & Therapy, 41, 991–1007.
Stanislav, S. W., Fabre, T., Crismon, M. L. et al. (1994). Buspirone’s efficacy in organic-induced aggression. Journal of Clinical Psychopharmacology, 14, 126–30.
Staring, A. B. P., Van der Gaag, M., Koopmans, G. T et al. (2010). Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. British Journal of Psychiatry, 197, December issue.
Stefano, S. C., Bacaltchuk, J., Blay, S. L. & Appolinario, J. C. (2008). Antidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysis. Eating Behavior, 9, 129–36.
Stein, M. B. & Kean, Y. M. (2000). Disability and quality of life in social phobia: epidemiologic findings. American Journal of Psychiatry, 157, 1606–13.
Stein, B. D., Jaycox, L., Kataoka, S. et al. (2003). A mental health intervention for schoolchildren exposed to violence: a randomised controlled trial. Journal of the American Medical Association, 290, 603–11.
Stein, D. J., Cameron, A., Amrein, R., Montgomery, S. A. & Moclobemide Social Phobia Clinical Study Group (2002). Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. International Clinical Psychopharmacology, 17, 161–70.
Stein, D. J., Westenberg, H. G., Yang, H., Li, D. & Barbato, L. M. (2003). Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multi-centre, randomized, placebo-controlled trial. International Journal of Neuropsychopharmacology, 6, 317–23.
Stein, M., Tiefer, L. & Melman, A. (1990). Follow-up observations of operated male-to-female transsexuals. Journal of Urology, 143, 1188–92.
Stein, M. B., Norton, G. R., Walker, J. R., Chartier, M. J. & Graham, R. (2000). Do SSRIs enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study. Psychiatry Research, 94, 191–200.
Stein, M. B., Pollack, M. H., Brystritsky, A., Kelsey, J. E. & Mangano, R. M. (2005). Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berlin), 177, 280–8.
Stephens, R. S., Roffman, R. A. & Curtin, L. (2000). Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898–908.
Stewart, R. (2002). The interface between cerebrovascular disease, depression and dementia. In: E. Chiu, D. Ames & C. Katona, eds. Vascular Disease and Affective Disorders. London: Martin Dunitz Publishing.
Stice, E. & Shaw, H. (2004). Eating disorder prevention programs: a meta-analytic review. Psychology Bulletin, 130, 206–07.
Stirman, S. W., DeRubeis, R. J., Crits-Christoph, P. & Brody, P. E. (2003). Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. Journal of Consulting and Clinical Psychology, 71, 963–72.
Stoffers, J., Vollm, B. A., Rucker, G., Timmer, A., Huband, N. & Lieb, K. (2010). Pharmacological interventions for borderline personality disorder. Cochrane Database of Systematic Reviews, 6, CD005653.
Strawn, J. R., Keeshin, B. R., DelBello, M. P. et al. (2010). Psychopharmacologic treatment of post traumatic stress disorder in children and adolescents: a review. Journal of Clinical Psychiatry, 71, 932–41.
Street, J. S., Clark, W. S., Gannon, K. S. et al. (2000). Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Archives of General Psychiatry, 57, 968–76.
Striegel-Moore, R. H., Leslie, D., Petrill, S. A., Garvin, V. & Rosenheck, R. A. (2000). One-year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: evidence from a national database of health insurance claims. International Journal of Eating Disorders, 27, 381–9.
Substance Abuse and Mental Health Services Administration (SAMHSA) (2008). Results from the 2007 National Survey on Drug Use and Health: national findings. Rockville, MD: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration.
Sultzer, D. L., Gray, K. F., Gunay, I., Berisford, M. A. & Mahler, M. E. (1997). A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. American Journal of Geriatric Psychiatry, 5, 60–9.
Sumathipala, A., Siribaddana, S., Abeysingha, M. R., et al. (2008). Cognitive-behavioural therapy v. structured care for medically unexplained symptoms: randomised controlled trial. British Journal of Psychiatry, 193, 51–9.
Sundgot-Borgen, J., Rosenvinge, J. H., Bahr, R. & Schneider, L. S. (2002). The effect of exercise, cognitive therapy, and nutritional counseling in treating bulimia nervosa. Medicine & Science in Sports & Exercise, 34(2), 190–5.
Susser, E., Valencia, E., Conover, S., Felix, A., Wei-Yann, T. & Wyatt, R. (1997). Preventing recurrent homelessness among mentally ill men: a “critical time” intervention after discharge from a shelter. American Journal of Public Health, 87, 256.
Swinson, R., Cox, B. & Woszczyna, C. (1992). Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. Canadian Medical Association Journal, 147, 878–83.
Szabo, C. P. & Green, K. (2002). Hospitalized anorexics and resistance training: impact on body composition and psychological well-being: a preliminary study. Eating and Weight Disorders, 7(4), 293–7.
Szekely, C. A., Thorne, J. E., Zandi, P. P. et al. (2004). Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer’s disease: a systematic review. Neuroepidemiology, 23, 159–69.
Taieb, O., Cohen, D., Mazet, P. et al. (2000). Adolescents’ experience with ECT. Journal of the American Academy of Child and Adolescence Psychiatry, 39, 943–4.
Tam, S. W., Worcel, M. & Wyllie, M. (2001). Yohimbine: a clinical review. Pharmacology and Therapeutics, 91, 215–43.
Taragano, F. E., Lysketos, C. G., Mangone, C. A. et al. (1997). A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitryptiline in the treatment of major depression complicating Alzheimer’s disease. Psychosomatics, 38, 246–52.
Tariot, P. N., Erb, R., Leibovici, A. et al. (1994). Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. Journal of the American Geriatrics Society, 42, 1160–6.
Tariot, P. N., Erb, R., Podgorski, C. A. et al. (1998). Efficacy and tolerability of carbamazepine therapy followed by further carbamazepine treatment in patients with dementia. Journal of Clinical Psychiatry, 60, 684–9.
Tariot, P. N., Cummings, J. L., Katz, I. R. et al. (2001). A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. Journal of the American Geriatrics Society, 49, 1590–9.
Tasca, G. A., Flynn, C. & Bissada, H. (2002). Comparison of group climate in an eating disorders partial hospital group and a psychiatric partial hospital group. International Journal of Group Psychotherapy, 52, 409–17.
Taub, E., Steiner, S. S., Weingarten, E. & Walton, K. G. (1994). Effectiveness of broad spectrum approaches to relapse prevention in severe alcoholism: a long-term, randomized, controlled trial of Transcendental Meditation, EMG biofeedback and electronic neurotherapy. Alcoholism Treatment Quarterly, 11, 187–220.
Tauscher, J., Tauscher-Wisniewski, D. & Kasper, S. (2000). Treatment of patients with delirium. American Journal of Psychiatry, 157, 1711.
Taylor, E., Dopfner, M., Sergeant, J. et al. (2004). European clinical guidelines for hyperkinetic disorder – first upgrade. European Child and Adolescent Psychiatry, 13 (Suppl. 1), 17–30.
Taylor, J. L., Novaco, R. W., Gillmer, B. & Thorne, I. (2002). Cognitive-behavioural treatment of anger intensity among offenders with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 15, 151–65.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Sousby, J. M. & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68(4), 615–23.
Tenneij, N. H., van Megen, H. J., Denys, D. A. & Westenberg, H. G. (2005). Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. Journal of Clinical Psychiatry, 66, 1169–75.
Terman, J. S., Terman, M., Lo, E. S. & Cooper, T. B. (2001). Circadian time of morning light administration and therapeutic response in winter depression. Archives of General Psychiatry, 58(1), 69–75.
Terman, M., Terman, J. S., Quitkin, F. M., McGrath, P. J., Stewart, J. W. & Rafferty, B. (1989). Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology, 2(1), 1–22.
Terman, M., Amira, L., Terman, J. S. & Ross, D. C. (1996). Predictors of response and nonresponse to light treatment for winter depression. American Journal of Psychiatry, 153(11), 1423–9.
Thase, M. E., Entsuah, A. R. & Rudolph, R. L. (2001). Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. British Journal of Psychiatry, 178, 234–41.
The TADS Team (2007). The treatment for adolescents with depression study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64, 1132–44.
Thompson, A., Shaw, M., Harrison, G., Verne, J., Ho, D. & Gunnell, D. (2004). Patterns of hospital admission for adult psychiatric illness in England: analysis of Hospital Episode Statistics data. British Journal of Psychiatry, 185, 334–41.
Thomsen, P. H. (1998). Obsessive-compulsive disorder in children and adolescents: clinical guidelines. European Child and Adolescent Psychiatry, 7, 1–11.
Thorén, P., Asberg, M., Cronholm, B., Jörnestedt, L. & Träskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Archives of General Psychiatry, 37, 1281–5.
Tiihonen, J., Lonnqvist, J., Wahlbeck, K. et al. (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet, 374, 620–7.
Titov, N., Andrews, G., Choi, I., Schwencke, G. & Mahoney, A. (2008). Shyness 3: randomized controlled trial of guided versus unguided Internet-based CBT for social phobia. Australian and New Zealand Journal of Psychiatry, 42, 1030–40.
Tohen, M., Kryzhanovskaya, L., Carlson, G. et al. (2007). Olanzapine versus placebo in the treatment of adolescents with bipolar mania. American Journal of Psychiatry, 164, 1547–56.
Tolin, D. F., Maltby, N., Diefenbach, G. J., Hannan, S. E. & Worhunsky, P. (2004). Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. Journal of Clinical Psychiatry, 65, 922–31.
Tollefson, G. D., Birkett, M., Koran, L.Genduso, L. (1994). Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. Journal of Clinical Psychiatry, 55 (Suppl), 69–76.
Tonigan, J. S., Toscova, R. & Miller, W. R. (2002). Meta-analysis of the literature on Alcoholics Anonymous: sample and study characteristics moderate findings. Journal of Studies on Alcohol, 57, 65–72.
Touyz, S. W., Beumont, P. J. V., Glaun, D., Phillips, T. & Cowie, I. (1984). A comparison of lenient and strict operant conditioning programmes in refeeding patients with anorexia nervosa. British Journal of Psychiatry, 144, 517–20.
Touyz, S. W., Garner, D. M. & Beumont, P. J. V. (1995). The inpatient management of the adolescent patient with anorexia nervosa. In: H-Ch. Steinhausen, ed. Anorexia and Bulimia Nervosa: Eating Disorders in Adolescence. Berlin, New York: Walter de Gruyter, pp. 247–70.
Treasure, J. L., Todd, G., Brolly, M., Tiller, J., Nehmed, A. & Denman, F. (1995). A pilot study of a randomized trial of cognitive analytical therapy vs. educational behavioural therapy for adult anorexia nervosa. Behaviour Research and Therapy, 33, 363–7.
Treasure, J., Angélica, M., Claudino, A. M. & Zucker, N. (2010). Eating disorders. Lancet, 375, 583–93.
Treatment for Adolescents with Depression Study (TADS) Team (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807–20.
Trigazis, L., Tennankore, D., Vohra, S. & Katzman, D. K. (2004). The use of herbal remedies by adolescents with eating disorders. International Journal of Eating Disorders, 35, 223–8.
Trivedi, M. H., Rush, A. J., Wisniewski, S. R. et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STARD*D: implications for clinical practice. American Journal of Psychiatry, 163(1), 28–40.
Trumpler, F., Oez, S., Stahli, P., Brenner, H. D. & Juni, P. (2003). Acupuncture for alcohol withdrawal: a randomized, controlled trial. Alcohol and Alcoholism, 38, 369–75.
Tsoi, W. F. (1993). Follow-up study of transsexuals after sex-reassignment surgery. Singapore Medical Journal, 34, 515–7.
Tsoi, W. F., Kok, L. P., Yeo, K. L. & Ratnam, S. S. (1995). Follow-up study of female transsexuals. Annals of the Academy of Medicine, Singapore, 24, 664–7.
Tumur, I., Kaltenthaler, E., Ferriter, M., Beverley, C. & Parry, G. (2007). Computerised cognitive behaviour therapy for obsessive-compulsive disorder: a systematic review. Psychotherapy and Psychosomatics, 76, 196–202.
Tyrer, P. (1986). How to Stop Taking Tranquillisers. London: Sheldon Press.
Tyrer, P. (2007). Personality diatheses: a superior explanation than disorder. Psychological Medicine, 37, 1521–5.
Tyrer, P. (2009). Harmonising the Environment with the Patient. London: RCPsych Press.
Tyrer, P. & Baldwin, D. (2006). Generalised anxiety disorder. Lancet, 368, 2156–66.
Tyrer, P. & Kendall, T. (2009). The spurious advance of antipsychotic drug therapy. Lancet, 373, 4–5.
Tyrer, P. J. & Lader, M. H. (1973). Effects of beta-blockade with sotalol in chronic anxiety. Clinical Pharmacology and Therapeutics, 14, 418–26.
Tyrer, P. & Lader, M. H. (1974). Response to propranolol and diazepam in somatic and psychic anxiety. British Medical Journal, 2, 14–16.
Tyrer, P., Rutherford, D. & Huggett, T. (1981). Benzodiazepine withdrawal symptoms and propranolol. Lancet, i, 520–2.
Tyrer, P., Owen, R. & Dawling, S. (1983). Gradual withdrawal of diazepam after long-term therapy. Lancet, i, 1402–6.
Tyrer, P., Murphy, S., Oates, G. & Kingdon, D. (1985). Psychological treatment for benzodiazepine dependence. Lancet, 1, 1042–3.
Tyrer, P., Seivewright, N., Murphy, S. et al. (1988). The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet, ii, 235–40.
Tyrer, P., Murphy, S. & Riley, P. (1990). The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders, 19, 53–61.
Tyrer, P., Mitchard, S., Methuen, C. & Ranger, M. (2003a). Treatment-rejecting and treatment-seeking personality disorders: Type R and Type S. Journal of Personality Disorders, 17, 265–70.
Tyrer, P., Sensky, T. & Mitchard, S. (2003b). The principles of nidotherapy in the treatment of persistent mental and personality disorders. Psychotherapy and Psychosomatics, 72, 350–6.
Tyrer, P., Oliver-Africano, P. C., Ahmed, Z. et al. (2008). Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in intellectual disability: randomised controlled trial. Lancet, 371, 55–61.
Tyrer, P., Milošeska, K., Whittington, C. et al. (2011). Nidotherapy in the treatment of substance misuse, psychosis and personality disorder: secondary analysis of a controlled trial. The Psychiatrist, 35, 9–14.
Tyrer, S. P., Walsh, A., Edwards, D. E. et al. (1984). Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progress in Neuropsychopharmacology and Biological Psychiatry, 8, 751–5.
Uehara, T., Kawashima, Y., Goto, M., Tasaki, S. I. & Someya, T. (2001). Psychoeducation for the families of patients with eating disorders and changes in expressed emotion: a preliminary study. Comprehensive Psychiatry, 42(2), 132–8.
Uher, R., Perroud, N., Ng, M. Y. et al. (2010). Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. American Journal of Psychiatry, 167, 555–64.
UK Alcohol Forum (2001). Guidelines for the Management of Alcohol Problems in Primary Care and General Psychiatry. High Wycombe, Bucks: Tangent Medical Education.
United Nations Office for Drug Control and Crime Prevention (2000). World Drug Report 2000. Oxford: Oxford University Press.
US Department of Health and Human Services (1999). TIP 32: Treatment of Adolescents with Substance Use Disorders (DHHS Publication No. SMA 99–3283). Rockville, MD: Author.
US Department of Health and Human Services (2003). Helping Patients with Alcohol Problems: A Health Practitioner’s Guide. National Institute of Health, National Institute on Alcohol and Alcoholism.
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C. Murray, CJL (2004). Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 184, 386–92.
van den Boom, D. C. (1994). The influence of temperament and mothering on attachment and exploration: an experimental manipulation of sensitive responsiveness among lower-class mothers with irritable infants. Child Development, 65, 1457–77.
van den Boom, D. C. (1995). Do first-year intervention effects endure? Follow-up during toddlerhood of a sample of Dutch irritable infants. Child Development, 66, 1798–816.
Van den Borre, R., Vermote, R., Buttiens, M. et al. (1993). Risperidone as add-on therapy in behavioral disturbances in mental-retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatrica Scandinavica, 87, 167–71.
Van den Hout, M. & Barlow, D. (2000). Attention, arousal and expectancies in anxiety and sexual disorders. Journal of Affective Disorders, 61, 241–56.
Van der Windt, F., Dohle, G. R., van der Tak, J. & Slob, A. K. (2002). Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction. BJU International, 89, 901–4.
Van Kesteren, P. J., Asscheman, H.Megens, J. A. & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47, 337–42.
Van Lankveld, J. J. D. M. (1998). Bibliotherapy in the treatment of sexual dysfunctions: a meta-analysis. Journal of Consulting and Clinical Psychology, 66, 702–8.
Van Putten, T. & Fawzy, F. I. (1976). Sex conversion surgery in a man with severe gender dysphoria: a tragic outcome. Archives of General Psychiatry, 33(6), 751–3.
Van Reekum, R., Clarke, D., Conn, D. et al. (2002). A randomized placebo-controlled trial of the discontinuation of long-term anti-psychotics in dementia. International Psychogeriatrics, 14, 197–210.
Vandereycken, W. & Pieters, G. (1978). Short-term weight restoration in anorexia nervosa through operant conditioning. Scandinavian Journal of Behaviour Therapy, 7, 221–36.
Vandereycken, W. (2003). The place of inpatient care in the treatment of anorexia nervosa: questions to be answered. International Journal of Eating Disorders, 34, 409–22.
Vandrey, R. G. & Haney, M. (2009). Pharmacotherapy for cannabis dependence: how close are we?CNS Drugs, 23, 543–53.
Vandrey, R. G., Budney, A. J., Moore, B. A. & Hughes, J. R. (2005). A cross-study comparison of cannabis and tobacco withdrawal. American Journal on Addictions, 14, 54–63.
Vasilaki, E. I., Hosier, S. G. & Cox, W. M. (2006). The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol and Alcoholism, 41, 328–35.
Vataja, R., Pohjasvaara, T., Leppavuori, A. & Erkinjutti, T. (2002). Post stroke depression. In E. Chiu, D. Ames & C. Katona, eds. Vascular Disease and Affective Disorders. London: Martin Dunitz Publishing.
Vaughn, C. E. & Leff, J. P. (1976). The influence of family and social factors on the course of psychiatric illness: a comparison of schizophrenic and depressed neurotic patients. British Journal of Psychiatry, 129, 125–37.
Verheul, R., Van Den Bosch, L. M., Koeter, M. W., De Ridder, M. A., Stijnen, T. & Van Den Brink, W. (2003). Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. British Journal of Psychiatry, 182, 135–40.
Versiani, M., Nardi, A. E., Mundim, F. D., Alves, A. B., Liebowitz, M. R. & Amrein, R. (1992). Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. British Journal of Psychiatry, 161, 353–60.
Vieten, C., Astin, J. A., Buscemi, R. & Galloway, G. P. (2010). Development of an acceptance-based coping intervention for alcohol dependence relapse prevention. Substance Abuse, 31, 108–16.
Vinks, A. A. & Walson, P. D. (2003). Pharmacokinetics 1: developmental principles. In: A. Martin, L. Scahill, D. S. Charney & J. F. Leckman, eds. Pediatric Psychopharmacology: Principles and Practice. Oxford: Oxford University Press.
Virtué-Ortega, J. (2010). Applied behavior analytic intervention for autism in early childhood: meta-analysis, meta-regression and dose–response meta-analysis of multiple outcomes. Clinical Psychology Review, 30, 387–99.
Vocks, S., Tuschen-Caffier, B., Pietrowsky, R., Rustenbach, S. J., Kersting, A. & Herpertz, S. (2010). Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder. International Journal of Eating Disorders, 43, 205–17.
Volpicelli, J. R., Rhines, K. C., Rhines, J. S. et al. (1997). Naltrexone and alcohol dependence: role of subject compliance. Archives of General Psychiatry, 54, 737–42.
Von Keitz, A. T., Stroberg, P., Bukofzer, S., Mallard, N. & Hibberd, M. (2002). A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction. BJU International, 89, 409–15.
Wagner, K. D., Ambrosini, P., Rynn, M. et al. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. Journal of the American Medical Association, 290, 1033–41.
Wagner, K. D., Kowatch, R. A., Emslie, G. J. et al. (2006). A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. American Journal of Psychiatry, 163, 1179–86.
Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M. & Heydorn, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161, 1079–83.
Wagner, K. D., Redden, L., Kowatch, R. A. et al. (2009). A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 519–32.
Waldinger, M. D., Hengeveld, M. W., Zwinderman, A. H. & Olivier, B. (2001). Effect of SSRI antidepressants on ejaculation: a double-blind randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. Journal of Clinical Psychopharmacology, 21(2), 241–2.
Walitzer, K. S. & O’Connors, G. J. (1999). Treating problem drinking. Alcohol Research and Health, 23, 138–43.
Walkup, J. T., Albano, A. M., Piacentini, J. et al. (2008). Cognitive behavioural therapy, sertraline or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–66.
Wallace, P., Cutler, S. & Haines, A. (1988). Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. British Medical Journal, 297, 663–8.
Waller, D. & Fairburn, C. G. (2004). Eating disorders. In D. Waller & A. McPherson, eds. Women’s Health, 5th edn. Oxford: Oxford University Press, pp. 519–51.
Waller, D., Fairburn, C. G., McPherson, A., Kay, R., Lee, A. & Nowell, T. (1996). Treating bulimia nervosa in primary care: a pilot study. International Journal of Eating Disorders, 19, 99–103.
Walsh, B. T., Fairburn, C. G., Mickley, D., Sysko, R. & Parides, M. K. (2004). Treatment of bulimia nervosa in a primary care setting. American Journal of Psychiatry, 161, 556–61.
Walter, G. & Rey, J. M. (2003). How fixed are child psychiatrists’ views about ECT in the young?The Journal of ECT, 19, 88–92.
Walsh, B. T., Seidman, S. N. et al. (2002). Placebo response in studies of major depression: variable, substantial, and growing. Journal of the American Medical Association, 287(14), 1840–7.
Walsh, R. & Shapiro, S. L. (2006). The meeting of meditative disciplines and Western psychology: a mutually enriching dialogue. American Psychologist, 61, 227–39.
Walter, G., Rey, J. M. & Mitchell, P. B. (1999). Practitioner review: electroconvulsive therapy in adolescents. Journal of Child Psychology and Psychiatry, 40, 325–34.
Webster-Stratton, C. (1981). Modification of mothers’ behaviors and attitudes through a videotape modeling group discussion program. Behavior Therapy, 12, 634–42.
Webster-Stratton, C. & Reid, M. J. (2004). Strengthening social and emotional competence in young children: the foundation for early school readiness and success incredible years classroom social skills and problem-solving curriculum. Infants and Young Children, 17, 96–113.
Webster-Stratton, C., Reid, M. J. & Hammond, M. (2004). Treating children with early-onset conduct problems: intervention outcomes for parent, child, and teacher training. Journal of Clinical Child and Adolescent Psychology, 33, 105–24.
Webster-Stratton, C.Reid, M. J. & Stoolmiller, M. (2008). Preventing conduct problems and improving school readiness: Evaluation of the Incredible Years teacher and child training programs in high-risk schools. Journal of Child Psychology and Psychiatry, 49, 471–88.
Weinmann, S., Roll, S., Schwarzbach, C., Vauth, C. & Willich, S. N. (2010). Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatrics, 10, 14.
Weisner, C., Greenfield, T. & Room, R. (1995). Trends in the treatment of alcohol problems in the U.S. general population, 1979 through 1990. American Journal of Public Health, 85, 55–60.
Weiss, B., Catron, T., Harris, V. & Phung, T. M. (1999). The effectiveness of traditional child psychotherapy. Journal of Consulting and Clinical Psychology, 67, 82–94.
Weissman, M. M. (1979). The psychological treatment of depression: evidence for the efficacy of psychotherapy alone, in comparison with, and in combination with pharmacotherapy. Archives of General Psychiatry, 36, 1261–9.
Weisz, J. R., Weiss, B., Alicke, M. D. & Klotz, M. L. (1987). Effectiveness of psychotherapy with children and adolescents: a meta-analysis for clinicians. Journal of Consulting and Clinical Psychology, 55, 542–9.
Weisz, J. R., Weiss, B., Han, S. S., Granger, D. A. & Morton, T. (1995). Effects of psychotherapy with children and adolescents revisited: a meta-analysis of treatment outcome studies. Psychological Bulletin, 117, 450–68.
Weisz, J. R., Hawley, K. M. & Doss, A. J. (2004). Empirically tested psychotherapies for youth internalizing and externalizing problems and disorders. Child and Adolescent Psychiatric Clinics of North America, 13, 729–815.
Wells, K. C. (2004). Treatment of ADHD in children and adolescents. In: P. M. Barrett & T. H. Ollendick, eds. Handbook of Interventions that Work with Children and Adolescents: Prevention and Treatment. Chichester, UK: John Wiley & Sons, Ltd, pp. 343–68.
Wells, K. C., Epstein, J. N., Hinshaw, S. P. et al. (2000). Parenting and family stress treatment outcomes in attention-deficit/hyperactivity disorder (ADHD): an empirical analysis in the MTA Study. Journal of Abnormal Child Psychology, 28, 543–53.
Wells-Parker, E., Bangert-Drowns, R., McMillen, R. & Williams, M. (1995). Final results from a meta-analysis of remedial interventions with drink/drive offenders. Addiction, 90, 907–26.
West, R., Hajek, P., Foulds, J., Nilsson, F., May, S. & Meadows, A. (2000). A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacologia, 149, 198–202.
West, S. L., O’Neal, K. K. & Graham, C. W. (2000). A meta-analysis comparing the effectiveness of buprenorphine and methadone. Journal of Substance Abuse, 12, 405–14.
Westermeyer, J., Weiss, R. & Ziedonis, D. (2003). Integrated Treatment for Mood and Substance Use Disorders. Baltimore, Maryland: The Johns Hopkins University Press.
Whalen, C. K., Henker, B. & Granger, D. A. (1990). Social judgment processes in hyperactive boys: effects of methylphenidate and comparisons with normal peers. Journal of Abnormal Child Psychology, 18, 297–316.
Whitaker-Azmitia, P. M., Druse, M., Walker, P. et al. (1996). Serotonin as a developmental signal. Behaviour Brain Research, 73, 19–29.
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363, 1341–5.
Whitworth, A. B., Fischer, F., Lesch, O. M. et al. (1996). Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet, 347, 1438–42.
WHO Collaborating Centre for Research and Training for Mental Health (2004). WHO Guide to Mental and Neurological Health in Primary Care. London: RSM Press.
Wilberg, T., Friis, S., Karterud, S.Mehlum, L., Urnes, O. & Vaglum, P. (1998). Outpatient group psychotherapy: a valuable continuation treatment for patients with borderline personality disorder treated in a day hospital? A 3-year follow-up study. Nordic Journal of Psychiatry, 52, 213–22.
Wilcock, G. K., Ballard, C. G., Cooper, J. A. & Loft, H. (2008). Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer’s disease: a pooled analysis of 3 studies. Journal of Clinical Psychiatry, 69, 341–8.
Wilfley, D. E., Welch, R. R., Stein, R. I. et al. (2002). A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Archives of General Psychiatry, 59(8), 713–21.
Wilfley, D. E., Crow, S. J., Hudson, J. I. et al. (2008). Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. American Journal of Psychiatry, 165, 51–8.
Wilk, A. I., Jensen, N. M. & Havighurst, T. C. (1997). Meta analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. Journal of General Internal Medicine, 12, 274–83.
Willer, M. G., Thuras, P. & Crow, S. J. (2005). Implications of the changing use of hospitalization to treat anorexia nervosa. American Journal of Psychiatry, 162, 2374–6.
Williams, M. A., Campbell, E. B., Raynor, W. J. et al. (1985). Reducing acute confusional states in elderly patients with hip fractures. Research in Nursing and Health, 8, 329–37.
Williams, S. K., Scahill, L., Vitiello, B. et al. (2006). Risperidone and adaptive behavior in children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 431–9.
Williamson, D. A., Thaw, J. M. & Varnado-Sullivan, P. J. (2001). Cost-effectiveness analysis of a hospital-based cognitive-behavioral treatment program for eating disorders. Behavior Therapy, 32, 459–77.
Willner, P., Jones, J., Tams, R. & Green, G. (2002). A randomised controlled trial of the efficacy of a cognitive-behavioural anger management group for adults with learning disabilities. Journal of Applied Research in Intellectual Disabilities, 15, 224–35.
Wilson, G. T. & Fairburn, C. G. (2002). Eating disorders. In: P. E. Nathan & J. M. Gorman, eds. Treatments that Work, 2nd edn. New York: Oxford University Press, pp. 559–92.
Wilson, G. T., Wilfley, D. E., Agras, W. S. & Bryson, S. W. (2010). Psychological treatments of Binge Eating Disorder. Archives of General Psychiatry, 67, 94–101.
Winblad, B., Engedal, K., Soininen, H. et al. & the Donepezil Nordic Study Group (2001). A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology, 57, 489–95.
Winblad, B., Black, S. E., Homma, A. et al. (2009). Donepezil treatment in severe Alzheimer’s disease: a pooled analysis of three clinical trials. Current Medical Research Opinion, 25, 2577–87.
Winston, A. & Webster, P. (2003). Inpatient treatment. In: J. Treasure, U. Schmidt & E. van Furth, eds. Handbook of Eating Disorders, 2nd edn. Chichester: John Wiley and Sons.
Winters, N. C. (2003). Feeding problems in infancy and early childhood. Primary Psychiatry, 10(6), 30–4.
Wiseman, C. V., Sunday, S. R., Klapper, F., Harris, W. A. & Halmi, K. A. (2001). Changing patterns of hospitalization in eating disorder patients. International Journal of Eating Disorders, 30, 69–74.
Wong, I. C., Camilleri-Novak, D., Stephens, P. et al. (2003). Rise in psychotropic drug prescribing in children in the UK: an urgent public health issue. Drug Safety, 26, 1117–8.
Woods, B., Spector, A., Jones, C., Orrell, M. & Davies, S. (2005). Reminiscence therapy for dementia. Cochrane Database of Systematic Reviews, 2, CD001120.
Woodside, D. B. & Kaplan, A. S. (1994). Day hospital treatment in males with eating disorders: response and comparison to females. Journal of Psychosomatic Research, 38, 471–5.
Woody, G. E., Luborsky, L., McLellan, A. T.et al. (1983). Psychotherapy for opiate addicts. Does it help?Archives in General Psychiatry, 40(6), 639–45.
Woolfenden, S. R., Williams, K. & Peat, J. K. (2002). Family and parenting interventions for conduct disorder and delinquency: a meta-analysis of randomised controlled trials. Archives of Disease in Childhood, 86, 251–6.
Wykes, T. & Huddy, V. (2009). Cognitive remediation for schizophrenia: it is even more complicated. Current Opinion in Psychiatry, 22(2), 161–7.
Wynne, L. C., Ryckoff, I. M., Day, J. & Hirsch, S. (1958). Pseudomutuality in the family relations of schizophrenics. Psychiatry, 21(2), 205–20.
Yagcioglu, A. E., Kivircik, A., Turgut, T. I. et al. (2005). A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. Journal of Clinical Psychiatry, 66, 63–72.
Yager, J., Siegfreid, S. L. & DiMatteo, T. L. (1999). Use of alternative remedies by psychiatric patients: illustrative vignettes and a discussion of the issues. American Journal of Psychiatry, 156, 1432–8.
Yamda, N., Martin-Iverson, M. T., Daimon, K., Tsujimoto, T. & Takashashi, S. (1995). Clinical and chronobiological effects of light therapy on non-seasonal affective disorders. Biological Psychiatry, 37, 866–73.
Yanos, P., Rosenfield, S. & Horwitz, A. (2001). Negative and supportive social interactions and quality of life among persons diagnosed with severe mental illness. Community Mental Health Journal, 37, 405.
Yaryura-Tobias, J. A. & Neziroglu, F. A. (1996). Venlafaxine in obsessive-compulsive disorder. Archives of General Psychiatry, 53, 653–4.
Yatham, L. N. (2003). Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics. Bipolar Disorders, 5 (Suppl. 2), 7–19.
Yoder, P. J. & Stone, W. L. (2006). Randomized comparison of two communication interventions for preschoolers with autism spectrum disorders. Journal of Consulting and Clinical Psychology, 74, 426–35.
Young, J. E. (1990). Cognitive Therapy for Personality Disorders: A Schema-Focused Approach. Sarasota, Florida: Professional Resource Exchange.
Zanarini, M. C., Frankenburg, F. R., Hennen, J. & Silk, K. R. (2004). Mental Health Service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. Journal of Clinical Psychiatry, 65, 28–36.
Zeanah, C. H., Smyke, A. T. & Dumitrescu, A. (2002). Attachment disturbances in young children: II. Indiscriminate behaviour and institutional care. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 983–9.
Zecevic, N. & Verney, C. (1995). Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex. Journal of Comparative Neurology, 351, 509–35.
Zgierska, A., Rabago, D., Zuelsdorff, M., Coe, C., Miller, M. & Fleming, M. (2008). Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. Journal of Addiction Medicine, 2, 165–73.
Zgierska, A., Rabago, D., Chawla, N., Kushner, K., Koehler, R. & Marlatt, A. (2009). Mindfulness meditation for substance use disorders: a systematic review. Substance Abuse, 30, 266–94.
Zhu, S., Melcer, T., Sun, J., Rosbrook, B. & Pierce, J. (2000). Smoking cessation with and without assistance: a population-based analysis. American Journal of Preventive Medicine, 18, 305–11.
Ziedonis, D. M. & Stern, R. (2001). Dual recovery therapy for schizophrenia and substance abuse. Psychiatric Annals, 31, 255–64.
Ziedonis, D., Smelson, D., Rosenthal, R. et al. (2005). Improving the care of individuals with schizophrenia and substance abuse disorders. Journal of Psychiatric Practice, 11, 1–25.
Zipfel, S., Reas, D. L., Thornton, C. et al. (2002). Day hospitalization programs for eating disorders: a systematic review of the literature. International Journal of Eating Disorders, 31, 105–17.
Zitman, F. G. & Couvée, J. E. (2001). Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off. Report on behalf of the Dutch Chronic Benzodiazepine Working Group. British Journal of Psychiatry, 178, 317–24.
Zito, J. M., Safer, D. J. & dosReis, S. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–30.
Zito, J. M., Safer, D. J., dosReis, S. et al. (2003). Psychotropic practice patterns for youth: a 10-year perspective. Archives of Pediatric and Adolescent Medicine, 157, 17–25.
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M. & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–30.
Zuercher, J. N., Cumella, E. J., Woods, B. K., Eberly, M. & Carr, J. K. (2003). Efficacy of voluntary tube feeding in female inpatients with anorexia nervosa. Journal of Parenteral and Enteral Nutrition, 27, 268–76.
Zweifel, J. E. & O’Brien, W. H. (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology, 22(3), 189–212.
Zwerling, C., Sprince, N. L., Wallace, R. B., Davis, C. S., Whitten, P. S. & Heeringa, S. G. (1996). Alcohol and occupational injuries among older workers. Accident Analysis and Prevention, 28, 371–6.